carbapenems has been researched along with Cronobacter Infections in 787 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (0.25) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 36 (4.57) | 29.6817 |
2010's | 599 (76.11) | 24.3611 |
2020's | 150 (19.06) | 2.80 |
Authors | Studies |
---|---|
Cremanns, M; Gatermann, SG; Nockelmann, L; Pfennigwerth, N | 1 |
Coppry, M; Pauquet, E; Rogues, AM; Sarlangue, J | 1 |
Doi, Y; Hosoda, T; Suzuki, M | 1 |
Chang, H; Liu, CP; Sun, FJ; Wang, NY; Wu, AY | 1 |
Jiang, X; Li, G; Shen, P; Tang, Y; Zhang, Y | 1 |
Berglund, B; Bi, Z; Börjesson, S; Chen, B; Nilsson, LE; Nilsson, M; Wang, S; Xiao, Y; Yin, H; Zheng, B | 1 |
Chen, S; Fang, X; Li, J; Liu, Z; Shangguan, S; Shen, J; Shen, Y; Walsh, TR; Wang, Y; Zhang, J; Zhang, R; Zheng, X; Zhou, R | 1 |
Choi, I; Lee, Y | 1 |
Bower, C; Jacob, JT; Sexton, ME | 1 |
Hsueh, PR; Huang, YT; Ko, WC; Kuo, YW; Lee, NY; Liao, CH; Teng, LJ; Tien, N | 1 |
Chen, M; Liu, H; Lyu, J; Qiu, S; Xue, L; Yu, G | 1 |
Amico, G; Conaldi, PG; Douradinha, B; Gruttadauria, S; Iannolo, G; Mularoni, A; Pampalone, M; Pietrosi, G; Vitale, G | 1 |
Abbo, L; Anderson, DJ; Bonomo, RA; Earley, M; Gallagher, JC; Grant, M; Howard-Anderson, JR; Jacob, JT; Kim, A; Komarow, L; Muñoz-Price, LS; van Duin, D | 1 |
Belete, MA; Genet, C; Kibret, M; Mulu, W; Tadesse, S | 1 |
Albrecht, V; Ansari, U; Beldavs, Z; Bower, C; Bulens, SN; Daniels, J; Duffy, N; Dumyati, G; Elkins, CA; Gross, A; Jacob, J; Janelle, S; Kainer, MA; Kallen, AJ; Karlsson, M; Lawsin, A; Lonsway, D; Lutgring, JD; Lynfield, R; McAllister, G; McKay, L; Phipps, EC; Rasheed, JK; Schutz, K; Walters, MS; Wilson, L; Witwer, ML | 1 |
Jin, FL; Lin, BY; Liu, JT | 1 |
Li, Y; Liu, Y; Qin, X; Wang, D; Zhang, Z | 1 |
Abdul Rahman, NB; Aung, MK; Aung, MO; Conceicao, EP; How, MKB; Ko, KKK; Lee, LC; Ling, ML; Sim, JXY; Tan, KY; Venkatachalam, I; Yang, Y | 1 |
Chang, E; Chang, HE; Choe, PG; Choi, EH; Kang, CK; Kim, NJ; Oh, MD; Oh, YR; Park, KU; Park, WB; Shin, IS | 1 |
Bakker, J; de Greeff, SC; Hendrickx, APA; Kuijper, EJ; Notermans, DW; Schoffelen, AF; Schouls, LM; Wielders, CCH; Woudt, SHS | 1 |
Boostrom, I; Criollo, JM; Farzana, R; Guest, MF; Hassan, B; Jones, LS; Kalam, MA; Mathias, J; Parkhill, J; Pervin, M; Portal, E; Rahman, MA; Sands, K; van Tonder, AJ; Walsh, TR; Watkins, WJ | 1 |
Azuma, M; Baba, H; Chikumi, H; Fujikura, Y; Fujita, J; Furuhashi, K; Hamada, Y; Igari, H; Iguchi, M; Ishiguro, N; Iwasaki, H; Kakeya, H; Kanai, S; Kasahara, K; Kato, H; Kawamura, H; Kusama, F; Matsumoto, A; Morioka, H; Nagamori, T; Nagao, M; Nakanishi, M; Nakata, H; Ohge, H; Oka, K; Saito, N; Shimono, N; Takahashi, S; Takajo, I; Tauchi, H; Tetsuka, N; Tokuda, K; Yagi, T | 1 |
Akeda, Y; Hamada, S; Ishihara, T; Kerdsin, A; Laolerd, W; Matsumoto, Y; Motooka, D; Nishi, I; Sakamoto, N; Santanirand, P; Sugawara, Y; Takeuchi, D; Tomono, K; Yamamoto, N | 1 |
Darkoh, C; DeSantis, SM; Fujimoto, K; Mgbere, O; Tadese, BK | 2 |
Al-Bayati, M; Samarasinghe, S | 1 |
Amatya, P; Baker, S; Basnyat, B; Dixit, SM; Dongol, S; Karkey, A; Manandhar, S; Nguyen, Q; Pham, DT; Rabaa, M | 1 |
Cury, AP; David-Neto, E; de Oliveira Garcia, D; Freire, MP; Lima, SG; Nahas, WC; Pea, CRD; Pierrotti, LC; Reusing Junior, JO; Rossi, F; Spadão, F | 1 |
Jeong, IS; Song, JY | 3 |
Henriques, I; Pinto, N; Tacão, M; Teixeira, P | 1 |
Fujita, K; Sugiyama, H; Takashima, H; Takata, I; Yoshida, I | 1 |
Alby, K; Cowden, L; Cressman, L; Dumm, R; Glaser, L; Gross, R; Jaskowiak-Barr, A; Lautenbach, E; Mannathoko, N; Mokomane, M; Mosepele, M; Otukile, D; Paganotti, GM; Reesey, E; Richard-Greenblatt, M; Sewawa, K; Sharma, A; Smith, RM | 1 |
Ahmed, W; Al-Hamzi, MA; Al-Turkistani, HH; Aljishi, Y; Almaghrabi, RS; Alodini, K; Alosaimi, R; Alraddadi, BM; Alshukairi, AN; Alswaiel, R; Althaqafi, A; Anani, M; Attalah, D; Eljaaly, K; Hassan, W; Heaphy, ELG; Hefni, LK; Qutub, MO; Saeedi, MF | 1 |
Gutiérrez-Durán, OA; Hoyos-Pulgarín, JA | 1 |
Gao, XY; Hu, ZD; Li, JY; Mu, L; Wang, H; Wang, JR; Yan, Z; Zheng, WQ | 1 |
Bonnin, RA; Creton, E; Dortet, L; Emeraud, C; Girlich, D; Godmer, A; Jousset, AB; Mahamdi, F; Naas, T; Vanparis, O | 1 |
Abe, R; Akeda, Y; Hamada, S; Iida, T | 1 |
Albrecht, V; Ansari, UA; Bamberg, W; Beldavs, ZG; Bower, CW; Bulens, SN; Carmon, C; Cassidy, PM; Daniels, J; Dumyati, G; Grass, JE; Jacob, JT; Janelle, SJ; Kainer, M; Karlsson, M; Laufer-Halpin, A; Lawsin, A; Lee, YK; Lutgring, JD; Lynfield, R; McAllister, G; Mounsey, JT; Muleta, D; Phipps, EC; Reses, HE; See, I; Shaw, KM; Tsay, R; Vaeth, E; Vagnone, PS; Walters, MS; Wilson, L; Yi, S | 1 |
Bouza, E; Burillo, A | 1 |
Abdala, E; Bartoletti, M; Cescon, M; D Albuquerque, LAC; de Oliveira, TA; Filho, ADPC; Freire, MP; Furtado, M; Giannella, M; Laici, C; Lemos, GT; Maccaro, A; Morelli, MC; Nunes, NN; Pasquini, Z; Rinaldi, M; Siniscalchi, A; Song, ATW; Terrabuio, DRB; Viale, P | 1 |
Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
Anderson, D; Arias, CA; Chen, L; Dai, W; Earley, M; Herc, E; Jacob, JT; Komarow, L; Luterbach, CL; Rydell, KB; Salata, R; Shrestha, R; van Duin, D; Weston, G; Wong, D | 1 |
Chen, X; Jian, Z; Li, H; Liu, W; Yan, Q; Zhou, M | 1 |
Ávila-Nuñez, M; Domínguez-López, C; Filgueira, A; González-Novoa, MC; Lima, O; Martínez-Lamas, L; Pérez-Castro, S; Pérez-Rodríguez, MT; Represa, M; Rubianes, M; Rubiñán, P; Sousa, A | 1 |
Chen, CL; Chen, HY; Chiu, CH; Hsiao, HL; Lee, CC; Tsai, TC; Yen, CS | 1 |
Carp, S; Cernat, RC; Dumitru, A; Dumitru, IM; Mitan, R; Nemet, C; Rugină, S; Vlad, ND; Voidăzan, S | 1 |
Cameron, A; Debnath, A; Dobrzynski, D; Martin, AJ; Pillinger, KE; Shulder, S | 1 |
Cheng, W; Li, L; Li, M; Ma, J; Shen, A; Song, X; Sun, H; Yu, Z; Zhang, W; Zhang, Y | 1 |
Chen, Y; Deng, D; Deng, Q; Deng, S; Gu, J; Guo, L; Ling, B; Wang, Z; Xu, J; Yang, C; Yang, Q; Yuan, W; Zhang, H; Zhang, L | 1 |
Cai, Y; Wang, J; Wang, Y; Xiao, Q; Xu, J; Zhang, H; Zhu, M | 1 |
Chen, X; Jiang, Z; Wen, X; Yan, Q | 1 |
Aboelhega, W; Alon, T; Badaan, S; de Kraker, MEA; Eluk, O; Geffen, Y; Hassoun-Kheir, N; Hussein, K; Karram, M; Paul, M; Peleg, S; Saffuri, M; Warman, S | 1 |
Chen, L; He, XP; Hong, SJ; Hua, J; Jing, RC; Luo, XY; Xue, HW; Yuan, CY; Yue, Y | 1 |
Jian, C; Li, Y; Ni, M; Ning, Q; Song, J; Tian, F; Wang, Y; Yu, B | 1 |
Chalin, A; Francius, L; Gonzalez, C; Legrand, C; Naas, T; Niol, L; Oueslati, S; Simon, S; Vogel, A; Volland, H | 1 |
Fanning, S; Fox, EM; Harding-Crooks, R; Smith, D | 1 |
Deng, Y; Feng, J; He, J; Zhang, J; Zhang, R; Zhao, M | 1 |
Bissong, MEA; Mkong, PB; Mobey, KN; Muma, V | 1 |
Burke, LP; Chueiri, A; Cormican, M; Devane, G; Duane, S; Farrell, ML; Gaze, WH; Hooban, B; Leonard, A; Maguire, M; Miliotis, G; Morris, D; O'Connor, L; Tuohy, A | 1 |
Cao, SS; Cui, B; Cui, F; Cui, J; Fan, BY; Fan, TT; Guan, Y; Ji, B; Li, MY; Li, SR; Wang, JW; Wang, L; Yan, CY; Zhang, W | 1 |
Feng, L; Huang, Z; Lin, Y; Liu, S; Wang, Y; Wang, Z; Yao, Z; Ye, J; Zhou, T | 1 |
Boszczowski, Í; Costa, SF; Cury, AP; Freire, MP; Lázari, CS; Levin, AS; Rossi, F; Salomão, MC; Segurado, AAC | 1 |
Cheng, Q; Dong, X; Hu, S; Jing, H; Wang, J; Xie, W; Zhang, X | 1 |
Boyer, P; Danion, F; Gravet, A; Hansmann, Y; Hoellinger, B; Kaeuffer, C; Lefebvre, N; Robert, A; Ruch, Y; Severac, F; Ursenbach, A | 1 |
Andrew, W; Angela, D; Kedišaletše, M; Mae, NF; Phumuzile, D | 1 |
Aboelhega, W; Alon, T; Badaan, S; Hassoun-Kheir, N; Hussien, K; Karram, M; Paul, M; Peleg, S; Pollak, D; Saffuri, M; Szwarcwort Cohen, M; Warman, S | 1 |
Alsharapy, SA; Bertrand, X; Brasme, L; Cholley, P; De Champs, C; Gharout-Sait, A; Guillard, T; Moghram, GS; Muggeo, A; Touati, A | 1 |
Gupta, V; Lawrence, K; Murray, J; Olesky, M; Ye, G; Yu, K | 1 |
Al-Agamy, MH; El-Mahdy, TS; Poirel, L; Radwan, HH | 1 |
Jeong, SH; Kim, D; Yoon, EJ | 1 |
Apisarnthanarak, A; Juntong, J; Kondo, S; Limpavitayaporn, P; Mahawongkajit, P; Mingmalairak, C; Mundy, LM; Sriussadaporn, E; Tongyoo, A | 1 |
Brown, CA; Codjoe, FS; Donkor, ES; Miller, K; Smith, TJ | 1 |
Cai, Y; Che, H; Wang, J; Wang, R | 1 |
Lee, J; Mills, MC | 1 |
Alfandari, S; Bleibtreu, A; Bru, JP; Chavanet, P; Gauzit, R; Lescure, X; Lesprit, P; Tattevin, P | 1 |
Essack, SY; Feldman, C; Maningi, NE; Mbelle, N; Modipane, L; Osei Sekyere, J | 1 |
Bielecki, JM; Budhram, DR; Mac, S; Patel, SN; Sander, B | 1 |
Alonso Acero, L; Gutiérrez Arroyo, A; Ramos Ramos, JC; Romero Gómez, MP | 1 |
Boutin, S; Dalpke, AH; Heeg, K; Kocer, K; Mutters, NT; Nurjadi, D | 1 |
Fridkin, SK | 1 |
Burnham, CD; D'Souza, AW; Dantas, G; Potter, RF; Wallace, MA; Yarbrough, ML | 1 |
David, SSB; Maor, Y; Schwartz, O; Yossepowitch, O; Zohar, I | 1 |
Ding, Y; Heath, PT; Hsia, Y; Sharland, M; Wang, Y | 1 |
Fauntleroy, KA; Jenkins, SG; Satlin, MJ; Sfeir, MM; Westblade, LF | 1 |
Byun, JH; Chong, Y; Kim, D; Kim, M; Lee, H; Lee, K; Seo, Y; Yong, D | 1 |
Akeda, Y; Chayangsu, S; Chopjitt, P; Deekae, S; Hamada, S; Hatrongjit, R; Kerdsin, A; Takeuchi, D; Tomono, K | 1 |
Cai, C; Li, X; Liu, M; Qian, W; Shen, L; Wang, T; Yang, M; Zhang, J | 1 |
Cheok, SJH; Chew, KL; Heng, ST; Lye, DC; Ng, TM; Ng, WHW; Tambyah, PA; Tan, SH; Wan, S; Wu, JE; Yap, MY; Yong, J | 1 |
Chiotos, K; Gerber, JS; Hayes, M; Tamma, PD | 1 |
Pan, F; Shi, Y; Sun, Y; Tian, D; Wang, B; Wang, C; Zhang, H | 1 |
Anderson, REV; Boerlin, P | 1 |
Baker, S; Barbosa, LS; Boinett, CJ; Croda, J; da Silva, KE; Nguyen, TNT; Simionatto, S; Tetila, A | 1 |
Brown, S; Delano, JP; Iovine, N; Predic, M; Prins, C; Tremblay, E | 1 |
Freire, MP; Levin, ASS; Salomão, MC | 1 |
Antonelli, G; Arcari, G; Beccaccioli, M; Bibbolino, G; Carattoli, A; Di Lella, FM; Faino, L; Mengoni, F | 1 |
Ackley, R; Anderson, WE; Capraro, GA; Meredith, J; Minor, S; Polk, C; Roshdy, D | 1 |
Bamford, C; Bhola, P; Chibabhai, V; Ismail, H; Mbelle, N; Nana, T; Perovic, O; Quan, V; Ramjathan, P; Singh-Moodley, A; Smith, M; Swe Swe-Han, K; Wadula, J; Whitelaw, A | 1 |
Ghafur, A; Krishnan, P; Palani, GS; Rayvathy, B; Thirunarayan, MA | 1 |
Brun-Buisson, C; Carteaux, G; de Prost, N; Decousser, JW; Mekontso Dessap, A; Phan, AD; Razazi, K; Rosman, J; Woerther, PL | 1 |
Bert, F; Dokmak, S; Dondero, F; Durand, F; Francoz, C; Giabicani, M; Grigoresco, B; Janny, S; Khoy-Ear, L; Logre, E; Paugam-Burtz, C; Roux, O; Soubrane, O; Toussaint, A; Weiss, E | 1 |
Craft, DW; England, MR; Hale, CM; Lesher, MD; Myers, DS; Wijetunge, DSS | 1 |
Abbo, LM; Bachman, WC; dePascale, D; Doi, Y; Fennie, K; Fowler, EL; Ibrahimou, B; Jimenez, A; Martinez, O; McElheny, CL; Munoz-Price, LS; Pekovic, V; Perez-Cardona, A; Sposato, K; Trepka, MJ | 1 |
Azzam, ZS; Berger, G; Fried, C; Gerassy-Vainberg, S; Hreish, M; Kashi, Y; Korach-Rechtman, H | 1 |
Kumudunie, WGM; Namalie, KD; Sunil-Chandra, NP; Wijayasinghe, YS; Wijesooriya, LI | 1 |
Bolaris, MA; Estevez, D; Evans, K; Flores, EA; Huang, SS; Launer, B; McKinnell, JA; Miller, LG | 1 |
Khawcharoenporn, T; Laichuthai, W | 1 |
Jeong, J; Kim, GR; Kim, S; Kim, SH; Shin, JH | 1 |
Bobadilla-Del-Valle, M; Caro-Vega, Y; Criollo-Mora, E; Esteban-Kenel, V; Galindo-Fraga, A; Leal-Vega, F; López Luis, BA; Olivas-Martínez, A; Ortiz-Brizuela, E; Ponce-de-León, A; Sifuentes-Osornio, J; Torres-González, P; Torres-Veintimilla, E; Tovar-Calderón, E | 1 |
Borer, A; Kassem, A; Michael, T; Raed, A; Sagi, O; Saidel-Odes, L; Shimoni, O | 1 |
Apisarnthanarak, A; Apisarnthanarak, P | 1 |
Ariza, B; Cortes, G; Gualtero, S; Muñoz-Velandia, O; Niño, A; Porras, Y; Rueda, D; Salgado, D; Valderrama, S; Valencia, M | 1 |
Armstrong, B; Bartlett, AW; McMullan, BJ; Palasanthiran, P; Williams, PCM | 1 |
Dong, L; Li, HY; Li, Z; Lin, XX; Liu, CX; Liu, PN; Ye, WJ | 1 |
Bar-Lavie, Y; Bar-Yoseph, H; Daoud, H; Even Dar, R; Geffen, Y; Hussein, K; Jabareen, A; Korytny, A; Lulu, C; Paul, M; Shklar, S | 1 |
Choi, SH; Chong, YP; Jung, J; Kim, HJ; Kim, MJ; Kim, SH; Kim, YS; Lee, SO; Seo, H; Woo, JH | 1 |
Adler, A; Katz, DE; Marchaim, D | 1 |
Alguacil-Guillén, M; Ara-Montojo, MF; de la Vega, Á; Escosa-García, L; Fernández-Camblor, C; Gómez-Gil, R; Losantos-García, I; Mellado-Peña, MJ; Plaza, D; Ramos-Boluda, E; Romero-Gómez, MP; Ruiz-Carrascoso, G; Schuffelmann-Gutiérrez, C; Seara, N; Zozaya, C | 1 |
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A | 1 |
Chiu, HC; Kao, CY; Tsai, YM; Wang, S; Wen, LL | 1 |
Alabaz, D; Gündeşlioğlu, ÖÖ; Haytoğlu, Z; Horoz, ÖÖ; Kocabaş, E; Yıldızdaş, D | 1 |
Cai, Y; Chung, J; Kwa, ALH; Lay, WQ; Lee, W; Liew, YX; Lim, FK; Teo, JQM | 1 |
Aunins, TR; Chatterjee, A; Erickson, KE | 1 |
Aguado, JM; Cano, Á; Carratalà, J; Clemente, WT; Cohen-Sinai, N; Cordero, E; Coussement, J; David, MD; Eriksson, BM; Fernández-Ruiz, M; Freire, MP; Grossi, PA; Gunseren, F; Gutiérrez-Gutiérrez, B; Hamiyet Demirkaya, M; Iyer, RN; Koçak Tufan, Z; Loeches, B; López-Medrano, F; Martín-Dávila, P; Martínez-Martínez, L; Mehta Steinke, S; Merino, E; Montejo, M; Mularoni, A; Oriol, I; Pascual, Á; Paul, M; Pérez-Nadales, E; Pierrotti, LC; Pilmis, B; Rana, M; Rizzi, M; Rodríguez-Baño, J; Roilides, E; San-Juan, R; Seminari, EM; Soldani, F; Tan, BH; Torre-Cisneros, J; Valerio, M; van Delden, C | 1 |
Aepfelbacher, M; Berinson, B; Berneking, L; Both, A; Hoffmann, A; Lütgehetmann, M; Rohde, H | 1 |
Fujitomo, Y; Hayakawa, K; Ide, S; Ishikane, M; Kaku, M; Kinoshita, N; Kodama, EN; Kusama, Y; Matsunaga, N; Mezaki, K; Nagashima, M; Nakamoto, T; Ohmagari, N; Saito, S; Sugiki, Y; Tajima, T; Toda, Y; Tsuzuki, S | 1 |
Hirabayashi, A; Kajihara, T; Shibayama, K; Sugai, M; Yahara, K | 1 |
Chen, L; Du, H; Huang, B; Jia, W; Qu, F; Shan, B; Tang, Y; Yu, H; Zhang, X | 1 |
Barth, AL; Martins, AS; Volpato, F; Wink, PL; Zavascki, AP | 1 |
Bonnin, RA; Creton, E; Dortet, L; Emeraud, C; Gauthier, L; Girlich, D; Jousset, AB; Jové, T; Naas, T | 1 |
Chang, SC; Chen, FJ; Chen, PY; Chen, YT; Huang, YS; Lauderdale, TL; Li, JJ; Tsai, WC; Wang, JT | 1 |
Abbo, L; Abdala, E; Alagna, L; Aranha Camargo, LF; Asensio, A; Bandera, A; Burra, P; Cescon, M; Fernandes, R; Fernandez Yunquera, A; Ferrarese, A; Franceschini, E; Freire, M; Giannella, M; Graziano, E; Grossi, P; Gruttadauria, S; Halpern, M; Lewis, R; Morelli, MC; Mularoni, A; Muñoz, P; Rinaldi, M; Rubin, A; Santana Girao, E; Shbaklo, N; Simkins, J; Statlender, L; Tandoi, F; Valerio, M; Viale, P; Yahav, D | 1 |
Bermudez-Gonzalez, J; Ginestre, MM; Gomez-Gamboa, L; Perozo-Mena, A; Velasquez, J; Villasmil, J; Villavicencio, C | 1 |
Carevic, B; Carmeli, Y; Cohen-Percia, S; Fallach, N; Frenk, S; Harbarth, S; Hoffman, T; Kariv, Y; Klausner, J; Lellouche, J; Nutman, A; Temkin, E | 1 |
Jeong, IS; Lee, S; Seo, SM; Song, JY | 1 |
Alışkan, HE; Göçmen, JS; Hortaç İştar, E | 1 |
Akatsuchi, T; Aoki, K; Doi, Y; Harada, S; Hayama, B; Ida, K; Ishii, Y; Moriya, K; Ohkushi, D; Okamoto, K; Shoji, D; Takehana, K | 1 |
Al-Tawfiq, JA; Bazzi, AM; Rabaan, AA; Saunar, JV | 1 |
Cantón, R; Cooper, BS; Crellen, T; de la Vega, C; DelaFuente, J; Díaz-Agero, C; Hernández-García, M; León-Sampedro, R; López-Fresneña, N; Musicha, P; Rodríguez-Beltrán, J; Ruiz-Garbajosa, P; San Millán, Á | 1 |
Chee, E; Chlebicki, MP; Kwa, ALH; Tang, SSL; Teo, JQ | 1 |
Hsu, LY; Sharland, M; Thwaites, GE; Turner, RM; Walker, AS; White, IR; White, NJ; Yeo, TW | 1 |
de Haan, A; Hendrickx, APA; Landman, F; Schouls, LM; van Santen-Verheuvel, MG; Witteveen, S | 1 |
Chen, HY; Hsueh, PR; Jean, SS; Ko, WC; Lee, YL; Liu, PY; Lu, MC | 1 |
Bartle, B; Evans, CT; Evans, M; Fitzpatrick, MA; Jones, M; Perencevich, E; Pfeiffer, CD; Rubin, MA; Suda, KJ; Wilson, GM | 1 |
Al-Sweih, NA; Moghnia, OH; Rotimi, VO | 1 |
Davido, B; Delory, T; Gaube, G; Gravier, S; Lafaurie, M; Le Pluart, D; Lepeule, R; Lesprit, P; Piet, E; Simeon, S | 1 |
Boyd, DA; Dingle, T; Hoang, L; Lefebvre, B; Mataseje, LF; McGeer, A; Melano, RG; Mulvey, MR; Stuart, I; Walkty, A; Wilmer, A | 1 |
Glaser, A; Jahangir, A; Mobarakai, N; Sahra, S; Sharif, MA | 1 |
Bai, L; Gao, X; Geng, Y; He, A; Lei, J; Lei, K; Liu, J; Liu, Z; Tang, YW; Tenover, FC | 1 |
Biedron, C; Bunthi, C; Chea, N; Janejai, N; Kolwaite, A; Lyman, M; Paveenkittiporn, W | 1 |
Cao, B; Gu, L; Lu, BH; Ma, LY; Su, JR; Wang, H; Wang, Q; Wang, XJ; Yang, CX; Zhang, AR; Zhang, JG; Zhao, JK; Zhou, CE | 1 |
Bonnin, RA; Cattoir, V; Cotellon, G; Creton, E; Girlich, D; Guerin, F; Iorga, BI; Muntean, AA; Muntean, MM; Naas, T; Oueslati, S; Popa, MI | 1 |
Abe, R; Akeda, Y; Hamada, S; Iida, T; Kawahara, R; Matsumoto, Y; Motooka, D; Sugawara, Y; Tomono, K; Yamamoto, N | 1 |
Tompkins, K; van Duin, D | 1 |
Chen, J; Chu, Y; Jiang, N; Li, F; Nian, H; Tian, S; Wang, R | 1 |
Arakawa, Y; Hayashi, M; Jin, W; Kawamura, K; Kimura, K; Matsuo, N; Nonogaki, R; Ogawa, M; Sarangi, J; Suzuki, M; Tamai, K; Wachino, JI; Yagi, T | 1 |
Abdalhamid, B; Al Musawi, S; Aljaroodi, SA; Aljindan, RY; Alkharsah, KR; AlShammari, L; Itbaileh, A; Mohammed, H; Saeed, N; Ur Rahman, J | 1 |
Dai, W; Huang, YL; Hung, YP; Ko, WC; Lin, TC; Lin, WT | 1 |
Bao, J; Ding, M; Du, G; Gu, B; Guo, L; Kang, H; Ma, Y; Wang, C; Zhou, Y | 1 |
Cai, Y; Liang, B; Wang, J; Zhang, H | 1 |
Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH | 1 |
Livermore, DM; Mushtaq, S; Vickers, A; Woodford, N | 1 |
Avcıküçük, H; Kaşkatepe, B; Öztürk, Ş; Yıldız, SS | 1 |
Bonten, MJ; Bravo-Ferrer, J; Cuperus, N; Daikos, G; de Kraker, M; Feifel, J; Folgori, L; Goossens, H; Gutiérrez-Gutiérrez, B; Kostyanev, T; O'Brien, S; Pascual, A; Raka, L; Rodríguez-Baño, J; Sojo-Dorado, J | 1 |
Logan, LK; Weinstein, RA | 1 |
Fan, W; Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD | 1 |
Bonomo, RA; Donskey, CJ; El Chakhtoura, NG; Patel, S; Perez, F; Saade, E; Wilson, BM | 1 |
Barba, MJ; Barbeyto, LP; Bou, G; Gómara, M; Oviaño, M; Revillo, MJ | 1 |
Khan, AU; Maryam, L; Zarrilli, R | 1 |
Cherng, BPZ; Choon, RFK; De, PP; Deepak, RN; Fisher, D; Hsu, LY; Khong, WX; Koh, TH; Krishnan, PU; Kurup, A; Lam, CW; Lee, JJ; Lin, RTP; Ling, ML; Marimuthu, K; Ng, OT; Ong, RT; Ooi, ST; Pada, SK; Peng, BAS; Sim, NTW; Smitasin, N; Tan, EL; Tan, TY; Teo, J; Teo, YY; Thoon, KC; Van La, M; Venkatachalam, I; Young, B | 1 |
Bias, T; Biason, K; El-Beyrouty, C; Gallagher, JC; Gardner, J; Harrington, N; Heil, E; Hiles, J; Huang, V; King, M; Kuriakose, S; McCoy, D; Richards, L | 1 |
Alikhani, MY; Aslani, MM; Bahador, A; Karimitabar, Z; Mahmoudi, H; Shahcheraghi, F; Solgi, H | 1 |
Acikgoz, O; Aktas, E; Cizmeci, Z; Ordekci, S; Otlu, B | 1 |
Alizadeh, M; Blanco, R; Bledsoe, CG; Buchanan, CM; Hickey, CL; Hoj, TR; Husseini, GA; McClellan, DS; Pitt, WG; Ravsten, TV; Robison, RA; Wood, ME; Wood, RL | 1 |
Bauraing, C; Berhin, C; Bogaerts, P; Glupczynski, Y; Hoebeke, M; Huang, TD | 1 |
Falagas, ME; Kofteridis, DP; Maraki, S; Mavromanolaki, VE; Perdikis, D; Samonis, G; Vardakas, KZ | 1 |
Capone, A; Carattoli, A; D'Arezzo, S; Di Caro, A; Fortini, D; Nisii, C; Petrosillo, N; Venditti, C; Villa, L; Vulcano, A | 1 |
Lodise, T; Ye, MJ; Zhao, Q | 1 |
Narvaez, GA; Perez, LRR | 1 |
Pilmis, B; Timsit, JF; Zahar, JR | 1 |
Bassetti, M; Carnelutti, A; Peghin, M; Righi, E | 1 |
Abdala, E; Akova, M; Álvarez, R; Cano, A; Carratalà, J; Cervera, C; Clemente, WT; Freifeld, A; Gómez, L; Gottlieb, T; Gudiol, C; Gurguí, M; Herrera, F; Maestro-de la Calle, G; Manzur, A; Martín-Dávila, P; Maschmeyer, G; Meije, Y; Montejo, M; Peghin, M; Rodríguez-Baño, J; Royo-Cebrecos, C; Ruiz-Camps, I; Sukiennik, TC; Tebe, C | 1 |
Kłoczko, J; Majewski, P; Ojdana, D; Sacha, P; Sieńko, A; Tryniszewska, E; Wieczorek, P; Łapuć, I | 1 |
Doumith, M; Findlay, J; Godoy, D; Gronthoud, F; Hopkins, KL; Meunier, D; Perry, C; Pike, R; Poirel, L; Shryane, T; Welfare, W; Woodford, N | 1 |
Blaylock, M; Browne, A; Clagon, S; DeBiasi, R; Dockery, B; Donegan, N; Hansen, K; Harmon, K; Harris, JE; Hooker, J; Iyengar, P; Jernigan, G; Kumar, P; Little, G; McFadden, M; Mirdamadi, J; Nelson, JA; Reuben, J; Sinatro, B; Song, X; Wagner, T; Walker, M; White, D; Wortmann, G; Yochelson, M | 1 |
Barrios, H; Bocanegra-Ibarias, P; Garza-González, E; Garza-Ramos, U; Morfín-Otero, R; Petersen-Morfin, S; Rodríguez-Noriega, E; Silva-Sanchez, J; Villarreal-Treviño, L | 1 |
Aminzadeh, Z; Badmasti, F; Giske, CG; Havaei, SA; Pourahmad, M; Shahcheraghi, F; Solgi, H; Vaziri, F | 1 |
Aburajab, M; Ballard, DD; Dua, A; Dua, KS; Graham, MB; Khan, AH; Ledeboer, NA; Saeian, K; Smith, ZL | 1 |
Chang, J; Gohil, SK; Gombosev, A; Huang, SS; Singh, R; Steger, P; Tjoa, T; Zahn, M | 1 |
Allouache, M; Bachiri, T; Bakour, S; Belkebla, N; Lalaoui, R; Rolain, JM; Touati, A | 1 |
Apichai, S; Chua, D; Macareo, LR; Navarro, FC; Nogrado, K; Peacock, T; Sirigade, R; Swierczewski, B; Valderama, MT; Velasco, JM; Warawadee, N | 1 |
Bogaerts, P; Bonnin, RA; Bouchahrouf, W; de Bolle, X; Dortet, L; Evrard, S; Glupczynski, Y; Huang, TD; Jove, T; Naas, T; Saegeman, V; Schuermans, A; Tande, D | 1 |
Hu, YY; Huang, L; Zhang, R | 1 |
Grys, TE; Kohli, DR; Pannala, R | 1 |
Guo, X; Han, L; Sun, J; Wang, X; Xie, L; Zhang, F; Zheng, Q | 1 |
Altshuler, J; Fedorenko, M; Kim, SA; Paris, D | 1 |
Bilker, WB; Chiotos, K; Flett, KB; Han, JH; Karandikar, MV; Naumann, M; Tamma, PD; Zaoutis, T | 1 |
Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Gasch, O; Giamarellou, H; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hernández, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Molina Gil-Bermejo, J; Oliver, A; Palacios-Baena, ZR; Paño-Pardo, JR; Pascual, Á; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Souli, M; Tacconelli, E; Torre-Cisneros, J; Tumbarello, M; Venditti, M; Viale, P | 1 |
Bonten, MJM; Bootsma, MCJ; Dautzenberg, MJD; Derde, LPG; Gniadkowski, M; Gurieva, T | 1 |
Gomez-Simmonds, A; McConville, TH; Sullivan, SB; Uhlemann, AC; Whittier, S | 1 |
Bahr, G; Bethel, CR; Bonomo, RA; González, LJ; Vila, AJ; Vitor-Horen, L | 1 |
van Loon, K; Voor In 't Holt, AF; Vos, MC | 1 |
Abbo, LM; Bonomo, RA; Camargo, JF; Hujer, AM; Martinez, O; Perez, F; Perez-Cardona, A; Rojas, LJ; Rosa, R; Rudin, SD | 1 |
Arena, F; Fani, L; Frullini, A; Laureano, R; Mannini, D; Meini, S; Passaleva, MT; Ripoli, A; Roberts, AT; Rossolini, GM; Sbrana, F; Tascini, C | 1 |
Bush, K; Kashikar, A; Zhang, Y | 1 |
Bhaurla, S; Epson, E; Hershey, C; Hindler, JA; Horwich-Scholefield, S; Humphries, RM; Marquez, P; Martinez, JB; McKinnell, JA; Mendez, J; Miller, LG; Moran, M; Pandes, L; Sinkowitz, J; Sinkowtiz, D; Terashita, D | 1 |
Davies, M; Hayashi, W; Hobson, J; Koide, S; Kubo, R; Nagano, N; Nagano, Y; Ohsaki, Y; Osaka, S; Taniguchi, Y | 1 |
Feng, Y; McNally, A; Yang, B; Zong, Z | 1 |
Bonomo, RA; Burd, EM; Conly, J; Limbago, BM; Poirel, L; Segre, JA; Westblade, LF | 1 |
Barth, AL; da Silva, AEB; Magagnin, CM; Martins, AF; Nodari, CS | 1 |
Adler, A; Shalom, O | 1 |
Cai, J; Cao, B; Chen, H; Gu, B; Guo, Z; Hu, T; Huang, J; Huang, W; Jia, X; Jin, L; Li, B; Li, H; Li, W; Liao, K; Liu, L; Ma, X; Man, S; Pei, F; Tian, J; Wang, H; Wang, Q; Wang, S; Wen, H; Xie, L; Yang, C; Yang, H; Yin, Y; Zhang, L; Zhang, X; Zhang, Y; Zou, C | 1 |
Hawken, SE; Newton, DW; Snitkin, ES; Washer, LL; Williams, CL | 1 |
Bland, CM; Chastain, DB; Cretella, DA; White, BP | 1 |
Adler, A; Ben-David, D; Carmeli, Y; Masarwa, S; Rubinovitch, B; Schwaber, MJ; Schwartz, D; Solter, E; Temkin, E | 1 |
Fukuda, N; Fukuda, S; Kida, K; Kimura, K; Kita, M; Kofuku, T; Komatsu, M; Kuchibiro, T; Mizutani, T; Nakai, I; Nakamura, A; Nakamura, T; Niki, M; Nishi, I; Nishio, H; Ohama, M; Ono, T; Orita, T; Satoh, K; Sawa, K; Shimura, S; Sueyoshi, N; Toda, H; Wada, Y; Watari, H; Yamasaki, K | 1 |
Bracher, S; Ciesielczuk, H; Davies, F; Donaldson, H; Ellington, MJ; Hawkey, PM; Irani, PM; Lancaster, O; Mushtaq, S; Rao, GG; Stone, GG; Verma, A; Wareham, DW; Woodford, N; Wu, HHT; Xu-McCrae, L | 1 |
Akamatsu, N; Hasegawa, H; Kaku, N; Kawamoto, Y; Kosai, K; Matsuda, J; Morinaga, Y; Uno, N; Yamakawa, H; Yanagihara, K | 1 |
Bolehovska, R; Chudejova, K; Habalova, K; Hobzova, L; Hrabak, J; Kukla, R; Medvecky, M; Papagiannitsis, CC; Pliskova, L; Zemlickova, H | 1 |
Boyd, DA; Fuller, J; Haldane, D; Hoang, L; Lefebvre, B; Mataseje, LF; Melano, RG; Mulvey, MR; Poutanen, S; Van Caeseele, P | 1 |
Bonomo, RA; Correa, A; De La Cadena, E; Hernández-Gómez, C; Muñoz, JS; Pallares, C; Perez, F; Rojas, LJ; Villegas, MV | 1 |
Akeda, Y; Aoki, K; Harada, S; Iida, T; Ishii, Y; Iwata, S; Moriya, K; Motooka, D; Nakamura, S; Tateda, K; Tomono, K; Yahara, K | 1 |
Bonnin, RA; Cotellon, G; Creton, E; Gauthier, L; Muntean, AA; Muntean, MM; Naas, T; Popa, MI | 1 |
Béchet, S; Biscardi, S; Bonacorsi, S; Cixous, E; Cohen, R; Craiu, I; Dubos, F; Galerne, A; Grimprel, E; Hees, L; Hentgen, V; Jung, C; Levy, C; Lorrot, M; Madhi, F; Timsit, S | 1 |
Al-Agamy, MH; Amin, MA; ElMahallawy, HA; Ragab, MM; Zafer, MM | 1 |
Alfandari, S; Bertrand, X; Dumartin, C; Gauzit, R; Gbaguidi-Haore, H; Muller, A; Péfau, M; Rogues, AM | 1 |
Eumkeb, G; Evans, K; Hobbs, G; Nakouti, I; Teethaisong, Y | 2 |
Del Bianco, F; Farabegoli, P; Morotti, M; Pedna, MF; Sambri, V | 1 |
Angoulvant, F; Bontemps, S; Cohen, R; Dessein, R; Dubos, F; Lagree, M; Madhi, F; Martinot, A | 1 |
Jeong, SH; Kim, JO; Lee, H; Lee, KJ; Yang, JW; Yoon, EJ | 1 |
Bado, I; Caiata, L; Cordeiro, N; García-Fulgueiras, V; Outeda, M; Papa-Ezdra, R; Seija, V; Vignoli, R | 1 |
Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Mikamo, H; Nishiyama, N; Sakanashi, D; Suematsu, H; Yamagishi, Y | 1 |
Bartsch, SM; Huang, SS; Lee, BY; McKinnell, JA; Miller, LG; Mueller, LE; Wong, KF | 1 |
Balloux, F; Bradley, P; Didelot, X; Dorai-Schneiders, T; Iqbal, Z; Jin, L; Liu, Y; Rieux, A; Shaw, LP; van Dorp, L; Wang, H; Wang, Q; Wang, R; Wang, X; Weinert, LA; Zhang, Q | 1 |
Bertrand, X; Bouiller, K; Bouxom, H; Fournier, D; Hocquet, D | 1 |
Abdul, W; Grigoriu, A; Smoke, SM; Vasant, D | 1 |
Barguellil, F; Ben Helal, R; Ben Moussa, M; Chedly, M; Dziri, R; El Asli, MS; Klibi, N | 1 |
Brown, AC; Capers, C; Cardo, DM; Craig, M; Edwards, J; Huang, JY; Kainer, MA; Kallen, AJ; Mahon, G; Malik, S; McDonald, LC; Patel, J; Paul, P; Shugart, A; Slayton, RB; Srinivasan, A; Walters, MS; Weiner, LM; Wilde, N; Woodworth, KR | 1 |
Bowman, AS; Daniels, JB; Feicht, SM; Mathys, DA; Mollenkopf, DF; Stull, JW; Wittum, TE | 1 |
Al-Kaabneh, A; Al-Maayteh, M; Alzoubi, H; Aqel, AA; Ellington, MJ; Findlay, J; Hopkins, KL; Masalha, I; Turton, J; Woodford, N | 1 |
Akeda, Y; Asada, R; Hagiya, H; Kawahara, R; Nishi, I; Shanmugakani, RK; Tomono, K; Ueda, A; Yamamoto, N; Yoshida, H | 1 |
Argaud, L; Azoulay, É; Bailly, S; Barbier, F; Darmon, M; de Montmollin, É; Goldgran-Toledano, D; Kallel, H; Marcotte, G; Misset, B; Mourvillier, B; Papazian, L; Reignier, J; Schwebel, C; Siami, S; Souweine, B; Timsit, JF; Zahar, JR | 1 |
Dai, E; Duan, X; Fang, H; Feng, J; Gao, B; Luo, Y; Tong, Y; Wang, J; Xu, Y; Yin, Z; Zhan, Z; Zhang, Y; Zhou, D | 1 |
Ebihara, Y; Imai, K; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Sakai, J; Taji, Y; Tarumoto, N; Watanabe, N; Yamaguchi, T | 1 |
Balkenende, EC; Blevins, AE; Chorazy, ML; Khader, K; Livorsi, DJ; Nair, R; Nelson, RE; Perencevich, EN; Samore, MH; Schweizer, ML | 1 |
Deenen, R; Kaasch, AJ; Köhrer, K; Kolbe-Busch, S; MacKenzie, CR; Meyer, S; Pfeffer, K; Wendel, AF; Willmann, M | 1 |
Chai, LYA; Chee, YL; Chng, WJ; Hsu, LY; Jin, J; Khoo, AL; Koh, LP; Lim, BP; Lim, SE; Poon, LM; Teng, M; Ying, D; Zhao, YJ | 1 |
Li, Y; Liu, J; Liu, Y; Shen, L; Yu, J; Zhu, W | 1 |
Choi, JK; Joo, EJ; Ko, JH; Lee, NR; Moon, SY; Park, DA; Peck, KR; Son, SK | 1 |
Avril, C; Belmonte, O; Benoit-Cattin, T; Bertrand, X; Bonnin, RA; Cholley, P; de Montera, AM; Dortet, L; Filleul, L; Hocquet, D; Jaffar-Bandjee, MC; Leclaire, A; Lugagne, N; Martak, D; Miltgen, G; Naas, T; Roquebert, B; Subiros, M; Thouverez, M; Traversier, N | 1 |
Annavajhala, MK; Giddins, MJ; Gomez-Simmonds, A; Hu, Y; Macesic, N; O'Malley, A; Torres, VJ; Toussaint, NC; Uhlemann, AC; Wang, Z; Whittier, S | 1 |
Eiamphungporn, W; Hiranphan, M; Phuadraksa, T; Thamlikitkul, V; Tiengrim, S; Yainoy, S | 1 |
Bercot, B; Bidet, P; Birgy, A; Bonacorsi, S; Caméléna, F; Cointe, A; Decré, D; Doit, C; Dortet, L; Hobson, C; Mathy, V; Monjault, A; Podglajen, I | 1 |
Baraniak, A; Gniadkowski, M; Gospodarek-Komkowska, E; Hryniewicz, W; Izdebski, R; Sekowska, A; Zabicka, D | 1 |
Lambourne McCulloch, I; Mullens, CL; Sarwari, AR; Shreve, J; Ueno, CM | 1 |
Aoki, W; Ariyoshi, T; Funakoshi, T; Hasegawa, N; Iwata, S; Kubota, H; Kuroda, M; Matsui, M; Murata, M; Okuno, R; Sadamasu, K; Sekizuka, T; Shinkai, T; Suzuki, S; Suzuki, Y; Uchitani, Y; Uwamino, Y; Yokoyama, K | 1 |
Büchler, AC; Egli, A; Gehringer, C; Tschudin-Sutter, S; Widmer, AF | 1 |
Guo, Q; Hu, F; Li, Y; Su, J; Wang, M; Wu, S; Xu, S | 1 |
Bathoorn, E; Becher, D; Bonn, F; de Jong, A; Grasso, S; Nepal, S; Otto, A; Rosema, S; Rossen, JW; Stobernack, T; van Dijl, JM; Wedema, R; Zhou, K | 1 |
Ha, K; Iregui, A; Landman, D; Meleney, K; Quale, J | 1 |
Brannigan, ET; Davies, F; Dyakova, E; Holmes, AH; Knight, GM; Mookerjee, S; Otter, JA | 1 |
Federico, MP; Furtado, GH | 1 |
Bao, M; Fu, Y; Gong, X; Su, S; Wang, Y; Zhang, J; Zhang, X | 1 |
Beader, N; Bedenić, B; Bielen, L; Franolić, I; Lukić-Grlić, A; Meštrović, T; Mihaljević, S; Zarfel, G | 1 |
Bae, IK; Lee, CH; Lee, JH | 1 |
Simner, PJ; Tamma, PD | 1 |
Bedenić, B; Bertoncelli, A; Centonze, AR; Mazzariol, A; Orza, P; Savio, C | 1 |
Doi, Y; Hill, JE; Hirsch, EB; Kane, KR; Kossmann, SE; Lewis, AE; Nasir, M; Rees, CA; Sezer, O; Smolinska, A; Zucchi, PC | 1 |
Alizadeh, N; Barhaghi, MHS; Ghotaslou, R; Hasani, A; Kafil, HS; Memar, MY; Milani, M; Rezaee, MA | 1 |
Ang, MLT; Chan, DSG; Lin, RTP; Ong, CH; Ratnayake, L | 1 |
Chen, L; Daniels, JB; Grooters, SV; Kreiswirth, BN; Mathys, DA; Mollenkopf, DF; Pancholi, P; Wittum, TE | 1 |
Bonnin, RA; Dortet, L; Gauthier, L; Golse, N; Jousset, AB; Mihaila, L; Naas, T | 1 |
Yoo, JH | 1 |
Fujita, J; Kirikae, T; Nakasone, I; Shimada, K; Tada, T; Uechi, K | 1 |
Godreuil, S; Hantova, S; Jean-Pierre, H; Jumas-Bilak, E; Laurens, C; Licznar-Fajardo, P; Martinez, O | 1 |
Andrawus, ER; Bar-Yoseph, H; Cohen, N; Even Dar, R; Geffen, Y; Hussein, K; Korytny, A; Paul, M | 1 |
Ito, A; Kobayashi, K; Mitsuboshi, S; Nakashita, M; Takahashi, S; Tsugita, M; Tsuruma, N; Watanabe, K | 1 |
Albornoz, E; Biondi, E; Corso, A; Faccone, D; Gomez, S; Melano, RG; Pasterán, F; Tijet, N; Vazquez, M | 1 |
Goossens, H; Kostyanev, T; Lammens, C; Timbermont, L; Van't Veen, A; Vilken, T | 1 |
Goneau, L; Jarvis, M; Matukas, L; Romaschin, A; Tadros, M | 1 |
Cao, B; Chen, H; Gu, B; Ji, P; Jin, C; Jin, L; Jin, Y; Li, W; Liao, K; Liu, Z; Ma, X; Man, S; Ouyang, P; Pei, F; Wang, H; Wang, J; Wang, Q; Wang, R; Wang, X; Wang, Z; Xie, L; Xu, X; Yang, C; Zhang, F; Zhang, X; Zhang, Y | 1 |
Bayet, M; Benvenuti, M; Bougnon, J; Bousquet, J; Castandet, J; Cerboni, G; Coelho, A; Cramp, MC; Davies, DT; De Luca, F; Docquier, JD; Everett, M; Jennings, N; Jones, MW; Juventhala, RR; Leiris, S; Lemonnier, M; Lozano, C; Mangani, S; Pallin, TD; Pattipati, R; Pothukanuri, S; Pottabathini, N; Pozzi, C; Raphy, G; Shankar, B; Sivasubrahmanyam, R; Soodhagani, AK; Sprynski, N; Zalacain, M | 1 |
Kanlidere, Z; Karatuna, O; Kocagöz, T | 1 |
Dona', D; Ellis, S; Heath, P; Sharland, M; Standing, JF; Thomas, R; Velaphi, S; Walker, AS | 1 |
Ertis, DH; Jessup, A; Sertkaya, A; Wong, HH | 1 |
Martínez-Martínez, L | 1 |
Aboklaish, AF; Böttger, EC; Cao, S; Crich, D; Ercan, O; Hobbie, SN; Hughes, D; Huseby, DL; Juhas, M; Petersson, A; Polikanov, YS; Rominski, A; Teo, J; Tyrrell, JM; Walsh, TR; Widlake, E | 1 |
Barrios-Camacho, H; Bocanegra-Ibarias, P; Duran-Bedolla, J; Garza-González, E; Garza-Ramos, U; Hernández-Castro, R; Lozano, L; Morfín-Otero, R; Silva-Sanchez, J | 1 |
Chastain, DB; Patel, S; Tsui, J; White, BP | 1 |
Anacker, M; Horn, ME; Houseman, J; Johnson, TJ; Kline, S; Lynfield, R; Pereira, EC; Vagnone, PS; Witwer, M | 1 |
Huang, M; Liang, Q; Xu, Z; Yan, C | 1 |
Barth, AL; de Lima-Morales, D; Gomes Dias, CA; Mott, MP; Paim, TG; Raro, OHF; Riche, CVW; Teixeira, UF; Waechter, FL | 1 |
Benzerara, Y; Compain, F; Constant, AL; Gallah, S; Garnier, M; Guerot, E; Labbe, V; Mainardi, JL; Montil, M; Quesnel, C; Siami, S; Vimont, S | 1 |
Egli, A; Emmanuel Martinez, A; Frei, R; Marsch, S; Pargger, H; Tschudin-Sutter, S; Tuchscherer, D; Widmer, A | 1 |
Beresford, RW; Maley, M | 1 |
Hamilton, F; Laurenson, IF; Russell, CD; Templeton, K; Toner, G | 1 |
Cai, Y; Chang, CW; Koh, TH; Kwa, AL; Leck, H; Lee, SJ; Ong, RT; Tan, TT; Tang, CY; Teo, JQ | 1 |
Doi, Y; Harris, PNA; Paterson, DL; Peri, AM; Potoski, BA; Righi, E | 1 |
Cosgrove, SE; Gadala, A; Goodman, KE; Kazmi, AQ; Klein, EY; Levin, S; Maragakis, LL; Milstone, AM; Rock, C; Simner, PJ; Tamma, PD; Toerper, MF | 1 |
Bartsch, SM; Cao, C; Gussin, GM; Huang, SS; Kim, DS; Lee, BY; McKinnell, JA; Miller, LG; Mueller, LE; Wong, KF | 1 |
Jia, X; Li, S; Liu, H; Sun, S; Wang, Y; Xia, Y; Zou, H | 1 |
Gutiérrez-Gutiérrez, B; Rodríguez-Baño, J | 1 |
Bonomo, RA; Perez, F | 2 |
Abi Hanna, P; Aliyu, S; Allignol, A; Alvarez-Moreno, C; Arora, A; Bagga, R; Barman, P; Bhattarai, B; Carvalho, MJ; Correa, AL; Delgado-Ramirez, MA; El-Banna, T; El-Bouseary, M; Feghali, R; Harbarth, S; Hassan, B; Iregbu, K; Kanj, SS; Kaur, A; Khanal, B; Le, TAT; Marimuthu, K; Munera, MI; Ovosi, JO; Owusu-Ofori, AK; Phukan, C; Saad, H; Saha, SK; Saleemi, MA; Sengupta, S; Sharma, L; Stewardson, AJ; Tran, TTN; Uddin, J; Uwaezuoke, NS; Valderrama-Beltrán, SL; Walsh, TR; Zahra, R | 1 |
Lutgring, JD | 1 |
Bhattacharya, S; Chandy, M; Das, S; Goel, G; Mukherjee, S; Roy, S; Walia, K | 1 |
Leelakanok, N; Soontaros, S | 1 |
Arcadipane, A; Arena, G; Campanella, O; Conaldi, PG; Douradinha, B; Gioè, S; Gridelli, B; Grossi, P; Gruttadauria, S; Hazen, B; Luca, A; Martucci, G; Medaglia, A; Mularoni, A; Tuzzolino, F | 1 |
Kirby, T | 1 |
Aung, MY; Kirikae, T; Kuwahara-Arai, K; Mya, S; Tada, T; Tin, HH; Tohya, M; Watanabe, S; Zan, KN; Zaw, NN; Zin, KN | 1 |
Amoah, J; Bergman, Y; Ekunseitan, E; Goodman, KE; Kazmi, A; Simner, PJ; Tamma, PD | 1 |
Cusack, TP; Dance, DAB; Duangmala, K; Hopkins, KL; Phan, HTT; Phimolsarnnousith, V; Phoumin, P; Shetty, N; Stoesser, N; Turton, J; Woodford, N | 1 |
Aoyagi, T; Ishibashi, N; Kaku, M; Kitagawa, M; Kunishima, H; Oka, K; Takahashi, M; Takemura, H; Wada, K; Yamasaki, Y | 1 |
Amudhan, M; Kalyanaraman, N; Lallitha, S; Mythreyee, M; Sekar, R; Srivani, S; Thenmozhi, P | 1 |
Antony, N; Antony, S; Chowdhury, O; Heydemann, J; Isaac, D; Khan, I | 1 |
Epson, E; Horwich-Scholefield, S; Rizzo, K | 1 |
Bonomo, RA; Cober, E; Doi, Y; Evans, S; Fowler, VG; Harris, A; Henderson, H; Kalayjian, RC; Kaye, KS; Luterbach, CL; Napravnik, S; Richter, SS; Salata, RA; Van Duin, D; Watkins, RR | 1 |
Barth, AL; Dalmolin, TV; Inamine, E; Martins, AS; Wink, PL | 1 |
Gatermann, SG; Marschal, M; Pfennigwerth, N; Schauer, J | 1 |
Boyd, S; Dubendris, H; Gable, P; Greene, S; Kornegay, R; MacFarquhar, J; Walters, M | 1 |
Boyer, A; Cockenpot, T; Dubois, V; Gruson, D; Lasheras, A; M'Zali, F; Prevel, R | 1 |
Ang, MLT; Chan, DSG; Chan, YFZ; Chan, YK; Cherng, BPZ; De, PP; Deepak, RN; Fong, RKC; Harbarth, S; Hsu, LY; Huan, X; Koh, TH; Krishnan, PU; Kwa, ALH; Lin, RTP; Marimuthu, K; Ng, OT; Ooi, ST; Pada, SK; Paterson, DL; Perencevich, E; Sengupta, S; Smitasin, N; Tan, TY; Tee, NWS; Teo, J; Thoon, KC; Venkatachalam, I; Zaw Linn, K | 1 |
Patel, V; Rodriguez, C; Singhal, T; Soman, R; Trivedi, M | 1 |
Assous, MV; Bdolah-Abram, T; Lachish, T; Wiener-Well, Y; Yinnon, AM; Zimmerman, FS | 1 |
García, P; Gutiérrez, C; Labarca, J; Moraga, M; Román, JC; Sanhueza, F; Wozniak, A | 1 |
Azar, R; Belausov, N; Ben-David, D; Castanheira, M; Gal-Mor, O; Gefen-Halevi, S; Hindiyeh, MY; Keller, N; Mendelson, E; Rahav, G; Smollan, G; Tal, I | 1 |
Carattoli, A | 1 |
Bao, Q; Chi, W; Guo, M; Lu, Y; Ye, J; Zhang, X; Zhou, T | 1 |
Perez, F; Van Duin, D | 1 |
Berhin, C; Bogaerts, P; Glupczynski, Y; Huang, TD | 1 |
Ang, B; Jureen, R; Krishnan, P; La, MV; Lin, RTP; Teo, JWP | 1 |
Douthwaite, S; Gonzalez-Zorn, B; Gutierrez, B; Hidalgo, L; Hopkins, KL; Ovejero, CM; Prasad, KN; Shukla, S; Woodford, N | 1 |
Castanheira, M; Deshpande, LM; Farrell, SE; Jones, RN; Mendes, RE | 1 |
Badal, RE; Hsueh, PR; Sheng, WH | 1 |
Kuehn, BM | 1 |
Blanco, VM; Camargo, RD; Correa, A; De La Cadena, E; Maya, JJ; Quinn, JP; Rojas, LJ; Villegas, MV | 1 |
Barrios, H; Camacho-Ortiz, A; Garza-Gonzalez, E; Garza-Ramos, U; Guzmán-López, S; Llaca-Diaz, JM; Reyna-Flores, F; Rojas-Moreno, T; Sanchez-Perez, A; Silva-Sanchez, J | 1 |
Albert, MJ; Jamal, W; Khodakhast, F; Nordmann, P; Poirel, L; Rotimi, VO | 1 |
Abreu-Lanfranco, O; Bheemreddy, S; Dhar, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Martin, ET; Mynatt, RP; Pogue, JM; Sunkara, B; Zhao, JJ | 1 |
Carroll, KC; Perl, TM; Savard, P; Wilson, LE | 1 |
Bonomo, RA; Watkins, RR | 1 |
Murray, PR | 1 |
Hsueh, PR; Ko, WC; Lee, CC; Lee, NY; Li, CW | 1 |
Aitken, SL; Altshuler, J; Arias, CA; Esaian, D; Guervil, D; Papadopoulos, J | 1 |
Baquero, F; Cantón, R; Coque, TM; Curiao, T; Gijón, D; Morosini, MI; Pintado, V; Ruiz-Garbajosa, P; Tato, M; Valverde, A | 1 |
Ede, N; Gungi, A; Solanki, R; Soory, A; Vanjari, L; Vemu, L | 1 |
Munoz-Price, LS; Quinn, JP | 1 |
Cunliffe, NA; Drew, RJ; Hill, RL; Livermore, DM; Paulus, S; Turton, JF; Woodford, N | 1 |
Blanco, VM; Gotuzzo, E; Guzman-Blanco, M; Labarca, J; Maya, JJ; Quinn, JP; Ruiz, SJ; Salles, M; Villegas, MV | 1 |
Bogan, C; Marchaim, D | 1 |
Nordmann, P; Poirel, L; Potron, A; Rondinaud, E | 1 |
Henderson, DK; Palmore, TN | 2 |
Pal, A; Tripathi, A | 1 |
Cascio, GL; Lleo, MM; Mazzariol, A; Soldani, F | 1 |
Shorr, AF; Zilberberg, MD | 1 |
Krogfelt, KA; Newman, MJ; Obeng-Nkrumah, N; Twum-Danso, K | 1 |
Andremont, A; Gottlieb, T; Grayson, L; Johnson, J; Kluytmans, J; Mehtar, S; Price, L; Wegener, HC | 1 |
Guerra, B; Teale, C; Wareham, DW; Woodford, N | 1 |
Ahmad, F; Bheemreddy, S; Chaudhry, A; Chopra, T; Kaye, KS; Lee, J; Marchaim, D; Mudegowdra, NS; Pogue, JM | 1 |
Burgess, DS; Lawson, KA; Lee, GC | 1 |
Hu, F; Qin, X; Yang, Y; Zhu, D | 1 |
Cuzon, G; Dortet, L; Nordmann, P | 1 |
Chan, JF; Chen, JH; Cheng, VC; Ho, PL; Kwan, GS; Tai, JW; To, KK; Tse, H; Wong, SC; Yan, MK; Yuen, KY | 1 |
Carmeli, Y; Schwaber, MJ | 2 |
West, K | 1 |
Andremont, A; Armand-Lefèvre, L; Birgand, G; Lolom, I; Lucet, JC; Neulier, C; Ruppé, É; Yazdanpanah, Y | 1 |
Carneiro, M; de Souza, JG; Gonçalves, RA; Krummenauer, EC; Machado, JA; Pina Trench, FJ; Teixeira, CB; Waib, LF | 1 |
Basu, S; Datta, S; Mitra, S; Saha, A; Viswanathan, R | 1 |
Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE | 1 |
Powell, S; Raich, TJ | 1 |
Jung, S; Kim, J; Kim, JS; Kim, SI; Lee, JY; Park, KG; Park, YJ; Song, W; Yu, JK | 1 |
Chen, R; Chen, Y; Guo, L; Han, L; Han, X; Luo, Y; Tian, S; Yang, J; Ye, L; Zhao, J; Zhao, Q | 1 |
Chen, Y; Guo, L; Guo, S; Han, L; Luo, Y; Song, Y; Sun, G; Yang, J; Ye, L; Zhou, G | 1 |
Boucher, HW; Johnson, K | 1 |
Jenkins, SG; Satlin, MJ; Walsh, TJ | 1 |
Altun Uludağ, H; Boral, B; Ergin, A; Eser, OK; Hasçelik, G; Sener, B | 1 |
Hurst, H; Landry, J | 1 |
AbdulRahman, EM; El-Rachidi, NG; Hassan, DM; Helal, SF | 1 |
Boehme, M; Brennan, BM; Buckley, BO; Coyle, JR; Finks, J; Kaye, KS; Malani, AN; Marchaim, D; Mollon, N; Pogue, JM; Sundin, DR; VerLee, KE; Washer, LL | 1 |
Arao, RF; Beldavs, ZG; Buser, GL; Cunningham, MC; Furuno, JP; Leitz, A; Pfeiffer, CD; Poissant, T; Thomas, A; Townes, JM | 1 |
Bolon, MK; Fitzpatrick, M; Malczynski, M; Qi, C; Zembower, T | 1 |
Harper, JE; Kallen, AJ; Limbago, BM; Lynfield, R; Pereira, EC; Shaw, KM; Vagnone, PM | 1 |
Beekmann, SE; Drekonja, DM; Elliott, S; Mukundan, D; Polenakovik, H; Polgreen, PM; Rosenthal, ME; Tamma, PD; Weissman, SJ | 1 |
Campos, J; DeBiasi, R; Dirajlal-Fargo, S; Song, X | 1 |
Alfieri, N; Conly, J; Gregson, D; Hope, K; Kamhuka, L; Lam-Li, D; Ledgerwood, D; Louie, T; Pearce, C; Peirano, G; Pidhorney, C; Pitout, J; Rajapakse, N; Rees, G; Vayalumkal, J | 1 |
Harper, JE; Lynfield, R; Shaw, KM; Vagnone, PS | 1 |
Baghdady, N; Ferraro, MJ; Galar, A; Guzmán-Suarez, BB; Hooper, DC; Kubiak, DW; Marty, FM; O'Brien, TF; Siedner, MJ | 1 |
Anders, A; Gatermann, SG; Kaase, M; Szabados, F | 1 |
Guh, AY; Kallen, AJ; Limbago, BM | 1 |
Betts, JW; Hornsey, M; Phee, LM; Wareham, DW; Woodford, N | 1 |
Lortholary, O; Parize, P; Pilmis, B; Zahar, JR | 1 |
Andrasevic, AT; Butic, I; Goic-Barisic, I; Jelic, M; Novak, A; Radic, M; Rubic, Z; Tonkic, M | 1 |
Baud, FJ; Deye, N; Marcadé, G; Mégarbane, B; Raskine, L; Rousseau, H; Vicaut, E; Vodovar, D | 1 |
Cao, B; Chen, H; Gao, H; Li, H; Liu, Y; Wang, H; Zhang, J | 1 |
Li, B; Lin, J; Liu, MB; Wu, J; Xu, XH; Zhao, ZC | 1 |
Feng, X; Fu, Y; Li, Y; Liu, HM; Qi, H; Qin, S; Rong, L; Shan, L; Tian, H; Wen, JG; Xu, H; Xu, L; Yu, Y; Zeng, L; Zhang, Q | 1 |
Barth, AL; da Silva, RC; Dalarosa, MG; Falci, DR; Luz, DI; Magagnin, CM; Ribeiro, VB; Rozales, FP; Sampaio, JM; Vieira, FJ; Zavascki, AP | 1 |
Bheemreddy, S; Bogan, C; Bonomo, RA; Chopra, T; Hayakawa, K; Kaye, KS; Lazarovitch, T; Lephart, PR; Marchaim, D; Perez, F; Pogue, JM; Zaidenstein, R | 1 |
Hall, RM; Harmer, CJ | 1 |
Chen, Y; Cimino, JJ; Dekker, JP; DeLeo, J; Drake, SK; Frank, KM; Garfield, MK; Gucek, M; Lau, AF; Stock, F; Suffredini, AF; Tso, H; Wang, H; Weingarten, RA; Youn, JH | 1 |
Stock, I | 1 |
Adler, A; Ben-David, D; Carmeli, Y; Masarwa, S; Mishali, H; Schwaber, MJ | 1 |
Cox, HL; Enfield, KB; Gosseling, MF; Hazen, KC; Huq, NN; Kundzins, JR; Lewis, JD; Low, DJ; Mathers, AJ; Sifri, CD; Slitt, G; Toney, DM; Zapata, HJ | 1 |
Falagas, ME; Karageorgopoulos, DE; Tansarli, GS; Vardakas, KZ | 1 |
Aras, S; Aydın, S; Aygün, G; Balkan, II; Kara, Z; Kuşkucu, M; Mete, B; Midilli, K; Mutcalı, SI; Özaras, R; Öztürk, R; Saltoğlu, N; Şemen, V; Tabak, F; Yemişen, M | 1 |
Bigot, S; Bouldouyre, MA; Bukreyeva, I; Ceci, JM; Daroukh, A; Delaunay, C; Maisonneuve, L; Porcheret, H; Raisin, J; Siddhoun, N | 1 |
Anderson, DJ; Chen, LF; Fowler, VG; Hazen, KC; Huslage, K; Jones, CD; Lewis, SS; Moehring, RW; Moore, ZS; Sexton, DJ; Thaden, JT | 1 |
Beldavs, ZG; Pfeiffer, CD | 1 |
Pop-Vicas, AE; Yamamoto, M | 1 |
Bard, JD; Cerini, C; Pannaraj, PS; Weissman, SJ | 1 |
Almeida, AC; de Castro, KK; de Morais, MM; Fehlberg, LC; Gales, AC; Vilela, MA | 1 |
Feng, JA; Hsieh, WS; Wang, NY; Weng, LC; Wu, HH | 1 |
Barišić, I; Hirschl, AM; Mitteregger, D; Noehammer, C; Wiesinger-Mayr, H | 1 |
Harris-Brown, TM; Havers, SM; Paterson, DL; Rogers, BA | 1 |
Adler, A; Carmeli, Y; Lerner, A; Temkin, E | 1 |
Carvalho, M; Hindler, J; Humphries, RM; Miller, S; Pollett, S; Uslan, D | 1 |
Falagas, ME; Rafailidis, PI | 1 |
Ajbani, K; Drego, L; Kazi, M; Nikam, C; Rodrigues, C; Shetty, A; Soman, R | 1 |
Rutala, WA; Weber, DJ | 3 |
Arwady, MA; Avillan, JJ; Black, S; Conover, C; Conway, J; Epstein, L; Frias, M; Gribogiannis, M; Guh, AY; Hunter, JC; Kallen, AJ; Kitchel, B; Laufer, AS; Limbago, BM; Lonsway, D; MacCannell, D; Moulton-Meissner, H; Noble-Wang, J; Pacilli, M; Rasheed, JK; Stein, L; Tsai, V; Vernon, M | 1 |
Dal Forno, NL; Hörner, R; Meneghetti, BH; Righi, RA; Salla, A; Seibert, G | 1 |
Chen, Z; Li, L; Sun, Z; Tian, L; Wang, Y; Yan, S; Zhang, B; Zhu, X | 1 |
Kiratisin, P; Netikul, T; Paterson, D; Sidjabat, H | 1 |
Barbarini, D; Brovarone, F; Capatti, C; Carretto, E; Colla, R; Moro, ML; Perilli, M; Russello, G | 1 |
Asakura, T; Ikeda, M; Kodera, S; Nakamura, A | 1 |
Ahn, S; Han, WD; Kim, ES; Kim, HB; Kim, NH; Kim, TS; Park, KU; Seo, HK; Shin, MJ; Song, KH; Yoo, JS | 1 |
Lowman, W; Schleicher, G | 1 |
Chukwuma, U; Clifford, RJ; Julius, MD; Kwak, YI; Lesho, EP; Maneval, M; McGann, P; Neumann, C; Nielsen, LE; Waterman, PE; Xie, S | 1 |
Miró, JM; Pascual, Á; Pintado, V; Rodríguez-Baño, J | 1 |
González-López, JJ; Martínez-Martínez, L | 1 |
Almirante, B; López-Cerero, L | 1 |
Miró, E; Navarro, F; Oteo, J; Pérez-Vázquez, M | 1 |
Bou, G; Castillo, FJ; Seral, C; Vila, J | 1 |
Cantón, R; Canut, A; Morosini, MI; Oliver, A | 1 |
Paño Pardo, JR; Pintado, V; Ramos Ramos, JC; Serrano Villar, S | 1 |
Cisneros, JM; Gudiol, C; Martínez, JA; Rodríguez-Baño, J | 1 |
Fariñas, MC; Horcajada, JP; Peña, C; Torre-Cisneros, J | 1 |
Asensio, Á; Cantero, M; Shaw, E; Vergara-López, S | 1 |
Ding, B; Guo, Q; Hu, F; Huang, J; Wang, M; Yang, Y | 1 |
Giske, CG; Tängdén, T | 1 |
Arend, LN; Pilonetto, M; Siebra, Cde A; Tuon, FF | 1 |
Avdic, E; Cosgrove, SE; Han, JH; Harris, AD; Hsu, AJ; Lautenbach, E; Rock, C; Tamma, PD | 1 |
Fu, Y; Xie, W; Xu, M; Zhou, H; Zhou, J | 1 |
Bai, KJ; Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW | 1 |
Daitch, V; Farbman, L; Lador, A; Leibovici, L; Paul, M; Tredler, Z; Zusman, O | 1 |
Doi, Y; Paterson, DL | 1 |
Mattke, S | 1 |
Ambretti, S; Bartoletti, M; Callea, E; Cavalli, M; Cristini, F; De Palma, A; Giannella, M; Gibertoni, C; Lewis, RE; Masina, R; Moro, ML; Mosci, D; Puggioli, MC; Tedeschi, S; Tumietto, F; Venturi, S; Viale, P | 1 |
Binford, LE; Carrico, RM; Guinn, BE; Kelley, RR; Mattingly, WA; Peyrani, P; Ramirez, JA; Wiemken, TL | 1 |
Chang, SC; Chen, MC; Hsu, LY; Lauderdale, TL; Li, SY; Wang, JT; Wu, UI | 1 |
Bart, Y; Eluk, O; Geffen, Y; Hussein, K; Paul, M; Rabino, G | 1 |
Bourgault, AM; Boyd, D; Doualla-Bell, F; Lefebvre, B; Lévesque, S; Mataseje, L; Mulvey, MR; Tremblay, C | 1 |
Kim, HK; Kim, MN; Park, JS; Sung, H | 1 |
Angebault, C; Bourhis, JH; Chachaty, E; de Botton, S; Gachot, B; Micol, JB; Pasquier, F; Pilorge, S; Woerther, PL | 1 |
Alves, Cde F; Asensi, MD; Carvalho-Assef, AP; de Almeida, R; de Souza, Mda P; Faria, C; Marques, Ede A; Pereira, PS; Tavares, CP | 1 |
Chow, DC; Fryszczyn, B; Hu, L; Nordmann, P; Palzkill, T; Poirel, L; Prasad, BV; Sankaran, B; Stojanoski, V | 1 |
Gangcuangco, LM; Saul, ZK | 1 |
Ciola, CS; da Silva, CB; da Silva, IG; de Araújo, MR; Doi, AM; Koga, PC; Martino, MD; Massaia, IF; Pasternak, J | 1 |
Andleeb, S; Burnham, CA; Dantas, G; Hussain, T; Pesesky, MW; Wallace, M; Wang, B | 1 |
Azouri, T; Bathina, P; Kandipalli, D; Kaplansky, T; Kaye, KS; Lazarovitch, T; Marchaim, D; Maskit, M; Ofer-Friedman, H; Sharma, S; Shefler, C; Tal-Jasper, R; Tirosh, A; Zaidenstein, R | 1 |
Du, X; Fang, L; Fu, Y; Shen, Y; Yang, Q; Yu, Y | 1 |
Demir, Y; Karaoglan, I; Zer, Y | 1 |
Corvalán, V; Hervé, B; Munizaga, R; Salas, A | 1 |
Chen, L; Kopacz, J; Kreiswirth, BN; Labaze, G; LaBombardi, VJ; Osorio, G; Segal-Maurer, S; Urban, CM | 1 |
Al-Abri, SS; Al-Jardani, A; Ghazawi, AA; Hashmey, R; Jamal, W; Pál, T; Rotimi, VO; Shibl, AM; Sonnevend, Á; Tariq, WU; Weber, S | 1 |
Fedorowsky, R; Liberman, D; Lipkin, V; Masarwa, S; Peles-Bortz, A; Rubinovitch, B | 1 |
Bachmann, TT; Gibb, AP; Henihan, G; Huang, JM; Macdonald, D; Michalowski, A; Schulze, H; Templeton, K | 1 |
Castanheira, M; Farrell, DJ; Flamm, RK; Jones, RN; Mendes, RE; Sader, HS | 1 |
Albano, E; Allard, M; Bry, L; Delaney, M; Dubois, A; Li, C; Li, N; Onderdonk, AB; Pecora, ND | 1 |
Deutsch, RF; Nailor, MD; Ross, JW | 1 |
Feng, X; Lang, S; Liu, C; Liu, HM; Liu, X; Qin, S; Xu, H; Xu, L; Zhao, D | 1 |
Bamberg, WM; Bulens, SN; Chea, N; Concannon, C; Culbreath, K; Dumyati, G; Guh, AY; Janelle, SJ; Kainer, MA; Kallen, AJ; Kongphet-Tran, T; Limbago, B; Lynfield, R; Muleta, DB; Phipps, EC; Shaw, KM; Vaeth, E; Vagnone, PS; Wilson, L | 1 |
Avdic, E; Carroll, KC; Cosgrove, SE; Hsu, AJ; Milstone, AM; Tamma, PD; Vilasoa, M | 1 |
Delory, T; Emirian, A; Groh, M; Lecuyer, H; Lesprit, P; Pilmis, B; Weiss, E; Zahar, JR | 1 |
Dekker, JP; Drake, SK; Frank, KM; Lau, AF; Weingarten, RA; Youn, JH | 1 |
Nabarro, LE; Veeraraghavan, B | 1 |
Cercenado, E | 1 |
Gilsanz, F; Maseda, E; Salgado, P | 1 |
Ackerman, B; Amity, K; Azouri, T; Bogan, C; Bonomo, RA; Coyle, JR; Hayakawa, K; Kaplansky, T; Kaye, KS; Lazarovitch, T; Lephart, PR; Marchaim, D; Maskit, M; Ofer-Friedman, H; Perez, F; Tal-Jasper, R; Zaidenstein, R | 1 |
Arwady, MA; Cheng-Leidig, R; Driscoll, M; Gao, W; Lin, MY; Runningdeer, E; Tang, AS; Trick, WE; Weinstein, RA | 1 |
Kiratisin, P; Netikul, T | 1 |
Chang, CM; Chen, PL; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC | 1 |
Rodrigues Perez, LR | 1 |
Bobadilla-Del Valle, M; Cervera-Hernandez, ME; Cruz-Hervert, LP; Galindo-Fraga, A; García-García, L; Leal-Vega, F; Martinez-Gamboa, A; Niembro-Ortega, MD; Ponce-de-Leon, A; Sifuentes-Osornio, J; Torres-Gonzalez, P | 1 |
Hayden, MK | 1 |
Bamberg, WM; Beldavs, Z; Bulens, SN; Cassidy, PM; Concannon, C; Cunningham, M; Dumyati, G; Guh, AY; Jacob, JT; Janelle, SJ; Kallen, AJ; Kenslow, N; Limbago, BM; Lonsway, D; Lynfield, R; Mu, Y; Phipps, EC; Rasheed, JK; Reno, J; Scott, J; Shaw, KM; Travis, T; Vaeth, E; Vagnone, PM; Wilson, LE | 1 |
Akin, D; Dilek, AR; Ozdas, S; Sahin, K; Sonmez, E; Tekin, A; Yapislar, H | 1 |
Appannanavar, SB; Hallur, V; Mohan, B; Sandhu, HK; Singh, G; Taneja, N | 1 |
Butić, I; Cornaglia, G; Crnek, SŠ; Gužvinec, M; Kocsis, E; Krešić, S; Mazzariol, A; Tambić, A | 1 |
Gandra, S; Laxminarayan, R; Logan, LK; Renschler, JP; Weinstein, RA | 1 |
Johnson, SW; Miller, BM | 1 |
Alfandari, S; Bedos, JP; Bru, JP; Gauzit, R; Pean, Y; Rabaud, C; Robert, J | 1 |
Almario, CV; Gupta, K; Jamil, LH; Lo, SK; May, FP; Murthy, R; Shaheen, NJ; Spiegel, BM | 1 |
Goodman, KE; Milstone, AM; Simner, PJ; Tamma, PD | 1 |
Abdile, AA; Doi, Y; Harris, PN; Huh, K; Huxley, RR; O'Neal, CS; Pandeya, N; Paterson, DL; Paynter, S; Shen, AW; Talbot, TR; Wei, JY | 1 |
Bagattini, M; Del Franco, M; Galotto, C; Giacomazzi, CG; Montanera, PG; Novati, R; Paone, L; Triassi, M; Zarrilli, R | 1 |
Bartels, M; Bercker, S; Hau, HM; Kaisers, UX; Lübbert, C; Mischnik, A; Mössner, J; Rodloff, A | 1 |
Aguilar, L; Gilsanz, F; Gimenez, MJ; Maseda, E | 1 |
Giardina, R; Haley, VB; Hazamy, PA; Knab, R; Lutterloh, E; Mayer, CL; Tsivitis, M | 1 |
Feng, Y; Huang, L; Wang, X; Xie, L; Xie, Y; Zong, Z | 1 |
Betts, JW; Momin, MH; Phee, LM; Shah, R; Wareham, DW | 1 |
Chan, R; Chapin, KC; Cunha, CB; Kassakian, SZ; Mermel, LA; Tenover, FC; Ziakas, P | 1 |
Kallen, A; Limbago, B; Lonsway, D; Lyman, M; Rasheed, K; Walters, M | 1 |
Aharon, I; Brodsky, D; Isakovich, N; Koifman, A; Labay, K; Mizrahi, H; Pastukh, N; Peretz, A | 1 |
Barbier, F; Boulain, T; Bret, L; Guigon, A; Guinard, J; Poignant, S; Poisson, DM | 1 |
Albiger, B; Glasner, C; Grundmann, H; Monnet, DL; Struelens, MJ | 1 |
El-Defrawy, I; Fernández-Martínez, M; Gamal, D; Martínez-Martínez, L; Montes, LÁ; Ocampo-Sosa, AA; Salem, D | 1 |
Ang, B; Chia, G; Fong, PB; Kum, JQ; Marimuthu, K | 1 |
Buckeridge, DL; Fontela, PS; Fortin, É; Platt, RW; Quach, C | 1 |
Adler, A; Baraniak, A; Bonten, MJ; Brun-Buisson, C; Carmeli, Y; Derde, LP; Fiett, J; Gniadkowski, M; Goossens, H; Herda, M; Hryniewicz, W; Izdebski, R | 1 |
Limbago, BM; Lutgring, JD | 1 |
Cheng, VC; Cheung, YY; Chow, KH; Ho, PL; Lai, EL; Lo, WU; Wang, Y | 1 |
Balicer, RD; Ben-Yosef, E; Ciobotaro, P; Flaks-Manov, N; Hoshen, M; Oved, M; Schattner, A; Zimhony, O | 1 |
Barbier, F; Clec'h, C; Darmon, M; Dumenil, AS; Essaied, W; Garrouste-Orgeas, M; Laurent, V; Lemiale, V; Lucet, JC; Marcotte, G; Mourvillier, B; Pommier, C; Ruckly, S; Schwebel, C; Souweine, B; Timsit, JF; Zahar, JR | 1 |
Borlaug, G; Kram, JJ; Safdar, N; Sethi, A | 1 |
Endimiani, A; Luzzaro, F; Pires, J; Thomas, B; Tinguely, R | 1 |
Cui, L; Lu, J; Zhao, J | 1 |
Berrio, I; Castro, B; Maldonado, N; Manjarrés, M; Robledo, C; Robledo, J | 1 |
Chavda, KD; Chen, L; Du, H; Kreiswirth, BN; Pandey, R; Tang, YW; Xie, X; Zhang, H | 1 |
Chen, L; Chwa, S; Kopacz, J; Kreiswirth, BN; Labaze, G; LaBombardi, VJ; Osorio, G; Pan, CX; Platis, D; Pollack, S; Prasad, N; Russo, D; Segal-Maurer, S; Urban, C | 1 |
Bonomo, RA; El Chakhtoura, NG; Papp-Wallace, KM; Perez, F; Wilson, BM | 1 |
Chi, K; Naryzhny, I; Silas, D | 1 |
Babouee Flury, B; Doumith, M; Ellington, MJ; Frei, R; Hinic, V; Hopkins, KL; Loy, R; Staves, P; Turton, JF; Woodford, N | 1 |
Altindis, M; Aydemir, ÖA; Erdem, AF; Karabay, O; Karatuna, O; Koroglu, M | 1 |
Bartsch, SM; Cao, C; Huang, SS; Jernigan, JA; Kallen, AJ; Kim, DS; Lee, BY; McKinnell, JA; Miller, LG; Slayton, RB; Wong, KF | 1 |
de Avila, RA; Safdar, N; Tischendorf, J | 1 |
Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; García-Vázquez, E; Gasch, O; Giamarellou, H; Gracia-Ahulfinger, I; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P | 1 |
Rimawi, RH | 1 |
Cui, J; Han, Y; Liu, J; Liu, Y; Ni, W; Wang, R; Wei, C; Zhao, J | 1 |
Hemarajata, P; Humphries, R; Kim, S; Makker, J; Mohamadnejad, M; Muthusamy, VR; Rubin, Z; Russell, D; Sedarat, A; Watson, RR; Yang, S | 1 |
Absar, MM; Abukhalid, N; Garaween, GA; Senok, AC; Somily, AM | 1 |
Dortet, L; Fusaro, M; Naas, T | 1 |
Albert, MJ; Jamal, WY; Rotimi, VO | 1 |
Lodise, TP; Martirosov, DM | 1 |
Matsumura, Y; Pitout, JD | 1 |
Livermore, DM; Mushtaq, S; Warner, M; Woodford, N | 1 |
Aksu, N; Baran, I | 1 |
Estes, LL; Narayanan, PP; Patel, R; Rivera, CG | 1 |
Anson, LW; Cox, HL; Crook, DW; Giess, A; Grim, CJ; Kasarskis, A; Mathers, AJ; Pankhurst, LJ; Peto, TE; Sebra, R; Sheppard, AE; Sifri, CD; Stoesser, N; Vaughan, A; Walker, AS; Wilson, DJ; Yeh, AJ | 1 |
Bruzzese, E; Colombo, S; Cursi, L; de Martino, M; Esposito, S; Galli, L; Lo Vecchio, A; Loy, A; Montagnani, C; Prato, M; Scolfaro, C; Tagliabue, C; Vuerich, M | 1 |
Gomez-Simmonds, A; Hu, Y; Sullivan, SB; Uhlemann, AC; Wang, Z; Whittier, S | 1 |
Bitterman, R; Eluk, O; Geffen, Y; Greenblatt, AS; Hussein, K; Neuberger, A; Paul, M; Rabino, G; Reisner, SA; Warman, S | 1 |
Bootsma, HJ; de Greeff, SC; Frakking, FN; Frentz, D; Haenen, A; Leenstra, T; Notermans, DW; Vlek, AL | 1 |
Chang, CL; Huang, LF; Lee, CT; Su, LH | 1 |
Abushaheen, A; Garbati, MA; Sakkijha, H | 1 |
Altindis, M; Demiray, T; Koroglu, M; Ozbek, A | 1 |
Abboud, CS; Barbosa, V; Dantas, D; Fonseca, MJ; Jacobs, DM; Kiffer, C; Monteiro, J; Pignatari, AC; Rao, GG; Sousa, EE; Stryjewski, ME; Zandonadi, EC | 1 |
Assaf, SM; Kanafani, ZA; Kanj, SS; Kmeid, J; Nawar, T; Zahreddine, N | 1 |
Bedenić, B; Bošnjak, Z; Frančula-Zaninović, S; Grisold, A; Krilanović, M; Lukić-Grlić, A; Luxner, J; Mareković, I; Sardelić, S; Šijak, D; Varda-Brkić, D; Zarfel, G | 1 |
Farrell, A; O'Horo, JC; Safdar, N; Sohail, MR | 1 |
Bueno, MF; Cury, AP; David Neto, E; de Faro, LB; de Oliveira Garcia, D; de Paula, FJ; Di Gioia, TS; Francisco, GR; Freire, MP; Levin, AS; Nahas, WC; Pierrotti, LC; Piovesan, AC; Rossi, F; Spadão, F; Tomaz, M | 1 |
Andreassen, S; Dickstein, Y; Geffen, Y; Leibovici, L; Paul, M | 1 |
Castanheira, M; Jones, RN; Mendes, RE; Sader, HS | 1 |
Baumann, B; Fischer, J; Friese, A; Guerra, B; Helmuth, R; Irrgang, A; Roesler, U; Roschanski, N; San José, M; Schmoger, S | 1 |
Chanawong, A; Charoensri, N; Lulitanond, A; Piyapatthanakul, S; Srisrattakarn, A; Supajeen, A; Wilailuckana, C; Wonglakorn, L | 1 |
Antony, SJ; Cameron, C; Mody, R; Parikh, MS; Soto, E | 1 |
Burgers, PC; Dekker, LJ; Goessens, WH; Kostzrewa, M; Luider, TM; Monteferrante, CG; Peer, M; Sparbier, K; Sultan, S; Ten Kate, MT | 1 |
Bar-Yoseph, H; Braun, E; Hussein, K; Paul, M | 1 |
Chen, W; He, Q; Huang, L; Li, B; Lin, Q; Liu, R; Zhang, J | 1 |
Mathers, A | 1 |
Boucher, A; Boussekey, N; Chiche, A; Delannoy, PY; Georges, H; Leroy, O; Meybeck, A; Patoz, P; Thellier, D; Valette, M | 1 |
Ayora, M; Famiglietti, Á; García, S; Nastro, M; Rodriguez, CH; Vay, C | 1 |
Humphries, RM; Miller, S | 1 |
Andrade Bastos, LQ; Andrade Bastos, VQ; Bastos, AN; Bastos, RV; Da Silva, VL; Dias, VC; Diniz, CG; Ferreira-Machado, AB; Pereira, RS; Resende, JA | 1 |
Betts, J; Liakopoulos, A; Mevius, D; Oikonomou, O; Phee, LM; Wareham, DW | 1 |
Bar-Lavie, Y; Dickstein, Y; Dror, T; Edelman, R; Hussein, K; Paul, M | 1 |
Cao, B; Chen, H; Li, H; Liu, Y; Wang, H; Wang, Q; Wang, R; Wang, X; Xian, H; Yao, X; Zhang, Y; Zhao, C | 1 |
Askin, G; Chen, L; Cohen, N; Gedrimaite, Z; Kreiswirth, BN; Ma, KC; Satlin, MJ; Seo, SK; Soave, R; Walsh, TJ | 1 |
Jia, N; Li, YN; Xu, C; Zhao, H; Zhao, JY; Zhu, YQ | 1 |
Abboud, CS; Barbosa, VL; Bianco, AC; Borges, LS; Braz, A; Cortez, D; de Souza, EE; Miglioli, L; Monaco, FC; Monteiro, J; Zandonadi, EC | 1 |
Deng, AM; Huang, Y; Li, JQ; Lü, KY; Tang, CQ; Wang, H; Xia, ZF; Xiao, SC | 1 |
Bobadilla-Del Valle, M; Cervera-Hernandez, ME; Martínez-Gamboa, A; Ortiz-Brizuela, E; Ponce-de-Leon, A; Sifuentes-Osornio, J; Torres-González, P | 1 |
Hirai, J; Mikamo, H; Yamagishi, Y | 1 |
Chew, KL; Lin, RT; Teo, JW | 1 |
Avery, BP; Boyd, D; Daignault, D; Desruisseau, A; Irwin, RJ; Janecko, N; Martz, SL; Mulvey, MR; Reid-Smith, RJ | 1 |
Fernández, J; Fernández-Suárez, J; Rodicio, MR; Rodríguez-Lucas, C; Vazquez, F | 1 |
Gong, JM; Pan, J; Shen, Y; Xiao, WQ; Xu, QX | 1 |
Bartsch, SM; Huang, SS; Jernigan, JA; Kazmierczak, K; Lee, BY; McKinnell, JA; Mueller, LE; Sahm, DF; Slayton, RB; Wong, KF | 1 |
Akova, M; Metan, G | 1 |
Bassetti, M; Pecori, D; Peghin, M | 1 |
Borlaug, G; Davis, JP; Elbadawi, LI; Gulvik, CA; Gundlach, KM; Kallen, A; Monson, T; Walters, MS; Warshauer, D | 1 |
Abdesselam, K; Amaratunga, K; Boyd, DA; Bryce, E; Embree, J; Gravel, D; Katz, K; Kibsey, P; Langley, J; Mataseje, LF; Mitchel, R; Mulvey, MR; Roscoe, D; Simor, AE; Taylor, G; Turgeon, N; Vachon, J | 1 |
Bamford, C; Du Plessis, A; Eley, B; Malande, OO; Rip, D | 1 |
Martínez, JA | 1 |
Bartsch, SM; Gohil, SK; Huang, SS; Lee, BY; McKinnell, JA; Miller, LG; Mueller, LE | 1 |
Bhattacharya, MK; Chowdhury, G; Ghosh, A; Mukhopadhyay, AK; Pazhani, GP; Rajendran, K; Ramamurthy, T; Sarkar, A | 1 |
Ashby, JP; Awad-El-Kariem, FM; Balakrishnan, I; Brown, D; Chadwick, PR; Coia, J; Cubbon, M; Donaldson, H; Doughton, M; Doughton, R; Hardiman, F; Harvey, G; Hopkins, KL; Horner, C; Lee, J; Lewis, J; Loughrey, A; Mallard, K; Manuel, R; Meunier, D; Parsons, H; Perry, JD; Pike, R; Shetty, N; Trepanier, P; Vanstone, G; White, G; Wiuff, C; Woodford, N | 1 |
Britz, E; Chetty, V; Perovic, O; Singh-Moodley, A | 1 |
Fu, Y; Liu, R; Pan, Z; Zhang, P; Zhou, H; Zhou, J | 1 |
Aguirre-Quiñonero, A; Martínez-Martínez, L | 1 |
Apisarnthanarak, A; Ghafur, A; Hsu, LY; Khan, E; Suwantarat, N; Tambyah, PA | 1 |
Beldavs, ZG; Buser, GL; Cassidy, PM; Morey, KE; Myers, JA; Pfeiffer, CD; Rayar, JK; Vega, R; Weissman, SJ | 1 |
Camargo, CH; Costa, SF; de Maio Carrilho, CM; de Oliveira, LM; Gaudereto, J; Grion, CM; Levin, AS; Perozin, JS; Urbano, MR | 1 |
D'Souza, AW; Dantas, G; Potter, RF | 1 |
Da Silva, G; Mendo, S; Ramalheira, E; Santos, C | 1 |
Eser, OK; Ilbay, A; Metan, G; Unal, S; Zarakolu, P | 1 |
Adams, MD; Bonomo, RA; Brinkac, L; Chavda, KD; Chen, L; Fouts, DE; Jenkins, SG; Kreiswirth, BN; Sutton, G | 1 |
Badolato, E; Bamberg, WM; de Man, T; Halpin, A; Janelle, SJ; Kallen, A; Knutsen, J; Limbago, B; Walters, M; Xavier, K | 1 |
Jeyaseelan, V; Mathew, G; Nabarro, LEB; Pragasam, AK; Shankar, C; Veeraraghavan, B; Verghese, VP | 1 |
Abdala, E; Bonazzi, PR; Camargo, CH; Costa, SF; de Oliveira, LM; DʼAlbuquerque, LA; Freire, MP; Oshiro, IC; Pierrotti, LC; Rossi, F; Song, AT; van der Heijden, IM | 1 |
Goodman, KE; Harris, AD; Roberts, A; Simner, PJ; Taiwo, A; Tamma, PD; Tekle, T | 1 |
Dobashi, H; Imataki, O; Kadowaki, N; Kuwahara, T; Matsuka, H; Mori, H; Nakayama-Imaohji, H; Ohue, Y; Uchida, S; Uemura, M | 1 |
Birren, BW; Cerqueira, GC; Chapman, SB; Cosimi, LA; Dekker, JP; Delaney, ML; Earl, AM; Ernst, CM; Feldgarden, M; Ferraro, MJ; Grad, YH; Hanage, WP; Hooper, DC; Huang, SS; Hung, DT; Kim, D; Kirby, JE; Murphy, CI; O'Brien, TF; Onderdonk, AB; Peterson, EM; Reis-Cunha, JL; Shea, TP; Wortman, JR; Young, S; Zeng, Q | 1 |
Endo, S; Kaku, M; Kasahara, K; Mikasa, K; Mizuno, F; Nakano, A; Nakano, R; Ogawa, Y; Saito, K; Suzuki, Y; Yano, H; Yonekawa, S | 1 |
Janse van Rensburg, S; Lekalakala, MR; Mbelle, N; Tshisevhe, VS; Tshuma, N | 1 |
Doi, Y; Fang, Y; Huang, X; Lei, L; Li, HY; Liu, JH; Ren, H; Shen, J; Shen, Y; Shen, Z; Tian, GB; Tyrrell, JM; Walsh, TR; Wang, S; Wang, Y; Wu, C; Zeng, KJ; Zhang, R; Zhong, LL; Zhou, H | 1 |
Detsis, M; Karanika, S; Mylonakis, E | 1 |
Bajolet, O; Barbe, C; Brasme, L; De Champs, C; Guillard, T; Limelette, A; Muggeo, A; Thierry, A; Vernet-Garnier, V | 1 |
Ahmed, AM; Hara, T; Ikeda, M; Kayama, S; Khalifa, HO; Kuroo, Y; Shimamoto, T; Soliman, AM; Sugai, M | 1 |
Doumith, M; Findlay, J; Hill, R; Hopkins, KL; Livermore, DM; Loy, R; Meunier, D; Mustafa, N; Pike, R; Woodford, N | 1 |
Cuzon, G; Dortet, L; Nordmann, P; Ponties, V | 1 |
Chan, EW; Chen, S; Zhang, R; Zhou, H | 1 |
Jitmuang, A; Kiratisin, P; Rattanaumpawan, P; Thamlikitkul, V; Werarak, P | 1 |
Perez, LRR | 1 |
Carmeli, Y; Friedman, ND; Schwaber, MJ; Walton, AL | 1 |
Carrilho, C; Costa, SF; Guimaraes, T; Levin, AS; Marchi, AP; Miranda, L; Rizek, C; Rosa, JF | 1 |
Chen, YG; Li, LJ; Qu, TT; Shen, P; Wei, ZQ; Yu, YS; Zhang, Y | 1 |
Aziz, N; Bahar, J; Bishara, J; Israel, S; Madar-Shapiro, L; Samra, Z | 1 |
Aslanzadeh, J; Kuti, JL; Nicasio, AM; Nicolau, DP | 1 |
Dunne, WM; Fraser, VJ; Frye, JG; Marschall, J; Tibbetts, RJ; Warren, DK | 1 |
Harada, S; Ishii, Y; Yamaguchi, K | 1 |
Bell, JM; Mendes, RE; Rhomberg, PR; Sader, HS; Turnidge, JD | 1 |
Athanassia, S; Giamarellos-Bourboulis, EJ; Giamarellou, H; Giannitsioti, E; Kanellakopoulou, K; Papadopoulos, A | 1 |
Chen, H; Chen, YG; Li, LJ; Yu, YS; Zhang, Y; Zheng, SS | 1 |
Martínez-Lamas, L; Moldes, L; Regueiro, BJ; Treviño, M; Varón, C | 1 |
Gordon, NC; Wareham, DW | 1 |
Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q | 1 |
Castanheira, M; Deshpande, LM; DiPersio, JR; Jones, RN; Kang, J; Weinstein, MP | 1 |
Cuzon, G; Naas, T; Nordmann, P | 1 |
Aggoune-Khinache, N; Bonnet, R; Delmas, J; Naim, M; Robin, F | 1 |
Han, L; Liu, Q; Ni, Y; Sun, J; Wu, Q | 1 |
Akan, OA; Carrër, A; Cuzon, G; Feriha, C; Honderlick, P; Matar, G; Nordmann, P; Poirel, L; Yilmaz, M | 1 |
Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY | 1 |
Poulou, A; Pournaras, S; Tsakris, A | 1 |
Andremont, A; Courvalin, P; Lasocki, S; Montravers, P; Muller-Serieys, C; Nucci, A; Ruimy, R; Skurnik, D | 1 |
Martínez-Pastor, JC; Pitart, C; Sierra, JM; Soriano, A; Vilchez, F | 1 |
Betriu, C; Culebras, E; Gómez, M; López-Fabal, F; Picazo, JJ; Rodríguez-Avial, I | 1 |
Du, X; Ji, S; Li, L; Qi, Y; Shen, P; Wei, Z; Yu, Y | 1 |
Bindayna, KM; Jamsheer, AE; Senok, AC | 1 |
Aujard, Y; Bingen, E; Biran, V; Doit, C; Gaudin, A; Mariani-Kurdjian, P | 1 |
Carrer, A; Nordmann, P | 1 |
Cantón, R; García, A; Gimeno, C; Gobernado, M | 1 |
Deshpande, P; Hedge, A; Kapadia, F; Rodrigues, C; Shetty, A; Soman, R | 2 |
Gasior, M; Gómez-Gil, MR; Lorenzo, M; Mingorance, J; Paño-Pardo, JR; Quiles, I; Romero-Gómez, MP | 1 |
Amine, S; Boutiba-Ben Boubaker, I | 1 |
Bonomo, RA; Patel, G; Perez, F | 1 |
Castanheira, M; Deshpande, LM; Jones, RN; Mendes, RE; Morfin-Otero, R; Rodriguez-Noriega, E | 1 |
Hsueh, PR | 1 |
Doumith, M; Livermore, DM; Maharjan, S; Mushtaq, S; Warner, M; Woodford, N; Zhang, JC | 1 |
Fuursted, K; Hammerum, AM; Hansen, F; Kristensen, B; Lester, CH; Toleman, MA; Walsh, TR | 1 |
Bogaerts, P; Denis, O; Glupczynski, Y; Jans, B; Verroken, A | 1 |
Bernabeu, S; Freneaux, C; Hombrouck-Alet, C; Nordmann, P; Poirel, L | 1 |
Campos, J; Canton, R; Carmeli, Y; Giske, CG; Gniadkowski, M; Grundmann, H; Jarlier, V; Livermore, DM; Pfeifer, Y; Rossolini, GM; Toth, A; Vatopoulos, A | 1 |
Giesecke, J; Magiorakos, AP; Monnet, DL; Santos O'Connor, F; Struelens, MJ | 1 |
Corso, A; Faccone, D; Gomez, S; Pasteran, F; Petroni, A; Rapoport, M; Togneri, A; Viegas-Caetano, J | 1 |
Du, X; Jiang, X; Li, G; Wang, Y; Wei, Q; Zhao, Y | 1 |
Toleman, MA; Walsh, TR | 1 |
Kanafani, ZA; Kanj, SS | 1 |
Adler, A; Carmeli, Y; Marcos, E; Moran-Gilad, J; Navon-Venezia, S; Schwartz, D | 1 |
Dihmess, A; Evans, A; Fiorenza, M; Graffunder, E; Harrington, S; Lodise, TP; Martis, P; Masoud, R; McNutt, LA; Patel, N; Woo, B | 1 |
Curran, MD; Ludlam, HA; Shet, VG; Swayne, RL; Woodford, N | 1 |
Bernabeu, S; Cherkaoui, A; Nordmann, P; Poirel, L; Renzi, G; Schrenzel, J | 1 |
Gupta, N; Kallen, AJ; Limbago, BM; Patel, JB | 1 |
Carbonne, A; Coignard, B; Jarlier, V; Thiolet, JM; Vaux, S | 1 |
Chen, S; Hu, F; Liu, Y; Wang, H; Zhang, Y; Zhu, D | 1 |
Kim, J; Kim, S; Kim, SM; Lee, HW; Seol, SY | 1 |
Berhin, C; Bogaerts, P; Denis, O; Deplano, A; Glupczynski, Y; Huang, TD; Jans, B | 1 |
Carmeli, Y; Moran Gilad, J; Navon-Venezia, S; Schwartz, D | 1 |
Ben Hassen, A; Ben Redjeb, S; Boutiba-Ben Boubaker, I; Ghozzi, R; Hammami, S; Kamoun, A; Lakhal, E; Saidani, M; Slim, A | 1 |
Ahmad, F; Bheemreddy, S; Blunden, C; Bonomo, RA; Campbell, M; Chen, TY; Chopra, T; Dhar, S; Hayakawa, K; Hujer, AM; Kaye, KS; Lephart, PR; Marchaim, D; Patel, D; Perez, F; Pogue, JM; Rudin, S; Salimnia, H; Shango, M; Slim, J; Varkey, J | 1 |
Cai, JC; Chen, GX; Nasu, M; Zhang, R; Zhou, HW | 1 |
Aktas, Z; Basustaoglu, AC; Bedir, O; Bulut, Y; Gumral, R; Kilic, A; Stratton, C; Tang, YW | 1 |
Huang, M; Kuai, SG; Shao, HF; Shi, DS; Wang, WP | 1 |
Chen, S; Guo, Y; Hu, F; Liu, Y; Xu, X; Zhang, Y; Zhu, D | 1 |
Parta, M | 1 |
Pike, R; Warner, M; Woodford, N; Zhang, J | 1 |
Grisold, AJ; Hoenigl, M; Krause, R; Leitner, E; Posch, J; Salzer, HJ; Valentin, T; Würstl, B; Zarfel, G | 1 |
Bonatti, H; Brassinga, AK; Carroll, J; Cox, HL; Hazen, KC; Kitchel, B; Mathers, AJ; Scheld, WM; Sifri, CD | 1 |
Little, ML; Qin, X; Weissman, SJ; Zerr, DM | 1 |
Bauraing, C; Bogaerts, P; Bouchahrouf, W; Denis, O; Deplano, A; Gérard, M; Glupczynski, Y; Huang, TD; Rezende de Castro, R; Verbruggen, AM | 1 |
Ambretti, S; Berlingeri, A; Cordovana, M; Farruggia, P; Gaibani, P; Landini, MP; Panico, M; Sambri, V | 1 |
Adler, A; Carmeli, Y | 1 |
Grif, K; Heller, I; Orth, D | 1 |
Barbosa-Vasconcelos, A; Da Costa, PM; Liu, W; Nordmann, P; Poirel, L; Simões, RR | 1 |
Bernusset, S; Cattoen, C; Cuzon, G; Naas, T; Nordmann, P | 1 |
Bourigault, C; Caroff, N; Corvec, S; Crémet, L; Guillouzouic, A; Juvin, ME; Lepelletier, D; Reynaud, A | 1 |
Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G | 1 |
Dahyot, S; Mammeri, H | 1 |
Gazin, M; Goossens, H; Malhotra-Kumar, S; Paasch, F | 1 |
Bosman, N; Clay, C; Coetzee, J; Duse, A; Lowman, W; Nana, T; Sriruttan, C; Venturas, J | 1 |
Clifford, RJ; Hang, J; Kuschner, RA; Kwak, YI; Lesho, EP; McGann, P; Waterman, PE; Yang, Y | 1 |
Bheemreddy, S; Blunden, C; Bonomo, RA; Campbell, ML; Chopra, T; Dhar, S; Hayakawa, K; Hujer, AM; Kaye, KS; Lee, J; Lephart, PR; Manickam, P; Marchaim, D; Martin, ET; Patel, D; Perez, F; Pogue, JM; Rudin, S; Shango, M; Varkey, J | 1 |
De Jesús, A; Hernández, L; Marcano, D; Torres, L | 1 |
Arlet, G; Bidet, P; Bingen, E; Birgy, A; d'Humières, C; Doit, C | 1 |
Tanne, JH | 1 |
Al Yaqoubi, F; Dortet, L; Nordmann, P; Poirel, L | 1 |
Cheong, HS; Chung, DR; Kang, CI; Ko, KS; Peck, KR; Song, JH | 1 |
Abreu-Lanfranco, O; Bhargava, A; Bheemreddy, S; Campbell, M; Chopra, T; Dhar, S; Hayakawa, K; Kaye, KS; Khandker, N; Ku, K; Lephart, PR; Marchaim, D; Martin, ET; Moshos, J; Pogue, JM; Wang, Y | 1 |
Daniil, I; Ghirardi, S; Kimouli, M; Koumaki, V; Ranellou, K; Tsakris, A; Voulgari, E; Vrioni, G; Zambardi, G | 1 |
Cai, Y; Kwa, AL; Lee, W; Tan, TT; Tan, TY; Tang, S; Teo, J | 1 |
Dortet, L; Nordmann, P; Poirel, L | 2 |
Khan, AU; Nordmann, P | 1 |
Nordmann, P; Poirel, L; Potron, A | 1 |
Cornaglia, G; Nordmann, P | 1 |
Akóva, M; Cantón, R; Carmeli, Y; Giske, CG; Glupczynski, Y; Gniadkowski, M; Livermore, DM; Miriagou, V; Naas, T; Nordmann, P; Rossolini, GM; Samuelsen, Ø; Seifert, H; Woodford, N | 1 |
Barguigua, A; El Otmani, F; Talmi, M; Timinouni, M; Zerouali, K | 1 |
Benouda, A; Elouennass, M; Hays, C; Nordmann, P; Poirel, L | 1 |
Carvalhaes, CG; da Silva, GL; de Alcântara, LR; Elias, LS; Gales, AC; Sandri, AM; Tavares Soares, SP; Zavascki, AP | 1 |
Carmeli, Y; Kazma, M; Kotlovsky, T; Mishali, H; Navon-Venezia, S; Schechner, V; Schwaber, MJ; Schwartz, D | 1 |
Aramă, V; Breuil, J; Hristea, A; Olaru, ID; Popoiu, M | 1 |
Araj, GF; El-Herte, RI; Kanj, SS; Matar, GM | 1 |
Gallardo, N; García, P; Keller, N; Mora, GC; Moraga, M; Román, JC; Undabarrena, A; Villagra, NA; Wozniak, A | 1 |
Logan, LK | 1 |
Antunes, P; Boaventura, L; Branquinho, R; Grosso, F; Novais, A; Peixe, L; Ribeiro, G; Rodrigues, C | 1 |
Damjanova, I; Jánvári, L; Juhász, E; Kristóf, K; Nobilis, A; Tóth, A | 1 |
Brink, A; Clay, C; Coetzee, J; Corcoran, C; Deetlefs, JD; Feldman, C; Nordmann, P; Nutt, L; Poirel, L; Richards, G; van Greune, J | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Ho, MW; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW | 1 |
Bhargava, A; Bheemreddy, S; Blunden, C; Bogan, C; Bonomo, RA; Chopra, T; Dhar, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Perez, F; Pogue, JM; Shango, M; Swan, J | 1 |
Chan, KS; Choudhury, S; Koh, TH | 1 |
Liang, Z; Su, X; Xia, Y; Xiong, Y | 1 |
Guh, A; Kallen, A | 1 |
Ferguson, JK; Harris, PN | 1 |
Barth, AL; Campos, JC; Nodari, CS; Ribeiro, VB; Sampaio, JL; Sandri, AM; Silva, MP; Zavascki, AP | 1 |
Brun-Buisson, C; Derde, LP; Legrand, P; Lesprit, P; Razazi, K; Verachten, M | 1 |
Falagas, ME; Rafailidis, PI; Tansarli, GS; Vardakas, KZ | 1 |
Calfee, DP; Chen, L; Fauntleroy, KA; Feldman, EJ; Helfgott, DC; Jenkins, SG; Kreiswirth, BN; Roboz, GJ; Satlin, MJ; Shore, TB; Soave, R; Walsh, TJ; Wilson, SJ | 1 |
Boutiba-Ben Boubaker, I; Hammami, S; Kammoun, A; Saïdani, M; Slim, A | 1 |
Altouvas, G; Mamali, V; Pitiriga, V; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Tziraki, M; Zarkotou, O | 1 |
Abreu-Lanfranco, O; Chopra, T; Collins, V; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Martin, ET; Pogue, JM; Tansek, R | 1 |
Chen, HM; Ko, WC; Lee, NY; Tsai, LH; Wang, MC; Wu, JJ; Yan, JJ | 1 |
Gendrel, D; Guinaud, J; Khalil, A; Lecuyer, H; Lortholary, O; Nassif, X; Prinapori, R; Viscoli, C; Zahar, JR | 1 |
Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
Abu-Hanna, J; Adler, A; Carmeli, Y; Lerner, A; Meitus, I; Navon-Venezia, S | 1 |
Adler, A; Aronov, R; Carmeli, Y; Geffen, Y; Gorenshtein, S; Khabra, E; Paikin, S | 1 |
Doi, A; Harada, S; Iwata, K; Kamiya, T; Shimada, T | 1 |
Araj, GF; Baroud, M; Dandache, I; Dbaibo, G; Kanafani, Z; Kanj, S; Khairallah, M; Matar, GM; Sabra, A; Shehab, M; Wakim, R | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Göttig, S; Hamprecht, A; Kaase, M; Nordmann, P; Poirel, L; Seifert, H | 1 |
Grover, N; Khajuria, A; Kumar, M; Praharaj, AK | 1 |
Huang, SR; Lin, CF; Liu, MF; Shi, ZY | 1 |
Dai, W; Huang, S; Sun, S; Yang, P; Zhang, L; Zhang, X | 1 |
Koumaki, V; Poulou, A; Tsakris, A; Voulgari, E | 1 |
Bonomo, RA; Kaye, KS; Neuner, EA; van Duin, D | 1 |
Apfalter, P; Hartl, R; Kerschner, H; Widhalm, S | 1 |
Dew, RB; Ferraro, MJ; Goering, RV; Hanson, ND; Hossain, A; Lockhart, TJ; Moland, ES; Pino, RM; Thomson, KS | 1 |
Chae, HS; Chang, E; Cho, SG; Kang, CS; Kim, JY; Lee, HK; Park, YJ | 1 |
González, JJ; Larrosa, N; Lavilla, S; Miró, E; Navarro, F; Prats, G; Sabaté, M; Tórtola, MT | 1 |
Chiu, S; Chou, YH; Huang, YC; Lien, RI; Lin, TY | 1 |
Baraniak, A; Bossaert, L; Demey, HE; Gniadkowski, M; Goethaert, K; Goossens, H; Ieven, M; Jansens, H; Jorens, PG; Lammens, C; Van Herck, K; Van Looveren, M | 1 |
Paterson, DL | 3 |
Chuang, YC; Walther-Rasmussen, J; Yu, WL | 1 |
Huang, SS; Lee, MH; Leu, HS | 1 |
Deshpande, LM; Fritsche, TR; Jones, RN; Sader, HS | 1 |
Ikonomidis, A; Poulou, A; Pournaras, S; Spanakis, N; Tsakris, A | 1 |
Barnard, AM; Bowden, SD; Burr, T; Coulthurst, SJ; Monson, RE; Salmond, GP | 1 |
Gfröer, S; Knabbe, C; Rahmig, H; Schroeppel, K; Susa, M; Weile, J | 1 |
Endimiani, A; Paterson, DL | 1 |
Cai, JC; Chen, GX; Zhang, R; Zhou, HW | 1 |
Anderson, KF; Biddle, JW; Chenoweth, C; Newton, DW; Patel, JB; Perrin, J; Rasheed, JK; Washer, L | 1 |
Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O | 1 |
Akova, M; Gür, D; Kocagöz, S; Köseoğlu , O | 1 |
Amir, J; Harel, L; Straussberg, R | 1 |
Burgess, DS; Lewis, JS; Nathisuwan, S | 1 |
Laufs, R; Mack, D; Sobottka, I; Stürenburg, E | 1 |
Chanal, C; Chanal, M; Cluzel, M; Cluzel, R; Sirot, D; Sirot, J | 1 |
Schliamser, SE | 1 |
110 review(s) available for carbapenems and Cronobacter Infections
Article | Year |
---|---|
Impact of carbapenem resistance on mortality in patients infected with
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2021 |
Risk factors for the colonization or infection of carbapenem-resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Enterobacteriaceae Infections; Humans; Risk Factors | 2022 |
Controversies over the management of infections caused by Amp-C- and ESBL-producing Enterobacterales : what questions remain for future studies?
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination | 2022 |
Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; COVID-19; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2023 |
Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lactams; Randomized Controlled Trials as Topic; Sepsis | 2023 |
Dissemination of carbapenemase-producing Enterobacteriaceae and associated resistance determinants through global food systems.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2023 |
Epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Enterobacterales in Africa: A systematic review.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Risk Factors | 2023 |
Ceftazidime/avibactam versus carbapenems for the treatment of infections caused by Enterobacteriaceae: A meta-analysis of randomised controlled trials.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2019 |
The threat of carbapenem-resistant bacteria in the environment: Evidence of widespread contamination of reservoirs at a global scale.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Global Health; Humans | 2019 |
Health outcomes attributable to carbapenemase-producing Enterobacteriaceae infections: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospital Mortality; Humans; Length of Stay | 2020 |
Advances in Data-Driven Responses to Preventing Spread of Antibiotic Resistance Across Health-Care Settings.
Topics: Carbapenems; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans | 2019 |
Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Neonatal Sepsis | 2019 |
Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Children.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Polymyxins; Sisomicin; Tetracyclines; Tigecycline | 2020 |
Carbapenemase-producing
Topics: Animals; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2020 |
The Continuing Plague of Extended-Spectrum β-Lactamase Producing Enterbacterales Infections: An Update.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Continuity of Patient Care; Early Diagnosis; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Time-to-Treatment | 2020 |
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam | 2020 |
Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infections.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Clinical Decision-Making; Enterobacteriaceae Infections; Humans; Randomized Controlled Trials as Topic | 2021 |
Carbapenem-Resistant Enterobacterales in Long-Term Care Facilities: A Global and Narrative Review.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Humans; Italy; Japan; Klebsiella pneumoniae; Long-Term Care; Spain; Taiwan; United States | 2021 |
Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae Infections; Humans | 2021 |
Non-carbapenem β-lactam/β-lactamase inhibitors versus carbapenems for urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: a systematic review.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Urinary Tract Infections | 2021 |
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Evolution, Molecular; Greece; Humans; Israel; Klebsiella pneumoniae; Latin America; Public Health; Risk Factors; United States | 2017 |
Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Public Health | 2017 |
How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Pneumonia; Pneumonia, Ventilator-Associated; Risk Factors | 2017 |
How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nebulizers and Vaporizers; Pneumonia; Pneumonia, Ventilator-Associated; Renal Insufficiency; Risk Factors | 2017 |
A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2018 |
Carbapenemase-Producing Organisms: A Global Scourge.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans; Prevalence | 2018 |
Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefepime; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans | 2018 |
A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Hospitals; Humans; Incidence; Long-Term Care; United States | 2018 |
Clinical effectiveness of carbapenems versus alternative antibiotics for treating ESBL-producing Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sepsis; Treatment Outcome | 2018 |
Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Immunoassay; Microbial Sensitivity Tests | 2018 |
Detection of carbapenem-resistant Enterobacteriaceae by chromogenic screening media.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromogenic Compounds; Culture Media; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2018 |
The Infinity War: How to Cope with Carbapenem-resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Republic of Korea | 2018 |
The use of polymyxins to treat carbapenem resistant infections in neonates and children.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Infant, Newborn; Polymyxin B; Polymyxins | 2019 |
Adding double carbapenem therapy to the armamentarium against carbapenem-resistant Enterobacteriaceae bloodstream infections.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans | 2019 |
Antimicrobial treatment challenges in the era of carbapenem resistance.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic | 2019 |
Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Immunocompromised Host; Randomized Controlled Trials as Topic; Urinary Tract Infections | 2019 |
Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Communicable Diseases, Emerging; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Phenotype | 2019 |
Association between carbapenem-resistant Enterobacteriaceae and death: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Humans; Odds Ratio; Risk Factors | 2019 |
Proposed Guidelines for the Management of ESBL in Prosthetic Joint Infections.
Topics: Administration, Intravenous; Aged; Anti-Bacterial Agents; Carbapenems; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Infusions, Intralesional; Joint Prosthesis; Male; Practice Guidelines as Topic; Prosthesis-Related Infections; Reoperation; Retrospective Studies | 2020 |
Plasmids and the spread of resistance.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; R Factors | 2013 |
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Minocycline; Tigecycline | 2013 |
Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2013 |
The role of antimicrobial stewardship in curbing carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Transmission, Infectious; Drug Prescriptions; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Health Policy; Humans; Infection Control; Organizational Policy; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?
Topics: Animals; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Environment; Humans; Public Health | 2014 |
An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiologic Methods; Guideline Adherence; Guidelines as Topic; Health Policy; Humans; Incidence; Infection Control; Israel | 2014 |
Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Sanitation; United States | 2014 |
[Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Germany; Humans | 2014 |
Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans; Infection Control | 2014 |
Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.
Topics: Alleles; Carbapenems; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Promoter Regions, Genetic | 2014 |
Options for treating carbapenem-resistant Enterobacteriaceae.
Topics: beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infection Control; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Practice Patterns, Physicians'; Prospective Studies; Retrospective Studies; Tigecycline; Treatment Outcome | 2014 |
Carbapenemases in Enterobacteriaceae: types and molecular epidemiology.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Global Health; Humans; Plasmids; Substrate Specificity; Zinc | 2014 |
Epidemiology of infections caused by carbapenemase-producing Enterobacteriaceae: reservoirs and transmission mechanisms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Commerce; Community-Acquired Infections; Cross Infection; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans; Infection Control; International Cooperation; Travel | 2014 |
Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Evolution, Molecular; Forecasting; Global Health; Humans; Infection Control; International Cooperation; Spain | 2014 |
Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; International Agencies; Microbial Sensitivity Tests; Monte Carlo Method; Population Surveillance; Practice Guidelines as Topic; Research Report; Time Factors | 2014 |
Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Comorbidity; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Postoperative Complications; Prognosis; Risk Factors; Superinfection; Travel | 2014 |
Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans; Models, Animal | 2014 |
Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Drugs, Investigational; Enterobacteriaceae; Enterobacteriaceae Infections; Forecasting; Humans | 2014 |
Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Checklist; Cross Infection; Diagnostic Tests, Routine; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Health Facilities; Humans; Infection Control; National Health Programs; Population Surveillance; Residential Facilities; Spain | 2014 |
Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Communicable Disease Control; Enterobacteriaceae Infections; Global Health; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2015 |
Nosocomial pneumonia caused by carbapenem-resistant Raoultella planticola: a case report and literature review.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Comorbidity; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tomography, X-Ray Computed | 2015 |
Carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2015 |
Combination therapy for carbapenem-resistant Enterobacteriaceae: increasing evidence, unanswered questions, potential solutions.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case Management; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Microbial Sensitivity Tests; Minocycline; Observational Studies as Topic; Polymyxins; Randomized Controlled Trials as Topic; Tigecycline; Treatment Outcome | 2015 |
[Laboratory detection of carbapenemase-producing Enterobacteriaceae].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2015 |
[Therapeutic options for carbapenemase-producing Enterobacteriaceae].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2015 |
Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Communicable Disease Control; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Gene Expression; Gene Transfer, Horizontal; Humans; Molecular Epidemiology; Mutation; Plasmids; United States | 2016 |
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae Infections; Humans; Quinolones; Serratia Infections; Survival Analysis; Treatment Outcome | 2016 |
[Clinical impact of infections with carbapenem-resistant enterobacteriaceae in liver transplant recipients].
Topics: Carbapenems; Causality; Comorbidity; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Liver Transplantation; Male; Postoperative Complications; Risk Assessment; Transplant Recipients; Treatment Outcome | 2015 |
Basis for selecting optimum antibiotic regimens for secondary peritonitis.
Topics: Abdominal Cavity; Anti-Bacterial Agents; Candida; Candidiasis; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Minocycline; Peritonitis; Practice Guidelines as Topic; Risk Factors; Tigecycline | 2016 |
The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Diagnostic Tests, Routine; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2016 |
Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Precision Medicine | 2016 |
Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Prevalence; Risk Assessment | 2016 |
Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Minocycline; Tigecycline | 2016 |
Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2016 |
Recent advances in the laboratory detection of carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Diagnostic Techniques | 2016 |
Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistant Enterobacter cloacae and dominance of ST171, 2007-14.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genetic Variation; Hospitals, Urban; Humans; Incidence; New York City; Retrospective Studies | 2016 |
Outbreaks of carbapenem-resistant Enterobacteriaceae infections associated with duodenoscopes: What can we do to prevent infections?
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disease Outbreaks; Duodenoscopes; Duodenoscopy; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Patient Safety | 2016 |
Carbapenem-resistant Enterobacteriaceae and endoscopy: An evolving threat.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disease Transmission, Infectious; Endoscopy; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2016 |
Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Intestines; Male; Middle Aged; Time Factors; Young Adult | 2016 |
Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrolysis; Microbial Sensitivity Tests | 2016 |
Reducing the impact of carbapenem-resistant Enterobacteriaceae on vulnerable patient groups: what can be done?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Colistin; Critical Illness; Drug Combinations; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Retrospective Studies; Thienamycins | 2016 |
The management of multidrug-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Prospective Studies; Retrospective Studies | 2016 |
[Approach to directed therapy after knowledge of the isolate: carbapenemase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Non-molecular detection of carbapenemases in Enterobacteriaceae clinical isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2017 |
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Asia, Southeastern; Asia, Western; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Microbial Sensitivity Tests; Prevalence | 2017 |
The rapid spread of carbapenem-resistant Enterobacteriaceae.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae Infections; Epidemiological Monitoring; Gene Expression; Humans; Isoenzymes; Plasmids; Replicon | 2016 |
ICU Acquisition Rate, Risk Factors, and Clinical Significance of Digestive Tract Colonization With Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gastrointestinal Tract; Hospitalization; Humans; Incidence; Intensive Care Units; Risk Factors | 2017 |
Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
Topics: Carbapenems; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Guidelines as Topic; Humans; Infection Control; Sentinel Surveillance | 2017 |
Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests | 2008 |
[KPC carbapenemases: what is at stake in clinical microbiology?].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; R Factors; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; Species Specificity; Substrate Specificity | 2010 |
Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Mass Screening; Microbial Sensitivity Tests | 2010 |
Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Minocycline; Organ Transplantation; Risk Factors; Tigecycline | 2010 |
Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2011 |
Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2011 |
Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Culture Techniques; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sensitivity and Specificity | 2012 |
Carbapenem resistance in Enterobacteriaceae: here is the storm!
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2012 |
Spread of carbapenemase NDM-1 producers: the situation in India and what may be proposed.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India | 2012 |
OXA-48-like carbapenemases: the phantom menace.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Global Health; Humans; Hydrolysis; Penicillins; Plasmids; Prevalence | 2012 |
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Evolution, Molecular; Female; Humans; Male; Prevalence; Time Factors | 2012 |
Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male | 2012 |
Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Quinolones | 2012 |
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Survival Analysis; Treatment Outcome | 2012 |
Carbapenemase-producing Enterobacteriaceae: now that the storm is finally here, how will timely detection help us fight back?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Gastrointestinal Tract; Humans; Microbial Sensitivity Tests; Molecular Typing | 2013 |
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes.
Topics: beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Treatment Outcome | 2013 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections | 2006 |
Resistance in gram-negative bacteria: Enterobacteriaceae.
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Quinolones | 2006 |
Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.
Topics: beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Epidemiology; Taiwan | 2006 |
Quorum sensing, virulence and secondary metabolite production in plant soft-rotting bacteria.
Topics: 4-Butyrolactone; Carbapenems; Enterobacteriaceae Infections; Erwinia; Gene Expression Regulation, Bacterial; Homoserine; Lactones; Plant Diseases; Quorum Sensing; Virulence | 2007 |
Optimizing therapy for infections caused by enterobacteriaceae producing extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Treatment Outcome | 2007 |
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2000 |
Extended-spectrum beta-lactamases: epidemiology, detection, and treatment.
Topics: beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Microbial Sensitivity Tests; Risk Factors | 2001 |
4 trial(s) available for carbapenems and Cronobacter Infections
Article | Year |
---|---|
Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive ca
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Deprescriptions; Enterobacteriaceae Infections; Equivalence Trials as Topic; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Mortality; Recurrence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 2019 |
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome | 2016 |
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2017 |
High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Critical Illness; Cross Infection; Drug Therapy, Combination; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
673 other study(ies) available for carbapenems and Cronobacter Infections
Article | Year |
---|---|
Evaluation of the rCIM for carbapenemase detection in Enterobacterales and Pseudomonas aeruginosa and description of the TSBrCIM, an optimized variant.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Microbiological Techniques; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity | 2021 |
Carbapenem stewardship program in a French university children's hospital.
Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Child; Child, Preschool; Enterobacteriaceae Infections; Female; France; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Male; Program Development; Retrospective Studies | 2021 |
Comparison of sCIM and Other Phenotypic Detection Methods for Carbapenemase-Producing
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Laboratories, Clinical; Sensitivity and Specificity; Serratia marcescens | 2021 |
Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Risk Factors | 2022 |
Replicative transposition contributes to the evolution and dissemination of KPC-2-producing plasmid in
Topics: beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; DNA Replication; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Evolution, Molecular; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids | 2022 |
Rapid increase in occurrence of carbapenem-resistant Enterobacteriaceae in healthy rural residents in Shandong Province, China, from 2015 to 2017.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Humans; Multilocus Sequence Typing | 2022 |
Active Surveillance for Carbapenem-resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Watchful Waiting | 2022 |
Risk factors for isolation of carbapenem-resistant Enterobacterales from normally sterile sites and urine.
Topics: Anti-Bacterial Agents; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Humans; Risk Factors; Urinary Tract Infections | 2022 |
Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Immunoassay; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity; Sepsis | 2022 |
A clinical prediction tool for extended-spectrum β-lactamase-producing Enterobacteriaceae urinary tract infection.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Urinary Tract Infections | 2022 |
Human Amnion-Derived Mesenchymal Stromal Cells: A New Potential Treatment for Carbapenem-Resistant
Topics: Amnion; Bacterial Load; beta-Lactam Resistance; Biomarkers; Carbapenems; Complement Activation; Complement System Proteins; Disease Susceptibility; Enterobacter; Enterobacteriaceae Infections; Humans; Immunomodulation; Inflammation Mediators; Macrophages; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Peritoneal Fibrosis; Peritonitis; Phagocytosis; Receptors, Pattern Recognition; Treatment Outcome | 2022 |
Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales.
Topics: Anti-Bacterial Agents; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Respiratory Sounds | 2022 |
Emergence of High Prevalence of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Citrobacter; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Ethiopia; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence | 2022 |
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; United States | 2022 |
Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity | 2022 |
Healthcare-associated multispecies outbreaks of OXA-48-positive carbapenemase-producing Enterobacteriaceae in a Singapore tertiary-care hospital.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Delivery of Health Care; Disease Outbreaks; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Retrospective Studies; Singapore; Tertiary Care Centers | 2023 |
Investigation on the transmission rate of carbapenemase-producing carbapenem-resistant Enterobacterales among exposed persons in a tertiary hospital using whole-genome sequencing.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Tertiary Care Centers | 2022 |
Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017-2019.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Netherlands | 2022 |
Genomic Insights Into the Mechanism of Carbapenem Resistance Dissemination in Enterobacterales From a Tertiary Public Heath Setting in South Asia.
Topics: Anti-Bacterial Agents; Asia, Southern; Bangladesh; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Genomics; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2023 |
Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Japan; Retrospective Studies; Sepsis; Treatment Outcome | 2022 |
Nationwide surveillance in Thailand revealed genotype-dependent dissemination of carbapenem-resistant
Topics: beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Gammaproteobacteria; Genotype; Humans; Thailand | 2022 |
Regional transmission patterns of carbapenemase-producing Enterobacterales: A healthcare network analysis.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Delivery of Health Care; Enterobacteriaceae Infections; Health Facilities; Humans; Retrospective Studies | 2023 |
Biofilm and Gene Expression Characteristics of the Carbapenem-Resistant Enterobacterales,
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2022 |
A fatal outbreak of neonatal sepsis caused by mcr-10-carrying Enterobacter kobei in a tertiary care hospital in Nepal.
Topics: Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Enterobacter; Enterobacteriaceae Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Microbial Sensitivity Tests; Neonatal Sepsis; Nepal; Tertiary Care Centers | 2022 |
Performance of two methods of carbapenem-resistant Enterobacterales surveillance on a kidney transplant ward: selective culture of and real-time PCR directly from rectal swabs.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Hospitals; Humans; Kidney Transplantation; Prospective Studies; Real-Time Polymerase Chain Reaction | 2022 |
Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans | 2022 |
KPC-3-, GES-5-, and VIM-1-Producing
Topics: Carbapenems; Enterobacteriaceae Infections; Humans; Klebsiella; Microbial Sensitivity Tests; Ponds | 2022 |
TP0586532, a Novel Non-Hydroxamate LpxC Inhibitor: Potentiating Effect on
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Butanols; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Gram-Negative Bacteria; Humans; Imidazoles; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) in healthcare and community settings in Botswana: an antibiotic resistance in communities and hospitals (ARCH) study.
Topics: Adult; Anti-Bacterial Agents; Botswana; Carbapenems; Cephalosporins; Child; Communicable Disease Control; COVID-19; Delivery of Health Care; Drug Resistance, Microbial; Enterobacteriaceae Infections; Hospitals; Humans | 2022 |
Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Female; Healthcare-Associated Pneumonia; Humans; Male; Middle Aged; Molecular Epidemiology; Prospective Studies; Saudi Arabia | 2022 |
[Risk of infection in cancer patients colonized by extended expectrum p-lactamases and carbapenem producing Enterobacteriaceae].
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hypoalbuminemia; Klebsiella pneumoniae; Neoplasms; Neutropenia; Retrospective Studies | 2022 |
Molecular and clinical characteristics of carbapenem-resistant Enterobacteriaceae isolates collected at a tertiary hospital in northern China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tertiary Care Centers | 2023 |
Clinical epidemiology of carbapenem-resistant Enterobacterales in the Greater Houston region of Texas: a 6-year trend and surveillance analysis.
Topics: Anti-Bacterial Agents; Carbapenems; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Texas; United States | 2022 |
Activity of mecillinam against carbapenem-resistant Enterobacterales.
Topics: Amdinocillin; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |
Population analysis profiling: is it still the gold standard for the determination of heteroresistance in carbapenemase-producing Enterobacteriaceae?
Topics: Agar; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests | 2022 |
Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Health Facilities; Humans; Microbial Sensitivity Tests; Risk Factors; United States | 2023 |
Prediction models for carbapenem-resistant Enterobacterales carriage at liver transplantation: A multicenter retrospective study.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Enterobacteriaceae Infections; Humans; Liver Cirrhosis; Liver Transplantation; Retrospective Studies; Risk Factors | 2022 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |
Characteristics of community-acquired carbapenem-resistant Enterobacterales.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Genetic Markers; Humans; Klebsiella pneumoniae | 2022 |
Risk factors for carbapenem-resistant Enterobacterales infection among hospitalized patients with previous colonization.
Topics: Carbapenems; Case-Control Studies; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Retrospective Studies; Risk Factors | 2022 |
Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Enterobacteriaceae Infections; Humans; Retrospective Studies; Risk Factors | 2022 |
Carbapenem-resistant Enterobacteriaceae infection in children less than one year old in an Asian medical center.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Retrospective Studies; Risk Factors | 2023 |
Predictors of carbapenem-resistant Enterobacteriaceae (CRE) strains in patients with COVID-19 in the ICU ward: a retrospective case-control study.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; COVID-19; Enterobacteriaceae Infections; Humans; Intensive Care Units; Retrospective Studies; Risk Factors; SARS-CoV-2 | 2022 |
Clinical Outcomes and Treatment Strategies in Patients With Non-Carbapenemase-producing Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacterales Infections.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Humans; Retrospective Studies | 2023 |
Clinical Risk Factors and Microbiological and Intestinal Characteristics of Carbapenemase-Producing
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Risk Factors | 2022 |
Prevalence and factors associated with carbapenem-resistant Enterobacterales (CRE) infection among hematological malignancies patients with CRE intestinal colonization.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Prevalence; Proton Pump Inhibitors; Retrospective Studies | 2023 |
Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Risk Factors | 2023 |
Comparison of the relative efficacy of β-lactam/β-lactamase inhibitors and carbapenems in the treatment of complicated urinary tract infections caused by ceftriaxone-non-susceptible Enterobacterales: a multicentre retrospective observational cohort study.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Lactams; Retrospective Studies; Urinary Tract Infections | 2023 |
Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Liver Diseases; Molecular Epidemiology; Multilocus Sequence Typing; Risk Factors | 2023 |
Evaluation of a new rapid immunochromatographic assay for the detection of GES-producing Gram-negative bacteria.
Topics: Agar; Bacteriological Techniques; beta-Lactamases; Carbapenems; Culture Media; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Immunoassay; Sensitivity and Specificity | 2023 |
Epidemiological characteristics of New Delhi Metallo-β-Lactamase-producing Enterobacteriaceae in the Fourth hospital of Hebei Medical University.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Universities | 2023 |
Reduced susceptibility to carbapenems in
Topics: Animals; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cameroon; Carbapenems; Cattle; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Microbial Sensitivity Tests | 2023 |
Assessing the impact of recreational water use on carriage of antimicrobial resistant organisms.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Feces; Gammaproteobacteria; Humans; Water | 2023 |
Efficacy and safety of piperacillin-tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum β-lactamase-producing
Topics: Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Urinary Tract Infections | 2023 |
Comparison of prevalence, resistance, biofilm-forming ability and virulence between carbapenem-non-susceptible and carbepenem-susceptible Enterobacter cloacae complex in clusters.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Prevalence; Virulence | 2023 |
Transmission of Carbapenem-Resistant Enterobacterales in an Overcrowded Emergency Department: Controlling the Spread to the Hospital.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Emergency Service, Hospital; Enterobacteriaceae Infections; Humans; Infection Control; Tertiary Care Centers | 2023 |
Molecular eidemiology of carbapenem-resistant Enterobacter cloacae complex in a tertiary hospital in Shandong, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tertiary Care Centers | 2023 |
Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC β-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective study.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Enterobacteriaceae; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Microbial Sensitivity Tests; Retrospective Studies; Sepsis | 2023 |
Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Clinical Relevance; Enterobacteriaceae Infections; Gammaproteobacteria; Humans | 2023 |
Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Clone Cells; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Hospitals, University; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Quinolones; Yemen | 2020 |
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Retrospective Studies; United States | 2019 |
Cooccurrence of NDM-1, ESBL, RmtC, AAC(6')-Ib, and QnrB in Clonally Related
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; RNA, Ribosomal, 16S; Saudi Arabia | 2019 |
Bloodstream infections and carbapenem-resistant Enterobacteriaceae in South Korea.
Topics: Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Developing Countries; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Prospective Studies; Republic of Korea | 2019 |
Outcomes of extended-spectrum beta-lactamases producing Enterobacteriaceae colonization among patients abdominal surgery patients.
Topics: Abdomen; Adolescent; Adult; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Logistic Models; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Surgical Wound Infection; Thailand; Young Adult | 2019 |
Genetic relatedness in carbapenem-resistant isolates from clinical specimens in Ghana using ERIC-PCR technique.
Topics: Acinetobacter baumannii; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; DNA, Bacterial; DNA, Intergenic; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ghana; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Pseudomonas aeruginosa; Repetitive Sequences, Nucleic Acid | 2019 |
Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cohort Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Observational Studies as Topic; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic | 2020 |
Genomic analysis of two drug-resistant clinical Morganella morganii strains isolated from UTI patients in Pretoria, South Africa.
Topics: Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Genome, Bacterial; Genomics; Humans; Integrons; Male; Microbial Sensitivity Tests; Middle Aged; Morganella morganii; Phylogeny; Plasmids; South Africa; Urinary Tract Infections | 2020 |
[Carbapenem-producing Enterobacteriaceae bloodstream infection: Microbiology's role in their rapid detection].
Topics: Bacteremia; Bacteriological Techniques; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Middle Aged; Time Factors | 2019 |
Comparative genomic analysis reveals a high prevalence of inter-species in vivo transfer of carbapenem-resistance plasmids in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Gene Transfer, Horizontal; Genomics; Gram-Negative Bacteria; Hematologic Neoplasms; Humans; Infant; Male; Middle Aged; Plasmids; Prevalence; Retrospective Studies; Whole Genome Sequencing; Young Adult | 2020 |
Breakpoint beware: reliance on historical breakpoints for Enterobacteriaceae leads to discrepancies in interpretation of susceptibility testing for carbapenems and cephalosporins and gaps in detection of carbapenem-resistant organisms.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Pakistan; United States | 2020 |
Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Urinary Tract Infections | 2020 |
Blood-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Carbapenemase-Producing
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Inactivation, Metabolic; Microbial Sensitivity Tests; Phenotype; Reproducibility of Results; Sensitivity and Specificity | 2020 |
An agar plate-based modified carbapenem inactivation method (p-mCIM) for detection of carbapenemase-producing Enterobacteriaceae.
Topics: Agar; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 2020 |
Genomic characterization of an emerging bla
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Female; Genome, Bacterial; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Whole Genome Sequencing | 2019 |
RETRACTED: Antibacterial and antibiofilm activity of ursolic acid against carbapenem-resistant Enterobacter cloacae.
Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Triterpenes; Ursolic Acid | 2020 |
Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cefepime; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2020 |
Dissemination of the
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gene Transfer, Horizontal; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2020 |
Risk factors for polymyxin-resistant carbapenemase-producing Enterobacteriaceae in critically ill patients: An epidemiological and clinical study.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Critical Illness; Enterobacteriaceae Infections; Humans; Polymyxins; Risk Factors | 2020 |
Evaluation of patient risk factors for infection with carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Enterobacteriaceae Infections; Humans; Risk Factors | 2020 |
Patients with carbapenem-resistant Enterobacteriaceae in emergency room; is this a real problem?
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Enterobacteriaceae Infections; Humans; Patients | 2019 |
A Multispecies Cluster of VIM-1 Carbapenemase-Producing
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Evolution, Molecular; Host Specificity; Humans; Italy; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2020 |
Meropenem-Vaborbactam versus Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant
Topics: Aged; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Boronic Acids; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cohort Studies; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2020 |
Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Enterobacteriaceae Infections; Epidemiological Monitoring; Female; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; South Africa; Tertiary Care Centers | 2020 |
Intestinal carriage of colistin resistant Enterobacteriaceae in hospitalized patients from an Indian center.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Carrier State; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Feces; Female; Hospitalization; Humans; India; Intestines; Klebsiella; Male; Microbial Sensitivity Tests; Mutation | 2020 |
Quantifying risk of disease due to extended-spectrum β-lactamase producing Enterobacteriaceae in patients who are colonized at ICU admission.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Middle Aged; Risk Factors | 2020 |
Risk Factors and Impact of Perioperative Prophylaxis on the Risk of Extended-spectrum β-Lactamase-producing Enterobacteriaceae-related Infection Among Carriers Following Liver Transplantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Carrier State; Databases, Factual; Enterobacteriaceae Infections; Feces; Female; Humans; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2021 |
Impact of removing ESBL designation from culture reports on the selection of antibiotics for the treatment of infections associated with ESBL-producing organisms.
Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Philadelphia; Retrospective Studies | 2020 |
Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016: Five years of experience with an internal registry.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; Florida; Hospitals; Humans; Registries; Retrospective Studies | 2020 |
Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Cohort Studies; Dysbiosis; Enterobacteriaceae Infections; Feces; Female; Gastrointestinal Microbiome; Humans; Intestines; Male; Metabolic Networks and Pathways; Middle Aged; Phylogeny; RNA, Ribosomal, 16S; Young Adult | 2020 |
Epidemiology of multidrug-resistant Enterobacteriaceae in Sri Lanka: First evidence of bla
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sri Lanka; Young Adult | 2020 |
Detection of carbapenem resistant enterobacteriace from fomite surfaces.
Topics: Anti-Bacterial Agents; Carbapenems; Enterobacteriaceae Infections; Fomites; Humans; Microbial Sensitivity Tests | 2021 |
Subsequent carbapenem-resistant Enterobacteriaceae (CRE)-associated infections among hospitalized patients with CRE colonization: Impact of antibiotic use and other factors.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Enterobacteriaceae Infections; Humans; Risk Factors | 2020 |
Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Hospitals, University; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Prevalence; Republic of Korea | 2020 |
The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Enterobacteriaceae Infections; Hospitals; Humans; Incidence; Microbial Sensitivity Tests; Time Factors | 2020 |
Risk factors and outcomes of patients colonized with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Infant; Retrospective Studies; Risk Factors | 2020 |
Carbapenem for Surgical Site Infection Prophylaxis in Prevalent Regions of Extended-Spectrum β-Lactamase Enterobacteriaceae.
Topics: beta-Lactamases; Carbapenems; Colorectal Surgery; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Prospective Studies; Surgical Wound Infection | 2020 |
Factors associated with mortality in Infections caused by Carbapenem-resistant Enterobacteriaceae.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cohort Studies; Colombia; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prognosis | 2020 |
Successful treatment of invasive carbapenemase-producing Enterobacteriaceae infections in children using carbapenem-aminoglycoside combination therapy: A case series.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Enterobacteriaceae Infections; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 2020 |
Epidemiological characteristics and risk factors of nosocomial carbapenem-resistant Enterobacteriaceae infections in children.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Cross Infection; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Risk Factors | 2020 |
Efficacy of a hospital policy of selective digestive decontamination for carbapenem-resistant Enterobacterales carriers: prospective before-after study.
Topics: Anti-Bacterial Agents; Carbapenems; Controlled Before-After Studies; Decontamination; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Interrupted Time Series Analysis; Non-Randomized Controlled Trials as Topic; Prospective Studies | 2020 |
Comparison of clinical outcomes of patients infected with KPC- and NDM-producing Enterobacterales: a retrospective cohort study.
Topics: Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Retrospective Studies; Seoul | 2021 |
Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Enterobacteriaceae Infections; Humans; Retrospective Studies; Sepsis | 2021 |
Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2020 |
Carbapenem and colistin resistance in children with Enterobacteriaceae infections.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Colistin; Enterobacteriaceae Infections; Humans; Infant, Newborn; Retrospective Studies | 2020 |
Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Retrospective Studies; Singapore; Treatment Outcome | 2020 |
Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Expression Profiling; Genome, Bacterial; Genomics; High-Throughput Nucleotide Sequencing; Humans; Meropenem; Microbial Sensitivity Tests; Oligonucleotides, Antisense; Transcriptome | 2020 |
Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project).
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Humans; Kidney Transplantation; Lactams; Retrospective Studies; Urinary Tract Infections | 2021 |
Performance of the BD Phoenix CPO detect assay for detection and classification of carbapenemase-producing organisms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Genotype; Humans; Sensitivity and Specificity | 2021 |
A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Enterobacteriaceae Infections; Humans; Japan; Risk Factors | 2021 |
Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Phenotype | 2020 |
Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxins | 2021 |
Increased frequency of bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Typing; Tertiary Care Centers | 2021 |
Genomic analysis of VIM-2-producing Enterobacter hormaechei subsp. steigerwaltii.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; France; Humans; Integrons; Microbial Sensitivity Tests; Mutation; Phenotype; Phylogeny; Plasmids; Polymorphism, Single Nucleotide | 2021 |
Increasing New Delhi metallo-β-lactamase-positive Escherichia coli among carbapenem non-susceptible Enterobacteriaceae in Taiwan during 2016 to 2018.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Taiwan | 2021 |
Development of a Risk Prediction Model for Carbapenem-resistant Enterobacteriaceae Infection After Liver Transplantation: A Multinational Cohort Study.
Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Enterobacteriaceae Infections; Humans; Liver Transplantation; Risk Factors | 2021 |
Detection of carbapenemase-producing bacteria in a public healthcare center from Venezuela.
Topics: Ambulatory Care Facilities; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Klebsiella pneumoniae; Phenotype; Pseudomonas aeruginosa; Public Health; Venezuela | 2020 |
The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefuroxime; Cephalosporins; Colorectal Surgery; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Metronidazole; Spectroscopy, Fourier Transform Infrared | 2021 |
Development of a Nomogram for Carbapenem-Resistant Enterobacteriaceae Acquisition Risk Prediction Among Patients in the Intensive Care Unit of a Secondary Referral Hospital.
Topics: Aged; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Catheter-Related Infections; Cross Infection; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Logistic Models; Male; Models, Statistical; Nomograms; Risk Assessment; Risk Factors; Secondary Care Centers | 2021 |
Diverse efficacy of CarbaNP test among OXA-48 carbapenemase producing Enterobacterales in an endemic region.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Endemic Diseases; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Predictive Value of Tests; Sensitivity and Specificity | 2021 |
Institutional outbreak involving multiple clades of IMP-producing Enterobacter cloacae complex sequence type 78 at a cancer center in Tokyo, Japan.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Enterobacter; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Integrons; Japan; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Whole Genome Sequencing | 2021 |
Genotypes and prevalence of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa in a hospital in Saudi Arabia.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Genotype; Hospitals; Humans; Prevalence; Pseudomonas aeruginosa; Saudi Arabia | 2022 |
Pervasive transmission of a carbapenem resistance plasmid in the gut microbiota of hospitalized patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gastrointestinal Microbiome; Gene Transfer, Horizontal; Hospitalization; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Phylogeny; Plasmids | 2021 |
Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Incidence; Intraabdominal Infections; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum; Recurrence; Risk Factors; Singapore; Skin; Tertiary Care Centers; Urine | 2021 |
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Netherlands; Plasmids | 2021 |
Risk Factors Associated With Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Positive Cultures in a Cohort of US Veterans.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Retrospective Studies; Risk Factors; United States; Veterans | 2021 |
Monitoring antibiotic resistance profiles of faecal isolates of Enterobacteriaceae and the prevalence of carbapenem-resistant isolates among food handlers in Kuwait.
Topics: beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Kuwait; Prevalence | 2021 |
Temocillin versus carbapenems for urinary tract infection due to ESBL-producing Enterobacteriaceae: a multicenter matched case-control study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2021 |
Emergence of
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; Whole Genome Sequencing | 2021 |
First case report of acute cholangitis secondary to Cronobacter sakazakii.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cholangitis; Cholecystostomy; Cronobacter sakazakii; Drainage; Enterobacteriaceae Infections; Humans; Male; Opportunistic Infections; Polymerase Chain Reaction; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Parallel Validation of the NG-Test Carba 5 and the Xpert Carba-R for Detection and Characterization of Carbapenem-Resistant Enterobacterales Causing Bloodstream Infections.
Topics: Adult; Aged; Bacteremia; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Sensitivity and Specificity | 2021 |
Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.
Topics: Aged; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Molecular Epidemiology; Thailand | 2021 |
[Risk factors and clinical prognosis analysis of carbapenem-resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Humans; Prognosis; Risk Factors | 2021 |
Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2021 |
Enhanced Carbapenem Resistance through Multimerization of Plasmids Carrying Carbapenemase Genes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2021 |
Carbapenem-resistant Enterobacter cloacae complex in a tertiary Hospital in Northeast China, 2010-2019.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; History, 21st Century; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Tertiary Care Centers; Young Adult | 2021 |
Molecular Epidemiology of Enterobacter cloacae Complex Isolates with Reduced Carbapenem Susceptibility Recovered by Blood Culture.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Epidemiology | 2022 |
mCIM test as a reliable assay for the detection of CRE in the Gulf region.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bahrain; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Middle East; Saudi Arabia; Sensitivity and Specificity; Young Adult | 2021 |
Risk factors and clinical impact of bacteremia due to carbapenem-nonsusceptible Enterobacteriaceae: A multicenter study in southern Taiwan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Odds Ratio; Risk Factors; Taiwan | 2021 |
Preliminary exploration on the serum biomarkers of bloodstream infection with carbapenem-resistant Klebsiella pneumoniae based on mass spectrometry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Biomarkers; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Enterobacteriaceae Infections; Female; Humans; Male; Mass Spectrometry; Mice; Mice, Inbred ICR; Middle Aged; Peptide Fragments; Sepsis; Young Adult | 2021 |
Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Propensity Score; Treatment Outcome | 2017 |
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cyclooctanes; Drug Discovery; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2017 |
Performance of CarbaNP and CIM tests in OXA-48 carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2017 |
EUropean prospective cohort study on
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cause of Death; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Hospitalization; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Mortality; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome; Urinary Tract Infections | 2017 |
Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Health Care Costs; Hospital Mortality; Hospitalization; Humans; Inappropriate Prescribing; Length of Stay; Male; Middle Aged; Pneumonia; Prevalence; Retrospective Studies; Risk Factors; Sepsis; Treatment Outcome; Urinary Tract Infections | 2017 |
Carbapenem-Resistant Enterobacter cloacae in Patients from the US Veterans Health Administration, 2006-2015.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; Geography, Medical; History, 21st Century; Humans; United States; Veterans Health | 2017 |
Towards the early detection of β-lactamase-producing Enterobacteriaceae by MALDI-TOF MS analysis.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Early Diagnosis; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2017 |
Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Electronic Health Records; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Incidence; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Surveys and Questionnaires; Young Adult | 2017 |
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospital Mortality; Humans; Microbial Sensitivity Tests; Retrospective Studies | 2017 |
Molecular study of carbapenemase genes in clinical isolates of Enterobacteriaceae resistant to carbapenems and determining their clonal relationship using pulsed-field gel electrophoresis.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction | 2017 |
Molecular characterization of carbapenem- resistant Enterobacteriaceae yields increasing rates of NDM-1 carbapenemases and colistin resistance in an OXA-48- endemic area.
Topics: Adolescent; Adult; Aged; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Microbial; Endemic Diseases; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Turkey; Young Adult | 2017 |
Rapid separation of very low concentrations of bacteria from blood.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Blood; Blood Sedimentation; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Filtration; Humans; Male; Time Factors | 2017 |
Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Belgium; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Hospitals; Humans; Microbial Sensitivity Tests | 2017 |
In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tigecycline | 2017 |
Circulation of
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Citrobacter freundii; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Humans; Italy; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2017 |
Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence; Retrospective Studies; United States | 2017 |
Understanding the β-Lactam/Inhibitor of β-Lactamase Combinations: Reassessment for Better Antimicrobial Stewardship.
Topics: Antimicrobial Stewardship; beta-Lactamases; Brazil; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella; Proteus | 2017 |
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Neutropenia | 2017 |
Emergence of a multidrug-resistant Citrobacter freundii ST8 harboring an unusual VIM-4 gene cassette in Poland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Citrobacter freundii; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae Infections; Escherichia coli; Female; Genes, Bacterial; Humans; Integrons; Isoenzymes; Leukemia, Myeloid, Acute; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Poland | 2017 |
FRI-2 carbapenemase-producing Enterobacter cloacae complex in the UK.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Plasmids; United Kingdom | 2017 |
Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Cross Infection; District of Columbia; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals; Humans; Male; Middle Aged; Nursing Homes; Prevalence; Real-Time Polymerase Chain Reaction; Skilled Nursing Facilities; Young Adult | 2017 |
Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biofilms; Carbapenems; Citrobacter freundii; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Mexico; Microbial Sensitivity Tests; Multilocus Sequence Typing; Virulence Factors | 2017 |
Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross-Sectional Studies; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Iran; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
A Novel Protocol Obviates Endoscope Sampling for Carbapenem-Resistant Enterobacteriaceae: Experience of a Center with a Prior Outbreak.
Topics: Adult; Aged; Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Disinfectants; Drug Resistance, Bacterial; Duodenoscopes; Endosonography; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Equipment Reuse; Ethylene Oxide; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pilot Projects; Program Evaluation; Rectum; Risk Factors; Sterilization; Wisconsin | 2017 |
Emergence of carbapenem-resistant Enterobacteriaceae in Orange County, California, and support for early regional strategies to limit spread.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; California; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Young Adult | 2017 |
Occurrence of Carbapenemase-Producing Enterobacteriaceae Isolates in the Wildlife: First Report of OXA-48 in Wild Boars in Algeria.
Topics: Algeria; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Feces; Gene Expression; Humans; Klebsiella pneumoniae; Macaca; Multilocus Sequence Typing; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA; Serogroup; Sus scrofa; Virulence | 2018 |
Carbapenemase-Producing Enterobacteriaceae and Nonfermentative Bacteria, the Philippines, 2013-2016.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Gene Expression; Humans; Isoenzymes; Microbial Sensitivity Tests; Multilocus Sequence Typing; Philippines; Plasmids; Prevalence; Tertiary Care Centers | 2017 |
OXA-427, a new plasmid-borne carbapenem-hydrolysing class D β-lactamase in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Belgium; beta-Lactamases; Carbapenems; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; High-Throughput Nucleotide Sequencing; Humans; Hydrolysis; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids | 2017 |
Prevalence of fosfomycin resistance and plasmid-mediated fosfomycin-modifying enzymes among carbapenem-resistant Enterobacteriaceae in Zhejiang, China.
Topics: Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Gene Transfer, Horizontal; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2017 |
Eliminating Duodenoscope-Associated Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE): In Search of an Optimal Strategy.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Duodenoscopes; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2017 |
A novel transposon, Tn6306, mediates the spread of bla
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; China; DNA Transposable Elements; DNA, Bacterial; Enterobacteriaceae Infections; Hospitals; Humans; Incidence; Microbial Sensitivity Tests; Plasmids; Retrospective Studies; Sequence Analysis, DNA | 2017 |
Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract Infections | 2018 |
Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Hospitals, Pediatric; Humans; Infant; Logistic Models; Male; Respiration, Artificial; Risk Factors; Surgical Procedures, Operative; Tertiary Care Centers; United States | 2017 |
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies | 2017 |
The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Intensive Care Units; Klebsiella Infections; Longitudinal Studies; Microbial Sensitivity Tests; Models, Theoretical; Prospective Studies | 2018 |
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
Topics: Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Cohort Studies; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Rectum | 2017 |
Clinical Evolution of New Delhi Metallo-β-Lactamase (NDM) Optimizes Resistance under Zn(II) Deprivation.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Zinc | 2018 |
"Double carbapenem" and oral fosfomycin for the treatment of complicated urinary tract infections caused by bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Humans; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2018 |
Clinical outcomes of elderly patients with bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae in an Italian Internal Medicine ward.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Italy; Male; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2018 |
In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Indiana; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Sisomicin | 2017 |
Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; California; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross-Sectional Studies; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Surveys and Questionnaires; Tertiary Care Centers | 2018 |
MASTDISCS combi Carba plus, a simple method for discriminating carbapenemase-producing Enterobacteriaceae, including OXA-48-type producers.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Assays; Enzyme Inhibitors; Humans; Meropenem; Sensitivity and Specificity; Thienamycins | 2018 |
Occurrence of Enterobacter hormaechei carrying bla
Topics: Adult; Aged; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; DNA, Bacterial; Enterobacter; Enterobacteriaceae Infections; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Phylogeny; Plasmids; Polymorphism, Single Nucleotide; Retrospective Studies | 2018 |
Carbapenem-heteroresistance among isolates of the Enterobacter cloacae complex: is it a real concern?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Tertiary Care Centers | 2018 |
Comparative study of 3 carbapenem-hydrolysis methods for the confirmation of carbapenemase production in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrolysis; Sensitivity and Specificity | 2018 |
Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Citrobacter freundii; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Urinary Tract Infections | 2018 |
Genomic Investigation of a Putative Endoscope-Associated Carbapenem-Resistant Enterobacter cloacae Outbreak Reveals a Wide Diversity of Circulating Strains and Resistance Mutations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Endoscopy; Enterobacter cloacae; Enterobacteriaceae Infections; Equipment Contamination; Genetic Variation; Genomics; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation | 2018 |
Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of Isolation.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Cross Infection; Disease Outbreaks; Enterobacteriaceae Infections; Guidelines as Topic; Health Policy; Hospitals; Humans; Israel; Mandatory Reporting; Patient Isolation; Public Health Administration; Registries; Risk Factors | 2018 |
Evaluation of the modified carbapenem inactivation method for the detection of carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Enzyme Assays; Microbial Sensitivity Tests; Sensitivity and Specificity | 2018 |
Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prevalence; Sentinel Surveillance; United Kingdom; Young Adult | 2018 |
Performance evaluation of BD Phoenix™, an automated microbiology system, for the screening of IMP-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; Carbapenems; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Inosine Monophosphate; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2018 |
Characterization of KPC-Encoding Plasmids from Enterobacteriaceae Isolated in a Czech Hospital.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Citrobacter freundii; Czech Republic; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Gene Expression; Hospitals; Humans; Isoenzymes; Klebsiella pneumoniae; Microbial Sensitivity Tests; Morganella morganii; Open Reading Frames; Plasmids; Sequence Analysis, DNA | 2018 |
Characterization of OXA-48-like carbapenemase producers in Canada, 2011-14.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Female; Genome, Bacterial; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Travel; Whole Genome Sequencing; Young Adult | 2018 |
Molecular characterisation of carbapenem-resistant Enterobacter cloacae complex in Colombia: bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colombia; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Multilocus Sequence Typing | 2018 |
Molecular Characterization of IMP-1-Producing Enterobacter cloacae Complex Isolates in Tokyo.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacter; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Expression; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Plasmids; Tokyo; Whole Genome Sequencing | 2018 |
Evaluation of the rapid carbapenem inactivation method (rCIM): a phenotypic screening test for carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; Mass Screening; Nephelometry and Turbidimetry; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2018 |
Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fever; France; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Prospective Studies; Risk Factors; Urinary Tract Infections | 2018 |
Spread of carbapenem resistant Enterobacteriaceae at tertiary care cancer hospital in Egypt.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cancer Care Facilities; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; Microbial Sensitivity Tests; Tertiary Healthcare | 2018 |
Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; France; Glycopeptides; Guidelines as Topic; Hospitals; Humans; Intensive Care Units; Logistic Models; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Prescriptions; Probability; Retrospective Studies | 2018 |
A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2018 |
Microbiological surveillance of plasmid mediated colistin resistance in human Enterobacteriaceae isolates in Romagna (Northern Italy): August 2016-July 2017.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Eggs; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Food Contamination; Food Microbiology; Foodborne Diseases; Humans; Italy; Meat; Plasmids; Risk Factors | 2018 |
Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Cystitis; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Hospitals, University; Humans; Inappropriate Prescribing; Male; Practice Patterns, Physicians'; Pyelonephritis; Retrospective Studies; Secondary Care Centers; Surveys and Questionnaires; Urinary Tract Infections | 2018 |
Carbapenemase-producing Enterobacteriaceae in South Korea: a report from the National Laboratory Surveillance System.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Laboratories; Microbial Sensitivity Tests; Multilocus Sequence Typing; Republic of Korea | 2018 |
Detection of qnrVC6, within a new genetic context, in an NDM-1-producing Citrobacter freundii clinical isolate from Uruguay.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Citrobacter freundii; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Middle Aged; Plasmids; Quinolones; Uruguay | 2018 |
The epidemiology and risk factor of carbapenem-resistant enterobacteriaceae colonization and infections: Case control study in a single institute in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Japan; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors | 2018 |
The Economic Value of the Centers for Disease Control and Prevention Carbapenem-Resistant Enterobacteriaceae Toolkit.
Topics: California; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Centers for Disease Control and Prevention, U.S.; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Cross Infection; Enterobacteriaceae Infections; Health Expenditures; Hospitals; Humans; Infection Control; United States | 2018 |
The global distribution and spread of the mobilized colistin resistance gene mcr-1.
Topics: Americas; Anti-Bacterial Agents; Asia; Carbapenems; Colistin; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Europe; Evolution, Molecular; Gene Expression; Gene Transfer, Horizontal; Genome, Bacterial; Humans; Plasmids; Population Dynamics | 2018 |
Which non-carbapenem antibiotics are active against extended-spectrum β-lactamase-producing Enterobacteriaceae?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam; Urinary Tract Infections | 2018 |
Effect of Carbapenem Selection on Drug Acquisition Costs and Carbapenem Resistance.
Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; United States | 2019 |
Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Tunisia | 2018 |
Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.
Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Centers for Disease Control and Prevention, U.S.; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; United States | 2018 |
Maintenance of Carbapenemase-Producing Enterobacteriaceae in a Farrow-to-Finish Swine Production System.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Farms; Feces; Female; Livestock; Male; Plasmids; Pregnancy; Swine; Swine Diseases | 2018 |
Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Hospitals; Humans; Jordan; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2018 |
Risk factors for fecal carriage of IMP-6-producing Enterobacteriaceae at a long-term care hospital in Japan: A follow-up report from the northern Osaka multicentre study group.
Topics: Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae Infections; Feces; Female; Follow-Up Studies; Hospitals; Humans; Inosine Monophosphate; Japan; Long-Term Care; Male; Prevalence; Risk Factors | 2018 |
Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.
Topics: Aged; beta-Lactamases; Carbapenems; Carrier State; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Intensive Care Units; Male; Pneumonia, Ventilator-Associated; Prospective Studies | 2018 |
Sequencing of pT5282-CTXM, p13190-KPC and p30860-NR, and comparative genomics analysis of IncX8 plasmids.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Evolution, Molecular; Fluoroquinolones; Gene Expression; Genetic Variation; Genomics; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multigene Family; Penicillins; Phylogeny; Plasmids; Replicon | 2018 |
First report of the isolation of bla
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Japan; Levofloxacin; Microbial Sensitivity Tests | 2018 |
Long-Term, Low-Frequency Cluster of a German-Imipenemase-1-Producing Enterobacter hormaechei ssp. steigerwaltii ST89 in a Tertiary Care Hospital in Germany.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Germany; Humans; Integrons; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Prospective Studies; Retrospective Studies; Tertiary Care Centers | 2018 |
Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Humans; Invasive Pulmonary Aspergillosis; Piperacillin, Tazobactam Drug Combination; Prospective Studies | 2018 |
Rapid detection of carbapenemase activity of Enterobacteriaceae isolated from positive blood cultures by MALDI-TOF MS.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Colistin; Comoros; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genome, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Young Adult | 2018 |
Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genome, Bacterial; Genomics; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids; United States | 2018 |
Evaluation of the Rapid Polymyxin NP test for detection of colistin susceptibility in Enterobacteriaceae isolated from Thai patients.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxins; Thailand | 2018 |
Development of a risk prediction model of carbapenem-resistant Enterobacteriaceae colonization among patients in intensive care units.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Intensive Care Units; Logistic Models; Retrospective Studies; Risk Factors | 2018 |
New guidelines on drug-resistant CRE.
Topics: Anti-Bacterial Agents; Australia; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae Infections; Guidelines as Topic; Humans | 2013 |
Within-a-Day Detection and Rapid Characterization of Carbapenemase by Use of a New Carbapenem Inactivation Method-Based Test, CIMplus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Time Factors | 2018 |
VIM/IMP carbapenemase-producing Enterobacteriaceae in Poland: epidemic Enterobacter hormaechei and Klebsiella oxytoca lineages.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemics; Humans; Integrons; Klebsiella oxytoca; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Poland | 2018 |
Considerations for Systemic and Topical Treatment of Morganella morganii Septicemia Arising from Maggot Infestation.
Topics: Administration, Intravenous; Administration, Topical; Aged, 80 and over; Carbapenems; Enterobacteriaceae Infections; Humans; Hydrotherapy; Hyperkeratosis, Epidermolytic; Insecticides; Lower Extremity; Male; Morganella morganii; Myiasis; Ointments; Permethrin; Postthrombotic Syndrome; Sepsis; Treatment Outcome | 2018 |
FRI-4 carbapenemase-producing Enterobacter cloacae complex isolated in Tokyo, Japan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Humans; Microbial Sensitivity Tests; Plasmids; Tokyo; Whole Genome Sequencing | 2018 |
Risk factors for colistin-resistant Enterobacteriaceae in a low-endemicity setting for carbapenem resistance - a matched case-control study.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Hospitals, University; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Switzerland | 2018 |
Comparison of empirical therapy with cefoperazone/sulbactam or a carbapenem for bloodstream infections due to ESBL-producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Case-Control Studies; Cefoperazone; China; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam | 2018 |
An ancient family of mobile genomic islands introducing cephalosporinase and carbapenemase genes in Enterobacteriaceae.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporinase; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Genome, Bacterial; Genomic Islands; Humans; Infant, Newborn; Klebsiella pneumoniae; Mass Spectrometry; Microbial Sensitivity Tests; Prophages; Sequence Analysis, DNA | 2018 |
Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emerges.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; New York City | 2018 |
Fast and expensive (PCR) or cheap and slow (culture)? A mathematical modelling study to explore screening for carbapenem resistance in UK hospitals.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Mass Screening; Models, Theoretical; Polymerase Chain Reaction; United Kingdom | 2018 |
Immediate and later impacts of antimicrobial consumption on carbapenem-resistant Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella spp. in a teaching hospital in Brazil: a 10-year trend study.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Brazil; Carbapenems; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Klebsiella; Pseudomonas aeruginosa; Pseudomonas Infections | 2018 |
Molecular characterization and epidemiology of carbapenem non-susceptible Enterobacteriaceae isolated from the Eastern region of Heilongjiang Province, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; China; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Retrospective Studies; Young Adult | 2018 |
NDM-1-producing Enterobacter aerogenes isolated from a patient with a JJ ureteric stent in situ.
Topics: Aged; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Microbial Sensitivity Tests; Stents; Ureteral Obstruction; Urinary Tract Infections | 2019 |
Emergence of IMP-4-Producing Enterobacter aerogenes Clinical Isolate.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Hospitals; Humans; Integrons; Male; Microbial Sensitivity Tests; Republic of Korea; Sequence Analysis, DNA | 2018 |
Evaluation of rapid KPC carbapenemase detection method based on MALDI-TOF VITEK MS spectra analysis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2018 |
Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles.
Topics: Anti-Bacterial Agents; Area Under Curve; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Europe; Genes, Bacterial; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; North America; Plasmids; ROC Curve | 2018 |
Diagnostic Accuracy of BD Phoenix CPO Detect for Carbapenemase Production in 190 Enterobacteriaceae Isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Diagnostic Tests, Routine; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2018 |
Enterobacter cloacae Complex Sequence Type 171 Isolates Expressing KPC-4 Carbapenemase Recovered from Canine Patients in Ohio.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Dogs; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Ohio; Phylogeny; Plasmids; Whole Genome Sequencing | 2018 |
Molecular characterization of plasmid-encoded Tripoli MBL 1 (TMB-1) in Enterobacteriaceae.
Topics: beta-Lactam Resistance; beta-Lactamases; Bile; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Citrobacter freundii; Conjugation, Genetic; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Plasmids; Rectum; Whole Genome Sequencing | 2019 |
Emergence of a carbapenem-resistant and colistin-heteroresistant Enterobacter cloacae clinical isolate in Japan.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Diarrhea; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Feces; Female; Humans; Japan; Microbial Sensitivity Tests; Mutation | 2019 |
Transmission of IMI-2 carbapenemase-producing Enterobacteriaceae from river water to human.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Male; Plasmids; Rivers | 2018 |
Risk factors for mortality among carbapenem-resistant enterobacteriaceae carriers with focus on immunosuppression.
Topics: Aged; Aged, 80 and over; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Case-Control Studies; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Immunosuppression Therapy; Israel; Male; Middle Aged; Prospective Studies; Risk Factors | 2019 |
Does Quick Sepsis-Related Organ Failure Assessment Suggest the Use of Initial Empirical Carbapenem Therapy in Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Bacteria? :A Multicenter Case-Control Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals; Humans; Male; Middle Aged; Organ Dysfunction Scores; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2019 |
Characterization of a multidrug resistant Citrobacter amalonaticus clinical isolate harboring bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Citrobacter; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Phylogeny | 2019 |
Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network: a COMBACTE LAB-Net survey.
Topics: Acinetobacter; Acinetobacter Infections; Bacteriological Techniques; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Europe; Humans; Prevalence; Procedures and Techniques Utilization; Surveys and Questionnaires | 2019 |
Rapid detection of resistance to carbapenems and cephalosporins in Enterobacteriaceae using liquid chromatography tandem mass spectrometry.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Chromatography, High Pressure Liquid; Enterobacteriaceae Infections; Escherichia coli; Humans; Hydrolysis; Microbial Sensitivity Tests; Tandem Mass Spectrometry; Time Factors | 2018 |
Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Epidemiological Monitoring; Escherichia coli; Escherichia coli Proteins; Genotype; Humans; Klebsiella pneumoniae; Longitudinal Studies; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phenotype; Polymerase Chain Reaction; Sequence Analysis, DNA | 2018 |
SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Inhibitory Concentration 50; Meropenem; Microbial Sensitivity Tests; Picolinic Acids; Protein Binding; Structure-Activity Relationship | 2019 |
Rapid detection of beta-lactamase production including carbapenemase by thin layer chromatography.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporin Resistance; Cephalosporins; Chromatography, Thin Layer; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2019 |
Societal willingness to pay to avoid mortality and morbidity from Clostridioides difficile and carbapenem-resistant Enterobacteriaceae infections in the United States.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Clostridium; Clostridium Infections; Cross Infection; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Morbidity; United States | 2019 |
Carbapenemases: The never-ending story.
Topics: Antimicrobial Stewardship; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Humans; R Factors | 2019 |
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Africa; Aminoglycosides; Anti-Bacterial Agents; Asia; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Genotype; Humans; Microbial Sensitivity Tests; Nebramycin; South America; Whole Genome Sequencing | 2019 |
Genetic characterization of multiple NDM-1-producing clinical isolates in Mexico.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Humans; Integrons; Mexico; Microbial Sensitivity Tests | 2019 |
Nitro-Carba test, a novel and simple chromogenic phenotypic method for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae Infections; Humans; Hydrolysis; Microbial Sensitivity Tests; Reproducibility of Results | 2019 |
A cluster of carbapenemase-producing Enterobacter cloacae complex ST171 at a tertiary care center demonstrating an ongoing regional threat.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Expression; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Minnesota; North Dakota; Phylogeny; Plasmids; Tertiary Care Centers; Whole Genome Sequencing | 2019 |
Preemptive isolation and active surveillance in the prevention and control of nosocomial infection reduce the incidence of carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Incidence; Patient Isolation; Risk Factors; Tertiary Care Centers | 2019 |
Putative horizontal transfer of carbapenem resistance between Klebsiella pneumoniae and Kluyvera ascorbata during abdominal infection: A case report.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Bile Ducts; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Kluyvera; Male; Microbial Sensitivity Tests | 2019 |
ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome.
Topics: Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Carrier State; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Rectum; Risk Factors; Switzerland; Treatment Outcome | 2019 |
Reduced Incubation Time of the Modified Carbapenem Inactivation Test and Performance of Carbapenem Inactivation in a Set of Carbapenemase-Producing Enterobacteriaceae with a High Proportion of
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Diagnostic Tests, Routine; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Time Factors | 2019 |
Phenotypic and molecular detection methods for carbapenemase-producing organisms and their clinical significance at two Scottish tertiary care hospitals.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Hydrolysis; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Diagnostic Techniques; Phenotype; Real-Time Polymerase Chain Reaction; Scotland; Sensitivity and Specificity; Tertiary Care Centers | 2019 |
Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Genotype; Hospitals; Humans; Male; Middle Aged; Multilocus Sequence Typing; Polymyxin B; Retrospective Studies; Risk Factors; Singapore; Treatment Outcome; Young Adult | 2019 |
Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission.
Topics: Adult; Aged; Baltimore; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Cohort Studies; Decision Trees; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Machine Learning; Male; Middle Aged; Patient Admission; Rectum; Sensitivity and Specificity; Young Adult | 2019 |
Tracking the spread of carbapenem-resistant Enterobacteriaceae (CRE) through clinical cultures alone underestimates the spread of CRE even more than anticipated.
Topics: Anti-Bacterial Agents; California; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Health Facilities; Humans | 2019 |
Detection and characterization of tigecycline heteroresistance in E. cloacae: clinical and microbiological findings.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; China; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Tigecycline | 2019 |
Carbapenem-resistant Enterobacteriaceae: global action required.
Topics: Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Developing Countries; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Prospective Studies | 2019 |
Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Developing Countries; Enterobacteriaceae Infections; Female; Hematologic Diseases; Humans; Male; Middle Aged; Prospective Studies; Retrospective Studies | 2019 |
Rapid and economical detection of eight carbapenem-resistance genes in Enterobacteriaceae, Pseudomonas spp, and Acinetobacter spp directly from positive blood cultures using an internally controlled multiplex-PCR assay.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Prospective Studies; Pseudomonas; Pseudomonas Infections | 2019 |
Epidemiology and successful containment of a carbapenem-resistant Enterobacteriaceae outbreak in a Southern Italian Transplant Institute.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacteriaceae Infections; Humans; Infection Control; Italy; Organ Transplantation; Regression Analysis; Risk Factors; Transplant Recipients | 2019 |
Souha Kanj.
Topics: Carbapenems; Cohort Studies; Drug Resistance, Microbial; Enterobacteriaceae Infections; Hematologic Diseases; Hospitalization; Humans; Poverty; Prospective Studies | 2019 |
Emergence of Carbapenem-Resistant
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Myanmar; Pseudomonas; RNA, Ribosomal, 16S | 2019 |
The Likelihood of Developing a Carbapenem-Resistant
Topics: Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Intensive Care Units; Length of Stay | 2019 |
Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People's Democratic Republic.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Laos; Male; Middle Aged; Public Health Surveillance | 2019 |
The effect of gut microbiota and probiotic organisms on the properties of extended spectrum beta-lactamase producing and carbapenem resistant Enterobacteriaceae including growth, beta-lactamase activity and gene transmissibility.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Gastrointestinal Microbiome; Humans; Microbial Sensitivity Tests; Probiotics | 2019 |
New Delhi Metallo-β-lactamase and other mechanisms of carbapenemases among Enterobacteriaceae in rural South India.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Humans; India; Klebsiella; Microbial Sensitivity Tests; Prevalence; Rural Population | 2019 |
Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA
Topics: beta-Lactam Resistance; California; Carbapenems; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Geography, Medical; Humans; Microbial Sensitivity Tests | 2019 |
The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies; Retrospective Studies; Risk Factors | 2020 |
Rapid detection of the main carbapenemases in Brazil directly from spiked blood culture using the RESIST-3 O.K.N. immunoassay.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Brazil; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Immunoassay | 2019 |
Genetic and biochemical characterization of FRI-3, a novel variant of the Ambler class A carbapenemase FRI-1.
Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; Germany; Humans; Hydrolysis; Intensive Care Units; Polymerase Chain Reaction; Rectum; Sequence Analysis, DNA | 2019 |
Imipenemase-producing carbapenem-resistant Enterobacteriaceae transmission in a long-term-care facility during a community-wide multidrug resistant organism outbreak-North Carolina, 2017.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Long-Term Care; Male; Middle Aged; North Carolina; Nursing Homes; Young Adult | 2020 |
Extended spectrum beta-lactamase producing
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged | 2019 |
Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Risk Factors | 2019 |
Validation of a carbapenem-resistant Enterobacteriaceae colonization risk prediction model: A retrospective cohort study in Korean intensive care units.
Topics: Age Factors; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Middle Aged; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Sex Factors | 2019 |
The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tertiary Healthcare; Treatment Outcome | 2012 |
Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Follow-Up Studies; Hospitals; Humans; Male; Middle Aged; Patient Discharge; Rectum; Time Factors | 2013 |
[Surveillance of carbapenem-resistant enterobacteria in stool cultures in a university hospital in Santiago, Chile].
Topics: Anti-Bacterial Agents; Carbapenems; Chile; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Hospitals, University; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prospective Studies | 2013 |
Vital signs: carbapenem-resistant Enterobacteriaceae.
Topics: Adolescent; Adult; Aged; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Klebsiella Infections; Middle Aged; Population Surveillance; United States; Young Adult | 2013 |
Isolation of genetically unrelated bla(NDM-1)-positive Providencia rettgeri strains in Israel.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Humans; Israel; Microbial Sensitivity Tests; Providencia; RNA, Ribosomal, 16S | 2013 |
Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction | 2013 |
Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence | 2013 |
Enterobacter cloacae producing an uncommon class A carbapenemase, IMI-1, from Singapore.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Fatal Outcome; Humans; Male; Microbial Sensitivity Tests; Singapore | 2013 |
Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in Enterobacteriaceae isolated in India and the UK.
Topics: Amikacin; Aminoglycosides; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; India; Methyltransferases; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; United Kingdom | 2013 |
Prevalence of β-lactamase-encoding genes among Enterobacteriaceae bacteremia isolates collected in 26 U.S. hospitals: report from the SENTRY Antimicrobial Surveillance Program (2010).
Topics: Bacteremia; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Promoter Regions, Genetic; Sequence Analysis, DNA; United States | 2013 |
Distribution of extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMA
Topics: Anti-Bacterial Agents; Asia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Pacific Ocean | 2013 |
"Nightmare" bacteria on the rise in US hospitals, long-term care facilities.
Topics: Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Long-Term Care; United States | 2013 |
First report of a nonmetallocarbapenemase class A carbapenemase in an Enterobacter cloacae isolate from Colombia.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colombia; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Microbial Sensitivity Tests | 2013 |
Health-care associated infection: USA on the right track.
Topics: Carbapenems; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Infection Control; United States | 2013 |
Isolation of carbapenem-resistant NDM-1-positive Providencia rettgeri in Mexico.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Female; Humans; Male; Mexico; Microbial Sensitivity Tests; Middle Aged; Plasmids; Providencia; Young Adult | 2013 |
High prevalence of VIM-4 and NDM-1 metallo-β-lactamase among carbapenem-resistant Enterobacteriaceae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Kuwait; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Plasmids; Sequence Analysis, DNA | 2013 |
Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Michigan; Microbial Sensitivity Tests; Urinary Tract Infections; Vancomycin Resistance | 2013 |
The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Patient Isolation | 2013 |
Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Early Diagnosis; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2013 |
Carbapenem-resistant Enterobacteriaceae: what has happened, and what is being done.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; United States | 2013 |
Carbapenem-resistant Enterobacteriaceae: a growing threat.
Topics: Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Practice Guidelines as Topic; United States | 2013 |
Reply to Altshuler et al.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
Treatment of extended-spectrum Beta-lactamase enterobacteriaceae with cefepime: the dose matters, too.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
Multiclonal dispersal of KPC genes following the emergence of non-ST258 KPC-producing Klebsiella pneumoniae clones in Madrid, Spain.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Molecular Typing; Plasmids; Spain; Young Adult | 2013 |
Evaluation of LAMP assay using phenotypic tests and conventional PCR for detection of blaNDM-1 and blaKPC genes among carbapenem-resistant clinical Gram-negative isolates.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Sensitivity and Specificity | 2013 |
Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Communicable Diseases, Emerging; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Minisatellite Repeats; Molecular Typing; Polymerase Chain Reaction; Prevalence; Retrospective Studies; Tertiary Care Centers; United Kingdom | 2013 |
Current status of carbapenemases in Latin America.
Topics: Acinetobacter baumannii; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Geography; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Latin America; Pseudomonas aeruginosa | 2013 |
Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011.
Topics: Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Female; Humans; Klebsiella pneumoniae; Plasmids; Polymerase Chain Reaction; Retrospective Studies; Time Factors | 2013 |
Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: a view from the trenches.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Disease Transmission, Infectious; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Humans; Infection Control | 2013 |
An in silico approach for understanding the molecular evolution of clinically important metallo-beta-lactamases.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Binding Sites; Carbapenems; Enterobacteriaceae Infections; Evolution, Molecular; Humans; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Phylogeny; Protein Binding; Receptors, Cell Surface; Sequence Alignment; Sequence Analysis, DNA; Thienamycins | 2013 |
The high incidence of carbapenem-resistant Klebsiella pneumoniae in urine from elderly hospital patients may facilitate the spread of resistant strains to the community.
Topics: Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Community-Acquired Infections; Enterobacteriaceae Infections; Gene Expression; Humans; Incidence; Italy; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Tertiary Healthcare | 2014 |
Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
Topics: Adult; Aged; Carbapenems; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; United States; Young Adult | 2013 |
High levels of extended-spectrum beta-lactamases in a major teaching hospital in Ghana: the need for regular monitoring and evaluation of antibiotic resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Female; Fluoroquinolones; Gene Expression; Ghana; Hospitals, Teaching; Humans; Infant; Infant, Newborn; Male; Middle Aged; Sulfonamides | 2013 |
Enterobacteria: Ban resistant strains from food chain.
Topics: Animals; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Food Contamination; Humans; Meat; Poultry; Public Health | 2013 |
Evaluation of the potential impact of a carbapenem de-escalation program in an academic healthcare system.
Topics: Academic Medical Centers; Acinetobacter; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Enterobacteriaceae Infections; Humans; Michigan; Models, Statistical; Pseudomonas; Retrospective Studies | 2014 |
Clinical epidemiology of carbapenem-resistant enterobacteriaceae in community hospitals: a case-case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Hospitals, Community; Humans; Male; Middle Aged; Texas | 2013 |
Hospital clonal dissemination of Enterobacter aerogenes producing carbapenemase KPC-2 in a Chinese teaching hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Case-Control Studies; China; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology | 2014 |
Dissemination of carbapenemase-producing Enterobacteriaceae in France, 2012.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Polymerase Chain Reaction; Sequence Analysis, DNA | 2014 |
Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Infection Control | 2013 |
Infection control update: the emerging threat of CRE. A potential new superbug resists antibiotics.
Topics: Anti-Bacterial Agents; Carbapenems; Disease Outbreaks; Disinfection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Guideline Adherence; Humans; Infection Control; United States | 2013 |
Enterobacteriaceae bacteremia: risk factors for ESBLPE.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Child; Child, Preschool; Databases, Factual; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Departments; Hospitals, Teaching; Humans; Infant; Infant, Newborn; Male; Middle Aged; Paris; Prevalence; Prospective Studies; Risk Factors; Substrate Specificity; Young Adult | 2014 |
New carbapenases in Brazil.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2014 |
Characterization of novel plasmid-mediated β-lactamases (SHV-167 and ACT-16) associated with New Delhi metallo-β-lactamase-1 harbouring isolates from neonates in India.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; India; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids; Sepsis; Sequence Analysis, DNA | 2014 |
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 2014 |
Notes from the Field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013.
Topics: beta-Lactamases; Carbapenems; Case-Control Studies; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Escherichia coli; Humans; Illinois | 2014 |
Diagnostics for superbugs.
Topics: Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Diagnostic Techniques; United States | 2013 |
Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Genotype; Humans; Intensive Care Units; Polymerase Chain Reaction; Prevalence; Republic of Korea | 2014 |
Characterization of KPC-2-producing Escherichia coli, Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Klebsiella oxytoca isolates from a Chinese Hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; China; Cross Infection; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Hospitals; Humans; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Survival Analysis | 2014 |
NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Humans; Plasmids; Tertiary Care Centers | 2014 |
Editorial commentary: imminent challenges: carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancy.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Hematologic Neoplasms; Humans; Transplant Recipients | 2014 |
The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Risk Factors; Transplant Recipients; Treatment Outcome | 2014 |
[Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Turkey | 2014 |
The emerging threat from carbapenem-resistant enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hand Hygiene; Humans; Infection Control; Practice Guidelines as Topic; Risk Assessment; United States | 2013 |
The presence of blaKPC-mediated resistance in Enterobacteriaceae in Cairo University hospitals in Egypt and its correlation with in vitro carbapenem susceptibility.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Klebsiella pneumoniae | 2014 |
Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Michigan; Middle Aged; Population Surveillance; Young Adult | 2014 |
Establishment of a statewide network for carbapenem-resistant enterobacteriaceae prevention in a low-incidence region.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Clinical Laboratory Techniques; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Incidence; Oregon; Population Surveillance; Real-Time Polymerase Chain Reaction | 2014 |
Outcomes of an enhanced surveillance program for carbapenem-resistant Enterobacteriaceae.
Topics: Adult; Aged; Aged, 80 and over; Carbapenems; Chicago; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Middle Aged; Population Surveillance; Program Evaluation; Retrospective Studies; Risk Factors | 2014 |
Thirty-day laboratory-based surveillance for carbapenem-resistant Enterobacteriaceae in the Minneapolis-St. Paul metropolitan area.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Child; Child, Preschool; Clinical Laboratory Techniques; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feasibility Studies; Female; Humans; Infant; Male; Middle Aged; Minnesota; Population Surveillance; Urban Population; Young Adult | 2014 |
Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae.
Topics: Adult; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Surveys and Questionnaires | 2014 |
Carbapenem-resistant Enterobacteriaceae in pediatric patients: epidemiology and risk factors.
Topics: Adolescent; Carbapenems; Case-Control Studies; Child; Child, Preschool; District of Columbia; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, Pediatric; Humans; Infant; Male; Odds Ratio; Risk Factors | 2014 |
Pilot testing of an out-of-country medical care questionnaire with screening and cost analysis of preemptive isolation for carbapenem-resistant Enterobacteriaceae in a large Canadian health region.
Topics: Canada; Carbapenems; Costs and Cost Analysis; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Pilot Projects; Primary Prevention; Surveys and Questionnaires; Travel; United States | 2014 |
Establishing surveillance for carbapenem-resistant Enterobacteriaceae in Minnesota, 2012.
Topics: Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Minnesota; Population Surveillance | 2014 |
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2014 |
Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany.
Topics: beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Germany; Humans; Microbial Sensitivity Tests | 2014 |
In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Moths; Tigecycline | 2014 |
Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephamycins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Retrospective Studies; Sepsis; Urinary Tract Infections | 2014 |
Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Critical Illness; Croatia; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Survival Analysis | 2014 |
I read about infections from the so-called "superbugs." Is antibiotic resistance increasing?
Topics: beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; United States | 2013 |
Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.
Topics: Aged; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Critical Illness; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Middle Aged; Risk Factors | 2014 |
Carbapenem-resistant Enterobacteriaceae: a call for cultural change.
Topics: Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; National Institutes of Health (U.S.); United States | 2014 |
[The genotype and epidemiological feature of the Enterobacteriaceae carrying carbapenemase in China].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2014 |
Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Case-Control Studies; Child; Child, Preschool; China; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hospitals, University; Humans; Infant; Male; Middle Aged; Risk Factors; Young Adult | 2014 |
High incidence and endemic spread of NDM-1-positive Enterobacteriaceae in Henan Province, China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Fosfomycin; Genotype; Humans; Incidence; Multilocus Sequence Typing; Plasmids | 2014 |
Heteroresistance to carbapenems in New Delhi metallo-β-lactamase-1-producing isolates: a challenge for detection?
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Disease Susceptibility; Drug Resistance, Multiple; Enterobacteriaceae Infections; Ertapenem; Humans; Meropenem; Providencia; Thienamycins | 2014 |
Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Critical Care; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Nursing Homes; Patient Discharge; Risk Factors | 2014 |
pRMH760, a precursor of A/C₂ plasmids carrying blaCMY and blaNDM genes.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Gene Expression Regulation, Bacterial; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Phenotype; Plasmids | 2014 |
A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Disease Outbreaks; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Molecular Epidemiology; Molecular Weight; Plasmids; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2014 |
A national intervention to prevent the spread of carbapenem-resistant Enterobacteriaceae in Israeli post-acute care hospitals.
Topics: Aged; Aged, 80 and over; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Infection Control; Israel; Male; Middle Aged; Organizational Policy; Prospective Studies | 2014 |
Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Intensive Care Units; Outcome Assessment, Health Care; United States; Virginia | 2014 |
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies; Retrospective Studies | 2014 |
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Case-Control Studies; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Hospital Mortality; Humans; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2014 |
Characteristics and costs of carbapenemase-producing enterobacteria carriers (2012/2013).
Topics: Aged; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Disease Outbreaks; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Hospital Costs; Hospital Units; Hospitals, General; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Patient Isolation; Personnel, Hospital; Retrospective Studies | 2014 |
Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States.
Topics: Asymptomatic Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Community; Humans; Microbial Sensitivity Tests; Prevalence; Retrospective Studies; Southeastern United States | 2014 |
Much to do about carbapenem-resistant Enterobacteriaceae: why supplementing surveillance may be the key to stopping spread.
Topics: Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Community; Humans | 2014 |
Pediatric carbapenem-resistant Enterobacteriaceae in Los Angeles, California, a high-prevalence region in the United States.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Genotype; Humans; Infant; Klebsiella pneumoniae; Los Angeles; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Tertiary Care Centers; Young Adult | 2015 |
Carbapenem-resistant Enterobacter gergoviae harbouring blaKPC-2 in Brazil.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Enterobacter; Enterobacteriaceae Infections; Genotype; Humans; Microbial Sensitivity Tests | 2014 |
Molecular surveillance and prevalence of carbapenem-resistant Enterobacteriaceae in Northern Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Prevalence; Public Health Surveillance; Taiwan | 2014 |
High diversity of beta-lactamases in the General Hospital Vienna verified by whole genome sequencing and statistical analysis.
Topics: Anti-Bacterial Agents; Austria; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Frequency; Genetic Variation; Genome, Bacterial; Hospitals, General; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2014 |
Predictors of use of infection control precautions for multiresistant gram-negative bacilli in Australian hospitals: analysis of a national survey.
Topics: Anti-Bacterial Agents; Australia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Hospitals; Humans; Infection Control | 2014 |
Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Delivery of Health Care; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Los Angeles; Microbial Sensitivity Tests; Molecular Typing; Real-Time Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tertiary Care Centers | 2014 |
Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India; Microbial Sensitivity Tests; Prevalence; Tertiary Care Centers | 2015 |
Gastrointestinal endoscopes: a need to shift from disinfection to sterilization?
Topics: Carbapenems; Disinfection; Duodenoscopes; Enterobacteriaceae Infections; Equipment Contamination; Escherichia coli; Female; Humans; Male | 2014 |
New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Case-Control Studies; Cohort Studies; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Bacterial; Duodenoscopes; Enterobacteriaceae Infections; Equipment Contamination; Escherichia coli; Female; Hospitals; Humans; Illinois; Male; Middle Aged | 2014 |
Nosocomial infections by Klebsiella pneumoniae carbapenemase producing enterobacteria in a teaching hospital.
Topics: Adolescent; Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Retrospective Studies; Young Adult | 2014 |
First report in China of Enterobacteriaceae clinical isolates coharboring blaNDM-1 and blaIMP-4 drug resistance genes.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Plasmids; Quinolones; Thienamycins | 2015 |
Emergence of novel bla(KPC-13) among carbapenem-resistant Enterobacteriaceae in Thailand.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Thailand | 2014 |
Evaluation of carbapenem-resistant Enterobacteriaceae in an Italian setting: report from the trench.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Italy; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Prospective Studies; Random Amplified Polymorphic DNA Technique | 2015 |
Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Urinary Tract Infections | 2014 |
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Imipenem; Incidence; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenotype; Prevalence; Prospective Studies; Republic of Korea; Retrospective Studies; Thienamycins | 2014 |
Antimicrobial treatment and outcomes of critically ill patients with OXA-48like carbapenemase-producing Enterobacteriaceae infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Critical Illness; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
Carbapenem-resistant Enterobacteriaceae and the correlation between carbapenem and fluoroquinolone usage and resistance in the US military health system.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Hospitals, Military; Humans; Incidence; Military Personnel; United States | 2015 |
Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans; Public Health; Spain | 2014 |
Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Body Fluids; Carbapenems; Carrier State; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Laboratories, Hospital; Microbial Sensitivity Tests; Phenotype; Proteomics | 2014 |
Four carbapenem-resistant gram-negative species carrying distinct carbapenemases in a single patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacter aerogenes; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2015 |
Phenotypic and molecular characterization of 942 carbapenem-resistant Enterobacteriaceae (CRE) in southern Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Typing; Phenotype; Predictive Value of Tests | 2015 |
Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cohort Studies; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Propensity Score; Proportional Hazards Models; Proteus mirabilis; Survival Rate; Time Factors | 2015 |
Editorial commentary: Bloodstream infection caused by extended-spectrum β-lactamase-producing Gram-negative bacteria: how to define the best treatment regimen?
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Enterobacteriaceae Infections; Female; Humans; Male; Penicillanic Acid | 2015 |
Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Taiwan; Thienamycins | 2015 |
Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hypoalbuminemia; Israel; Middle Aged; Prospective Studies; Risk Factors | 2015 |
Sterilization of endoscopic instruments.
Topics: Carbapenems; Disinfection; Duodenoscopes; Enterobacteriaceae Infections; Equipment Contamination; Escherichia coli; Female; Humans; Male | 2015 |
Sterilization of endoscopic instruments--reply.
Topics: Carbapenems; Disinfection; Duodenoscopes; Enterobacteriaceae Infections; Equipment Contamination; Escherichia coli; Female; Humans; Male | 2015 |
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Incidence; Italy; Population Surveillance; Seasons | 2015 |
Efficacy of a novel skin antiseptic against carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Infective Agents, Local; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Silver; Skin | 2015 |
Carbapenem-nonsusceptible Enterobacteriaceae in Taiwan.
Topics: Anti-Infective Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Phylogeny; Prevalence; Species Specificity; Taiwan | 2015 |
Risk Factors for Recurrence of Carbapenem-Resistant Enterobacteriaceae Carriage: Case-Control Study.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Carrier State; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Israel; Male; Middle Aged; Patient Readmission; Prospective Studies; Prostheses and Implants; Rectum; Recurrence; Risk Factors; Time Factors | 2015 |
Carbapenem non-susceptible enterobacteriaceae in Quebec, Canada: results of a laboratory surveillance program (2010-2012).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Quebec; Young Adult | 2015 |
Further Modification of the Modified Hodge Test for Detecting Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Multiplex Polymerase Chain Reaction; Phenotype | 2015 |
Monitoring antibiotic-resistant enterobacteria faecal levels is helpful in predicting antibiotic susceptibility of bacteraemia isolates in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Young Adult | 2015 |
Molecular epidemiology of KPC-2-producing Enterobacteriaceae (non-Klebsiella pneumoniae) isolated from Brazil.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Genetic Variation; Genotype; Humans; Molecular Epidemiology; Molecular Typing | 2015 |
Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Ceftazidime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Iodides; Klebsiella Infections; Klebsiella pneumoniae; Molecular Docking Simulation; Protein Conformation | 2015 |
A novel case of Raoultella planticola urinary tract infection in a female: comment on 'Nosocomial pneumonia caused by carbapenem-resistant Raoultella planticola: a case report and literature review'.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2015 |
Evaluation of a new rapid test for carbapenemase detection in carbapenem resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Polymerase Chain Reaction | 2015 |
KPC and NDM-1 genes in related Enterobacteriaceae strains and plasmids from Pakistan and the United States.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Computational Biology; Enterobacteriaceae; Enterobacteriaceae Infections; Genomics; Humans; Microbial Sensitivity Tests; Pakistan; Plasmids; United States | 2015 |
Carbapenems Versus Piperacillin-Tazobactam for Bloodstream Infections of Nonurinary Source Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Intraabdominal Infections; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Skin Diseases, Bacterial; Soft Tissue Infections | 2015 |
Dissemination of NDM-1-Producing Enterobacteriaceae Mediated by the IncX3-Type Plasmid.
Topics: Aged; Aged, 80 and over; beta-Lactamases; Blotting, Southern; Carbapenems; China; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Host-Pathogen Interactions; Humans; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2015 |
Investigation of VIM, IMP, NDM-1, KPC AND OXA-48 enzymes in Enterobacteriaceae strains.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrolysis; Isoenzymes; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prospective Studies | 2015 |
[Active surveillance of rectal colonization by carbapenemase-producing Enterobacteriaceae in hospitalized patients at the critical unit of private hospital in Santiago, Chile].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Chile; Enterobacteriaceae Infections; Escherichia coli; Hospitals, Private; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Rectum | 2015 |
Evaluation of Remel Spectra CRE Agar for Detection of Carbapenem-Resistant Bacteria from Rectal Swabs Obtained from Residents of a Long-Term-Care Facility.
Topics: Agar; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Long-Term Care; Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Time Factors | 2015 |
Characterization of Carbapenem-Resistant Enterobacteriaceae with High Rate of Autochthonous Transmission in the Arabian Peninsula.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle East | 2015 |
Carbapenem-resistant Enterobacteriaceae carriers in acute care hospitals and postacute-care facilities: The effect of organizational culture on staff attitudes, knowledge, practices, and infection acquisition rates.
Topics: Anti-Bacterial Agents; Attitude of Health Personnel; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Guideline Adherence; Health Facilities; Health Knowledge, Attitudes, Practice; Health Personnel; Hospitals; Humans; Infection Control; Israel; Organizational Culture | 2015 |
Rapid Electrochemical Detection of New Delhi Metallo-beta-lactamase Genes To Enable Point-of-Care Testing of Carbapenem-Resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrochemical Techniques; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Protein Array Analysis; Time Factors | 2015 |
Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010-2013).
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Europe; Humans; Microbial Sensitivity Tests; Minocycline; Multiplex Polymerase Chain Reaction; Sequence Analysis, DNA; Tigecycline | 2015 |
Genomically Informed Surveillance for Carbapenem-Resistant Enterobacteriaceae in a Health Care System.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Boston; Carbapenems; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Epidemiological Monitoring; Genes, Bacterial; Genetic Variation; Genome, Bacterial; Genotype; Hospitals; Humans; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2015 |
Carbapenem-Resistant Enterobacteriaceae: A Case Series of Infections at Hartford Hospital.
Topics: Aged; Aged, 80 and over; Carbapenems; Connecticut; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors | 2015 |
New Delhi Metallo-β-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cluster Analysis; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids | 2015 |
Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Communicable Disease Control; Communicable Diseases, Emerging; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Phenotype; Public Health Surveillance; United States | 2015 |
The Use of a Combination Antibiogram to Assist with the Selection of Appropriate Antimicrobial Therapy for Carbapenemase-Producing Enterobacteriaceae Infections.
Topics: Anti-Bacterial Agents; Carbapenems; Databases, Factual; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2015 |
Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cohort Studies; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Young Adult | 2015 |
Clinical Performance of a Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Method for Detection of Certain blaKPC-Containing Plasmids.
Topics: Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Plasmids; Prospective Studies; Retrospective Studies; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
The Complex Epidemiology of Carbapenem-Resistant Enterobacter Infections: A Multicenter Descriptive Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Israel; Kaplan-Meier Estimate; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Michigan; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Retrospective Studies; Severity of Illness Index | 2015 |
Electronic Public Health Registry of Extensively Drug-Resistant Organisms, Illinois, USA.
Topics: Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae Infections; Health Information Exchange; Humans; Illinois; Population Surveillance; Public Health; Registries; United States | 2015 |
Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Thailand; Young Adult | 2015 |
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2015 |
Carbapenem-Resistant Enterobacteriaceae: A Major Prevalence Difference due to the High Performance of Carbapenemase Producers when compared to the Nonproducers.
Topics: Brazil; Carbapenems; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Prevalence; Rectum | 2015 |
Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Carrier State; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hospitalization; Humans; Incidence; Infection Control; Intensive Care Units; Male; Middle Aged; Prevalence; Risk Factors; Tertiary Healthcare | 2015 |
Measuring Carbapenem-Resistant Enterobacteriaceae in the United States: A Critical Step for Control.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2015 |
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Colorado; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Georgia; Humans; Incidence; Infant; Male; Maryland; Middle Aged; Minnesota; New Mexico; New York; Oregon; Population Surveillance; Sex Distribution | 2015 |
Evaluation of carbapenem resistance using phenotypic and genotypic techniques in Enterobacteriaceae isolates.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genes, Bacterial; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multiplex Polymerase Chain Reaction; Phenotype; Prevalence; Turkey; Young Adult | 2015 |
Occurrence of blaNDM-₁ & absence of blaKPC genes encoding carbapenem resistance in uropathogens from a tertiary care centre from north India.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India; Microbial Sensitivity Tests; Urinary Tract Infections | 2015 |
blaNDM-1 Carriage on IncR Plasmid in Enterobacteriaceae Strains.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Citrobacter koseri; Colistin; Conjugation, Genetic; Croatia; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Expression; Gene Transfer, Horizontal; Humans; Isoenzymes; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Plasmids; Sequence Analysis, DNA; Tigecycline | 2016 |
Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.
Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant; Intensive Care Units; Prevalence; United States | 2015 |
Demographic and infection characteristics of patients with carbapenem-resistant Enterobacteriaceae in a community hospital: Development of a bedside clinical score for risk assessment.
Topics: Adolescent; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Demography; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Hospitals, Community; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; ROC Curve; Sensitivity and Specificity | 2016 |
Carbapenem use in French hospitals: A nationwide survey at the patient level.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis; Surveys and Questionnaires; Young Adult | 2015 |
Cost Utility of Competing Strategies to Prevent Endoscopic Transmission of Carbapenem-Resistant Enterobacteriaceae.
Topics: Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cholecystectomy, Laparoscopic; Choledocholithiasis; Cost-Benefit Analysis; Decision Support Techniques; Disease Transmission, Infectious; Drug Resistance, Bacterial; Duodenoscopes; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Monte Carlo Method; Primary Prevention; Quality-Adjusted Life Years; Sterilization; United States | 2015 |
Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
Topics: Anti-Infective Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Italy; Klebsiella pneumoniae; Molecular Epidemiology; Plasmids | 2015 |
Lessons learned from initial reporting of carbapenem-resistant Enterobacteriaceae in New York State hospitals, 2013-2014.
Topics: beta-Lactam Resistance; Carbapenems; Cross Infection; Data Collection; Disease Notification; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Health Personnel; Hospitals, State; Humans; Incidence; Medical Audit; National Health Programs; New York; Public Health Surveillance | 2016 |
First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Colistin; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Leukemia; Male; Molecular Sequence Data; Molecular Typing; Sequence Analysis, DNA | 2015 |
Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromatography, Affinity; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity | 2016 |
Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hospitalization; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Nursing Homes; Rhode Island; Risk Factors; Young Adult | 2016 |
Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Centers for Disease Control and Prevention, U.S.; Cluster Analysis; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitalization; Humans; Internationality; Middle Aged; Travel; United States | 2015 |
Efficacy of an Enrichment Media for Increasing Threshold for Carbapenem-Resistant Enterobacteriaceae Screening.
Topics: Anti-Bacterial Agents; Carbapenems; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2016 |
Risk Factors and Outcomes for Intestinal Carriage of AmpC-Hyperproducing Enterobacteriaceae in Intensive Care Unit Patients.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Intestines; Length of Stay; Male; Middle Aged; Retrospective Studies; Risk Factors | 2015 |
Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Microbial Sensitivity Tests; Surveys and Questionnaires | 2015 |
Carbapenem-resistant Klebsiella pneumoniae isolates from Egypt containing blaNDM-1 on IncR plasmids and its association with rmtF.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Egypt; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA | 2016 |
Identifying Patients at High Risk for Carbapenem-Resistant Enterobacteriaceae at Admission: Nurse-Led or Doctor-Led?
Topics: Carbapenems; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Humans; Infection Control; Nurses; Physicians; Sentinel Surveillance; Singapore | 2016 |
Predicting Antimicrobial Resistance Prevalence and Incidence from Indicators of Antimicrobial Use: What Is the Most Accurate Indicator for Surveillance in Intensive Care Units?
Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Intensive Care Units, Neonatal; Pseudomonas; Pseudomonas Infections; Retrospective Studies | 2015 |
KPC-Like Carbapenemase-Producing Enterobacteriaceae Colonizing Patients in Europe and Israel.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Citrobacter freundii; DNA Transposable Elements; Enterobacteriaceae Infections; Escherichia coli; Europe; Humans; Israel; Klebsiella pneumoniae; Plasmids | 2015 |
Characterization of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae from a healthcare region in Hong Kong.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Hong Kong; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Phenotype; Polymerase Chain Reaction; Porins | 2016 |
Predictors of Persistent Carbapenem-Resistant Enterobacteriaceae Carriage upon Readmission and Score Development.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Carrier State; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Hospitals, University; Humans; Israel; Male; Middle Aged; Multivariate Analysis; Patient Readmission; Retrospective Studies; Risk Factors; Young Adult | 2016 |
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Topics: Aged; beta-Lactamases; Carbapenems; Cause of Death; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Outcome Assessment, Health Care; Population Surveillance; Proportional Hazards Models | 2016 |
Development and Distribution of Educational Materials for Carbapenem-Resistant Enterobacteriaceae Among Acute and Long-term Care Facilities.
Topics: Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Health Facilities; Health Personnel; Humans; Infection Control; Long-Term Care; Needs Assessment; Population Surveillance; Surveys and Questionnaires; Wisconsin | 2015 |
Comparison of the in-house made Carba-NP and Blue-Carba tests: Considerations for better detection of carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; Bacterial Typing Techniques; Bacteriological Techniques; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors | 2016 |
Molecular characteristics of extended spectrum β-lactamase and carbapenemase genes carried by carbapenem-resistant Enterobacter cloacae in a Chinese university hospital.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Catheter-Related Infections; China; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Parenteral Nutrition; Respiration, Artificial; Retrospective Studies; Urinary Catheterization; Young Adult | 2015 |
Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors.
Topics: Aged; Antimicrobial Stewardship; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cefepime; Colombia; Cross Infection; Diagnosis-Related Groups; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2017 |
Genomic Characterization of Enterobacter cloacae Isolates from China That Coproduce KPC-3 and NDM-1 Carbapenemases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Expression; Humans; Integrons; Microbial Sensitivity Tests; Plasmids; Replicon; Survival Analysis; Tertiary Care Centers | 2016 |
Asymptomatic rectal colonization with carbapenem-resistant Enterobacteriaceae and Clostridium difficile among residents of a long-term care facility in New York City.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asymptomatic Diseases; beta-Lactam Resistance; Carbapenems; Carrier State; Clostridioides difficile; Clostridium Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Long-Term Care; Male; Middle Aged; New York City; Prevalence; Rectum; Retrospective Studies; Risk Factors; Young Adult | 2016 |
Impact of ethylene oxide gas sterilization of duodenoscopes after a carbapenem-resistant Enterobacteriaceae outbreak.
Topics: Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Bacterial; Duodenoscopes; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Ethylene Oxide; Gases; Humans; Infection Control; Sterilization | 2016 |
Association of Novel Nonsynonymous Single Nucleotide Polymorphisms in ampD with Cephalosporin Resistance and Phylogenetic Variations in ampC, ampR, ompF, and ompC in Enterobacter cloacae Isolates That Are Highly Resistant to Carbapenems.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; INDEL Mutation; Microbial Sensitivity Tests; Multilocus Sequence Typing; N-Acetylmuramoyl-L-alanine Amidase; Phylogeny; Polymorphism, Single Nucleotide; Porins; Promoter Regions, Genetic; Sequence Analysis, DNA | 2016 |
The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Turkey | 2016 |
The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit.
Topics: California; Carbapenems; Centers for Disease Control and Prevention, U.S.; Computer Simulation; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Forecasting; Health Facilities; Hospitalization; Humans; Infection Control; Models, Theoretical; Population Surveillance; Prevalence; United States | 2016 |
Can a Lack of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Rectal Carriage Help Avoid Carbapenem Prescription?
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2016 |
Risk factors associated with the transmission of carbapenem-resistant Enterobacteriaceae via contaminated duodenoscopes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bile Duct Neoplasms; Carbapenems; Carrier State; Case-Control Studies; Child; Cholangiocarcinoma; Cholangiopancreatography, Endoscopic Retrograde; Drug Resistance, Bacterial; Duodenoscopes; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Female; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Stents; Young Adult | 2016 |
Comparison of Molecular and Phenotypic Methods for the Detection and Characterization of Carbapenem Resistant Enterobacteriaceae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Saudi Arabia; Young Adult | 2016 |
Improvement of the Xpert Carba-R Kit for the Detection of Carbapenemase-Producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Humans; Plasmids; Reagent Kits, Diagnostic | 2016 |
High Prevalence of New Delhi Metallo-β-Lactamase-1 (NDM-1) Producers among Carbapenem-Resistant Enterobacteriaceae in Kuwait.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Infant; Klebsiella pneumoniae; Kuwait; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence | 2016 |
In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tetracyclines; Tigecycline | 2016 |
Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Humans; Male; Phenotype; Prospective Studies; Tertiary Care Centers; Turkey | 2016 |
Impact of Cefepime Susceptible-Dose-Dependent MIC for Enterobacteriaceae on Reporting and Prescribing.
Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Prescriptions; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2016 |
Nested Russian Doll-Like Genetic Mobility Drives Rapid Dissemination of the Carbapenem Resistance Gene blaKPC.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; DNA Transposable Elements; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Gene Transfer, Horizontal; High-Throughput Nucleotide Sequencing; Homologous Recombination; Humans; Phylogeny; Plasmids; Public Health Surveillance; Tertiary Care Centers; Virginia | 2016 |
Carbapenem-resistant Enterobacteriaceae Infections in Children: An Italian Retrospective Multicenter Study.
Topics: Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Italy; Male; Retrospective Studies | 2016 |
Rate of colonization of health care workers by carbapenem-resistant Enterobacteriaceae in an endemic hospital: A prospective study.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Health Personnel; Hospitals; Humans; Incidence; Prevalence; Prospective Studies; Surveys and Questionnaires | 2016 |
Detection and epidemiology of carbapenemase producing Enterobacteriaceae in the Netherlands in 2013-2014.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; History, 21st Century; Humans; Microbial Sensitivity Tests; Molecular Typing; Netherlands; Workflow | 2016 |
A Snapshot of Co-Resistance to Carbapenems and Tigecycline in Clinical Isolates of Enterobacter cloacae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Clone Cells; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Multidrug Resistance-Associated Proteins; Multilocus Sequence Typing; Porins; Taiwan; Tigecycline | 2017 |
Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Risk Factors; Saudi Arabia; Survival Rate; Treatment Outcome; Young Adult | 2016 |
A rare cause of infection, Raoultella planticola: emerging threat and new reservoir for carbapenem resistance.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Middle Aged; Retrospective Studies; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult | 2016 |
Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Mediastinitis; Middle Aged; Polymyxins; Retrospective Studies; Surgical Wound Infection; Survival Analysis; Thoracic Surgery | 2016 |
Retrospective case series of infections caused by carbapenem-resistant Enterobacteriaceae at a tertiary care centre in Lebanon.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lebanon; Retrospective Studies; Tertiary Care Centers | 2016 |
Molecular characterization of class b carbapenemases in advanced stage of dissemination and emergence of class d carbapenemases in Enterobacteriaceae from Croatia.
Topics: beta-Lactamases; Carbapenems; Croatia; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny | 2016 |
Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Disease Outbreaks; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Kidney Transplantation; Male; Middle Aged; Sequence Analysis, DNA; Transplant Recipients; Urinary Tract Infections; Young Adult | 2016 |
Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Retrospective Studies; Urinary Tract Infections; Urine | 2016 |
Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in U.S. Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests | 2016 |
Spread and persistence of VIM-1 Carbapenemase-producing Enterobacteriaceae in three German swine farms in 2011 and 2012.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Farms; Germany; Livestock; Plasmids; Poultry; Poultry Diseases; Retrospective Studies; Salmonella; Swine; Swine Diseases | 2017 |
Modification and evaluation of the Carba NP test by use of paper strip for simple and rapid detection of carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Assays; Humans; Imipenem; Phenotype; Polymerase Chain Reaction; Pseudomonas; Reagent Strips | 2016 |
Extended-Spectrum Beta-Lactamase Infections in Orthopedic-Related Devices and Prosthetic Joints.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Joint Prosthesis; Male; Orthopedic Fixation Devices; Prosthesis Failure; Prosthesis-Related Infections; Reoperation; Retrospective Studies; Risk Factors | 2016 |
Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Clinical Laboratory Techniques; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Hydrolysis; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Performance evaluation of three automated identification systems in detecting carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Genotype; Hospitals, University; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA | 2016 |
Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Interspersed Repetitive Sequences; Microbial Sensitivity Tests | 2016 |
Alternatives to carbapenems in ventilator-associated pneumonia due to ESBL-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated | 2016 |
Rapid Blue-Carba test: reduction in the detection time of carbapenemases performed from a 4-hour bacterial lawn.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Argentina; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Inactivation, Metabolic; Molecular Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Time Factors | 2017 |
Physiological and molecular characteristics of carbapenem resistance in Klebsiella pneumoniae and Enterobacter aerogenes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Biofilms; Brazil; Carbapenems; Cross-Sectional Studies; Disinfectants; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Oxidative Stress; Polymerase Chain Reaction; Stress, Physiological; Tertiary Care Centers; Young Adult | 2016 |
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Gene Expression; Gene Transfer, Horizontal; Greece; Humans; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Plasmids; Providencia; Quinolones; Replicon; Survival Analysis | 2016 |
Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Critical Illness; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Assessment; Risk Factors; Young Adult | 2016 |
Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; China; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome | 2016 |
Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; New York City; Prevalence; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2016 |
Identification of an NDM-5-producing Escherichia coli Sequence Type 167 in a Neonatal Patient in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Infant, Newborn; Microbial Sensitivity Tests; Plasmids; Sputum | 2016 |
Carbapenem-resistant Enterobacteriaceae on a cardiac surgery intensive care unit: successful measures for infection control.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disease Outbreaks; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Intensive Care Units; Surgical Wound Infection; Thoracic Surgery | 2016 |
[Empirical therapy of bloodstream infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae].
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitalization; Hospitals; Humans | 2016 |
Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case-control-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Cities; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Mexico; Middle Aged; Retrospective Studies; Tertiary Care Centers; Treatment Outcome | 2016 |
[Progress in Diagnostic Technology and Management of Infectious Diseases. Topics: I. Infection Diseases with Special Concern; 1. Carbapenem-resistant enterobacteriaceae].
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2014 |
Transmissible colistin resistance encoded by mcr-1 detected in clinical Enterobacteriaceae isolates in Singapore.
Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Plasmids; Singapore; Urine | 2016 |
Carbapenem-Resistant Enterobacter spp. in Retail Seafood Imported from Southeast Asia to Canada.
Topics: Asia, Southeastern; beta-Lactam Resistance; Canada; Carbapenems; Communicable Diseases, Imported; Electrophoresis, Gel, Pulsed-Field; Enterobacter; Enterobacteriaceae Infections; Food Contamination; Food Microbiology; Foodborne Diseases; Genome, Bacterial; Humans; Multilocus Sequence Typing; Seafood; Whole Genome Sequencing | 2016 |
Identification of Enterobacteriaceae and detection of carbapenemases from positive blood cultures by combination of MALDI-TOF MS and Carba NP performed after four hour subculture in Mueller Hinton.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Blood Culture; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Detection of New Delhi Metallo-Beta-Lactamase (Encoded by bla
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies | 2017 |
Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Clinical Laboratory Services; Disease Transmission, Infectious; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Microbial Sensitivity Tests; Time; United States; United States Government Agencies | 2016 |
Carbapenem-Resistant Enterobacteriaceae Transmission in Health Care Facilities - Wisconsin, February-May 2015.
Topics: Aged; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Health Facilities; Humans; Male; Middle Aged; Wisconsin | 2016 |
Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Canada; Carbapenems; Child; Child, Preschool; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gene Expression; Hospitals; Humans; Infant; Infant, Newborn; Male; Middle Aged; Multilocus Sequence Typing; Plasmids; Polymorphism, Restriction Fragment Length; Prevalence; Public Health Surveillance; Survival Analysis; Travel | 2016 |
Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: A case series.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child, Preschool; Cross Infection; Enterobacteriaceae Infections; Escherichia coli; Female; Hospitals, Pediatric; Humans; Infant; Infection Control; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Severity of Illness Index; South Africa; Survival Analysis | 2016 |
Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.
Topics: Anti-Bacterial Agents; Carbapenems; Computer Simulation; Cost of Illness; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Models, Economic; Monte Carlo Method; Risk Factors; United States | 2017 |
Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; Diarrhea; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gene Transfer, Horizontal; Humans; India; Microbial Sensitivity Tests; R Factors; Species Specificity; Vibrio | 2016 |
Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Incidence; Infection Control; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Surveys and Questionnaires; United Kingdom | 2017 |
Molecular detection of carbapenemase-producing genes in referral Enterobacteriaceae in South Africa: A short report.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; South Africa | 2016 |
Combination of Tigecycline and Levofloxacin for Successful Treatment of Nosocomial Pneumonia Caused by New Delhi Metallo-β-Lactamase-1-Producing Raoultella planticola.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Gene Expression; Humans; Levofloxacin; Male; Minocycline; Plasmids; Polymerase Chain Reaction; Sputum; Tigecycline; Treatment Outcome | 2017 |
Evaluation of the Carba NP Test in Oregon, 2013.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2017 |
A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Kidney Failure, Chronic; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Polymerase Chain Reaction; Prospective Studies; Renal Dialysis; Risk Factors; Shock, Septic; Urinary Tract Infections | 2016 |
Genetically unrelated multidrug- and carbapenem-resistant Citrobacter freundii detected in outpatients admitted to a Portuguese hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Citrobacter freundii; Disk Diffusion Antimicrobial Tests; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals; Humans; Integrons; Interspersed Repetitive Sequences; Molecular Epidemiology; Molecular Typing; Outpatients; Portugal; RNA, Ribosomal, 16S | 2017 |
A Silent Epidemic of Colistin- and Carbapenem-Resistant Enterobacteriaceae at a Turkish University Hospital.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans | 2017 |
Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacter; Enterobacter cloacae; Enterobacteriaceae Infections; Evolution, Molecular; Gene Transfer, Horizontal; Genetic Variation; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids | 2016 |
Notes from the Field: New Delhi Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacteriaceae Identified in Patients Without Known Health Care Risk Factors - Colorado, 2014-2016.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Colorado; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Middle Aged; Risk Factors; Travel; Young Adult | 2016 |
Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
Topics: Adolescent; Bacteremia; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Infant; Infant, Newborn; Male; Retrospective Studies; Risk Factors | 2017 |
Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes.
Topics: Adolescent; Adult; Aged; Carbapenems; Chi-Square Distribution; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Humans; Liver Transplantation; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Assessment; Risk Factors; Surgical Wound Infection; Time Factors; Transplant Recipients; Treatment Outcome; Young Adult | 2017 |
Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cohort Studies; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Thienamycins; Treatment Outcome | 2017 |
Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.
Topics: Adult; Aged; beta-Lactamases; Carbapenems; Cohort Studies; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Hospital Units; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Young Adult | 2017 |
Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Boston; Carbapenems; Clone Cells; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Enterobacteriaceae; Enterobacteriaceae Infections; Genetic Variation; Genome, Bacterial; Humans; Prospective Studies; R Factors; Sequence Alignment; Transformation, Bacterial | 2017 |
Suitability of Carbapenem Inactivation Method (CIM) for Detection of IMP Metallo-β-Lactamase-Producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2017 |
Outbreak of carbapenem-resistant Providencia rettgeri in a tertiary hospital.
Topics: Adult; Carbapenems; Coinfection; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Pressure Ulcer; Providencia; South Africa; Tertiary Care Centers; Urinary Tract Infections; Wound Infection | 2016 |
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study.
Topics: Animals; Carbapenems; Case-Control Studies; China; Colistin; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Healthy Volunteers; Humans; Molecular Epidemiology; Plasmids; Prevalence; Prospective Studies; Retrospective Studies; Risk Factors; Sex Factors | 2017 |
Factors associated with carriage of carbapenem-non-susceptible Enterobacteriaceaein North-Eastern France and outcomes of infected patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; Case-Control Studies; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Female; France; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors | 2017 |
High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Egypt; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gene Expression; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Morganella morganii; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia Infections; Serratia marcescens | 2017 |
OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA; United Kingdom | 2017 |
Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2017 |
Prevalence and genetic characteristics of carbapenem-resistant Enterobacteriaceae strains in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Enterobacteriaceae; Enterobacteriaceae Infections; Microbial Sensitivity Tests; Prevalence | 2017 |
Does Second Place Count? Lessons from a Major Discrepancy Between Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Enterobacter cloacae in a One-Year Follow-Up Study.
Topics: Brazil; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; Follow-Up Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Tertiary Care Centers | 2017 |
Clonality, outer-membrane proteins profile and efflux pump in KPC- producing Enterobacter sp. in Brazil.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter; Enterobacteriaceae Infections; Female; Fosfomycin; Genes, Bacterial; Hospitals; Humans; Male; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Minocycline; Polymerase Chain Reaction; Polymyxin B; Tigecycline; Young Adult | 2017 |
In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases.
Topics: Adult; Amino Acid Sequence; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Fatal Outcome; Humans; Imipenem; Liver Transplantation; Male; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Thienamycins | 2008 |
Evaluation of CHROMagar KPC for rapid detection of carbapenem-resistant Enterobacteriaceae.
Topics: Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity | 2008 |
Influence of automated screening and confirmation of extended-spectrum beta-lactamase-producing members of the Enterobacteriaceae on prescribing of antibiotics.
Topics: Adult; Aged; Anti-Bacterial Agents; Automation; beta-Lactamases; Carbapenems; Cohort Studies; Drug Prescriptions; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Retrospective Studies | 2008 |
Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Middle Aged; Missouri; Predictive Value of Tests | 2009 |
Carbapenem-resistant Enterobacteriaceae: a potential threat.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans | 2008 |
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2009 |
Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Infection Control; Population Surveillance; United States | 2009 |
Chronic bone infections due to Enterobacter cloacae: current therapeutic trends and clinical outcome.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Diseases, Infectious; Carbapenems; Chronic Disease; Ciprofloxacin; Combined Modality Therapy; Debridement; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Young Adult | 2009 |
Sepsis resulting from Enterobacter aerogenes resistant to carbapenems after liver transplantation.
Topics: Adult; Carbapenems; Drug Resistance, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Humans; Liver Abscess; Liver Transplantation; Male; Multiple Organ Failure; Postoperative Care; Shock, Septic | 2009 |
Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain).
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Gene Amplification; Genotype; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Spain | 2009 |
Failure of the MicroScan WalkAway system to detect heteroresistance to carbapenems in a patient with Enterobacter aerogenes bacteremia.
Topics: Anti-Bacterial Agents; Automation; Bacteremia; beta-Lactam Resistance; Carbapenems; Enterobacter aerogenes; Enterobacteriaceae Infections; False Negative Reactions; Humans; Microbial Sensitivity Tests | 2009 |
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
First descriptions of blaKPC in Raoultella spp. (R. planticola and R. ornithinolytica): report from the SENTRY Antimicrobial Surveillance Program.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; New Jersey; Ohio; Population Surveillance | 2009 |
Novel VIM metallo-beta-lactamase variant from clinical isolates of Enterobacteriaceae from Algeria.
Topics: Algeria; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genome, Bacterial; Hospitals, Military; Imipenem; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phenotype | 2010 |
Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem-resistant Enterobacter cloacae in China.
Topics: Aminoglycosides; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Methyltransferases; Microbial Sensitivity Tests; Plasmids; RNA, Ribosomal | 2010 |
Spread of OXA-48-encoding plasmid in Turkey and beyond.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Egypt; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids; Turkey | 2010 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence | 2010 |
Emergence of carbapenem-resistant Hafnia: the fall of the last soldier.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae Infections; Hafnia; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2010 |
Antibiotic resistance in orthopaedic surgery: acute knee prosthetic joint infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Debridement; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Knee Joint; Male; Middle Aged; Prevalence; Prosthesis-Related Infections | 2010 |
Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Detection of a common plasmid carrying blaKPC-2 in Enterobacteriaceae isolates from distinct cities in China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; China; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Hospitals, Urban; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction | 2010 |
Prevalence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Bahrain.
Topics: Adult; Aged; Anti-Bacterial Agents; Bahrain; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Urine | 2009 |
[Implication of extended-spectrum beta-lactamase enterobacteriaceae in nosocomial infections in neonates].
Topics: Anal Canal; beta-Lactamases; Carbapenems; Cross Infection; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella pneumoniae; Paris; Prospective Studies; Rectum | 2010 |
[Carbapenemases in enterobacteriaceae].
Topics: Asia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Greece; Israel; Klebsiella Infections; Klebsiella pneumoniae; Prevalence | 2010 |
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas Infections; Spain; Thienamycins | 2010 |
New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Amplification; Humans; India; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction | 2010 |
Detection of KPC-2-producing Citrobacter freundii isolates in Spain.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Citrobacter freundii; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Fatal Outcome; Humans; Male; Microbial Sensitivity Tests; Spain; Young Adult | 2010 |
[New carbapenems: should we be worried?].
Topics: beta-Lactam Resistance; Carbapenems; Enterobacteriaceae Infections; Humans | 2010 |
Comment on: role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases.
Topics: Adolescent; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Evolution, Molecular; Humans; Male; Mexico; Microbial Sensitivity Tests; Mutant Proteins | 2011 |
New Delhi metallo 1: have carbapenems met their doom?
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India | 2010 |
New Delhi metallo-ß-lactamase-1 (NDM-1): an emerging threat among Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2010 |
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Sisomicin; tRNA Methyltransferases | 2011 |
Global spread of New Delhi metallo-β-lactamase 1.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Denmark; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA | 2010 |
Global spread of New Delhi metallo-β-lactamase 1.
Topics: Anti-Bacterial Agents; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Male; Microbial Sensitivity Tests; Travel | 2010 |
Global spread of New Delhi metallo-β-lactamase 1.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2010 |
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts.
Topics: Advisory Committees; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Microbial Sensitivity Tests | 2010 |
New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactamases; Carbapenems; Child; Child, Preschool; Disease Notification; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Guidelines as Topic; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Polymerase Chain Reaction; Population Surveillance; Risk Assessment; Surveys and Questionnaires; Young Adult | 2010 |
Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans; International Cooperation; Microbial Sensitivity Tests | 2010 |
Emergence of metallo-β-lactamases in Enterobacteriaceae from Argentina.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Argentina; beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multigene Family | 2011 |
Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Citrobacter freundii; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins | 2011 |
The new medical challenge: why NDM-1? Why Indian?
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India; Microbial Sensitivity Tests | 2011 |
Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs.
Topics: Agar; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Humans; Mass Screening; Microbial Sensitivity Tests; Sensitivity and Specificity | 2011 |
Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.
Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Case-Control Studies; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Meropenem; Middle Aged; Risk Factors; Thienamycins | 2011 |
Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Chromatography, Gel; DNA Primers; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Taq Polymerase; Time Factors; Transition Temperature | 2011 |
Molecular analysis of NDM-1-producing enterobacterial isolates from Geneva, Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Hospitals, University; Humans; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; Switzerland; tRNA Methyltransferases | 2011 |
Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011.
Topics: Africa; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Notification; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; France; Greece; Humans; India; Paris; Population Surveillance; Retrospective Studies; Travel | 2011 |
Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; China; Citrobacter freundii; Cluster Analysis; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Female; Genotype; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction | 2011 |
Providencia isolates carrying bla (PER-1) and bla (VIM-2) genes: biofilm-forming capacity and biofilm inhibitory concentrations for carbapenem antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactamases; Biofilms; Carbapenems; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Providencia; Thienamycins | 2011 |
Rapid emergence of carbapenemase-producing Enterobacteriaceae isolates in Belgium.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Belgium; beta-Lactamases; Carbapenems; Communicable Diseases, Emerging; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2011 |
Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenems; Culture Media; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sensitivity and Specificity | 2011 |
Characterization and molecular epidemiology of extended spectrum beta-lactamase producing Enterobacter cloacae isolated from a Tunisian hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Infant; Male; Middle Aged; Molecular Epidemiology; Phylogeny; Plasmids; Sequence Analysis, DNA; Tunisia | 2012 |
Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Colistin; Disease Reservoirs; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Hospital Mortality; Humans; Infant; Length of Stay; Male; Michigan; Middle Aged; Minocycline; Nursing Homes; Retrospective Studies; Tigecycline; Treatment Outcome; Young Adult | 2011 |
Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxin B; Sequence Analysis, DNA; Tigecycline | 2011 |
Identification and characterization of OXA-48 producing, carbapenem-resistant Enterobacteriaceae isolates in Turkey.
Topics: Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child, Preschool; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Polymerase Chain Reaction; Turkey; Young Adult | 2011 |
Identification of bla KPC-2 on different plasmids of three Morganella morganii isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Conjugation, Genetic; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Escherichia coli; Gene Transfer, Horizontal; Genotype; Humans; Intensive Care Units; Molecular Typing; Morganella morganii; Plasmids; Sequence Analysis, DNA | 2012 |
Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Prevalence | 2012 |
Impact of adopting minimum inhibitory concentration as the determinant of susceptibility to cephalosporins and carbapenems in multi-drug resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Research Design | 2012 |
Evaluation of a commercial microarray to detect carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Oligonucleotide Array Sequence Analysis; Sensitivity and Specificity | 2011 |
Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Austria; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Female; Hospitals; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Middle Aged | 2011 |
Molecular dissection of an outbreak of carbapenem-resistant enterobacteriaceae reveals Intergenus KPC carbapenemase transmission through a promiscuous plasmid.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gene Transfer, Horizontal; Humans; Klebsiella pneumoniae; Male; Middle Aged; Phylogeny; Plasmids; Young Adult | 2011 |
Molecular diversity in mechanisms of carbapenem resistance in paediatric Enterobacteriaceae.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Pediatric; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Porins | 2012 |
Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing | 2012 |
Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011.
Topics: beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Hospitalization; Humans; India; Italy; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies | 2011 |
Dissemination of the Klebsiella pneumoniae carbapenemase in the health care settings: tracking the trails of an elusive offender.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Klebsiella pneumoniae; Male; Plasmids | 2011 |
Emergence of VIM-1-carbapenemase-producing Enterobacter cloacae in Tyrol, Austria.
Topics: Anti-Bacterial Agents; Austria; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2012 |
Environmental KPC-producing Escherichia coli isolates in Portugal.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Portugal; Rivers; Water Microbiology | 2012 |
First identification of blaIMI-1 in an Enterobacter cloacae clinical isolate from France.
Topics: Adult; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacter cloacae; Enterobacteriaceae Infections; France; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tazobactam | 2012 |
Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Gastrointestinal Tract; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests | 2012 |
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins | 2012 |
Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Cloning, Molecular; Enterobacteriaceae Infections; Escherichia coli; Humans; Hydrolysis; Kinetics; Male; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Peritonitis; Postoperative Complications; Protein Structure, Tertiary | 2012 |
NDM-1 has arrived: first report of a carbapenem resistance mechanism in South Africa.
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; South Africa; Sputum | 2011 |
Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a Providencia stuartii strain isolated in Afghanistan.
Topics: Afghanistan; beta-Lactamases; Burns; Carbapenems; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Open Reading Frames; Plasmids; Providencia; Quinolones; Real-Time Polymerase Chain Reaction | 2012 |
"Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cohort Studies; Coinfection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
[Frequency of enzymes associated with reduced sensitivity to beta-lactam antibiotics in enterobacteria isolates, Caracas, Venezuela].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Hospitals, Urban; Humans; Microbial Sensitivity Tests; Phenotype; Substrate Specificity; Venezuela | 2011 |
Use of a new screening medium to detect carbapenem-non-susceptible members of the Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Mass Screening; Microbial Sensitivity Tests | 2012 |
Resistance of enterobacteria to carbapenem antibiotics is a global crisis.
Topics: Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Humans; Male; Middle Aged | 2012 |
NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Oman | 2012 |
Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Female; Humans; Immunosuppressive Agents; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Survival Rate; Young Adult | 2012 |
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cohort Studies; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Michigan; Middle Aged; Minocycline; Retrospective Studies; Severity of Illness Index; Survival Analysis; Tigecycline; Treatment Outcome | 2012 |
Comparative evaluation of a prototype chromogenic medium (ChromID CARBA) for detecting carbapenemase-producing Enterobacteriaceae in surveillance rectal swabs.
Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenems; Culture Media; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Klebsiella pneumoniae; Mass Screening; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Rectum; Sensitivity and Specificity | 2012 |
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Risk Factors; Singapore; Treatment Outcome; Young Adult | 2012 |
Carbapenemase-producing Enterobacteriaceae: a call for action!
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans | 2012 |
Emergence of carbapenem-resistant Enterobacteriaceae isolates in the Moroccan community.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Microbial Sensitivity Tests; Morocco | 2012 |
Nosocomial occurrence of OXA-48-producing enterobacterial isolates in a Moroccan hospital.
Topics: Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Hospitals, University; Humans; Klebsiella oxytoca; Klebsiella pneumoniae; Middle Aged; Morocco | 2012 |
Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biomarkers; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; Enterobacteriaceae Infections; Female; Humans; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Providencia | 2012 |
Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Israel; Male; Middle Aged; Rectum; Risk Factors | 2013 |
Urinary tract infection caused by carbapenem-resistant K. pneumoniae and P. aeruginosa.
Topics: Aged; Anastomosis, Surgical; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Nephrolithiasis; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms; Urinary Tract Infections | 2011 |
The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lebanon; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence | 2012 |
Porin alterations present in non-carbapenemase-producing Enterobacteriaceae with high and intermediate levels of carbapenem resistance in Chile.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chile; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Porins | 2012 |
Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Plasmids; Porins; Portugal; Sequence Analysis, DNA | 2012 |
Emergence of VIM-4- and SHV-12-producing Enterobacter cloacae in a neonatal intensive care unit.
Topics: beta-Lactamases; Carbapenems; Ceftazidime; Deoxyribonucleases, Type II Site-Specific; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Environmental Microbiology; Female; Genes, Bacterial; Gestational Age; Humans; Hungary; Infant, Newborn; Integrons; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests | 2012 |
The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Population Surveillance; Risk Factors; South Africa | 2012 |
Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Linear Models; Meropenem; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Taiwan; Thienamycins | 2012 |
Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitalization; Humans; Intraabdominal Infections; Liver Diseases; Longitudinal Studies; Microbial Sensitivity Tests; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Taiwan; Time Factors | 2012 |
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies | 2012 |
Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Risk Factors | 2012 |
Use of meropenem Adatabs dissolved in MacConkey agar for screening NDM-1 positive Enterobacteriaceae in faecal surveillance cultures.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Culture Media; Drug Stability; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Thienamycins | 2012 |
Characterization of carbapenemase genes in Enterobacteriaceae species exhibiting decreased susceptibility to carbapenems in a university hospital in Chongqing, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; DNA Fingerprinting; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Hospitals, University; Humans; Microbial Sensitivity Tests; Sequence Analysis, DNA | 2012 |
United States Centers for Disease Control and Prevention issue updated guidance for tackling carbapenem-resistant enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Centers for Disease Control and Prevention, U.S.; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Practice Guidelines as Topic; United States | 2012 |
Detection of blaKPC-2 in a carbapenem-resistant Kluyvera georgiana.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Enterobacteriaceae Infections; Humans; Kluyvera; Microbial Sensitivity Tests; Sequence Analysis, DNA | 2012 |
Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.
Topics: Aged; Antibiotic Prophylaxis; beta-Lactam Resistance; Carbapenems; Carrier State; Community-Acquired Infections; Cross Infection; Enterobacteriaceae Infections; Escherichia coli Infections; Female; France; Humans; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Prevalence; Prospective Studies; Risk Factors | 2012 |
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Young Adult | 2013 |
Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Tunisia | 2012 |
Rapid detection of carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrolysis; Sensitivity and Specificity | 2012 |
Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2012 |
The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients.
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Decision Support Techniques; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Predictive Value of Tests | 2013 |
Bloodstream infections caused by IMP-8-producing Enterobacteriaceae isolates: the need for clinical laboratory detection of metallo-β-lactamases?
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Taiwan | 2013 |
Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2013 |
Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome | 2013 |
Environmental contamination by carbapenem-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Shedding; Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Environmental Microbiology; Humans; Time Factors | 2013 |
Detection of the plasmid-mediated KPC-2 carbapenem-hydrolysing enzyme in three unusual species of the Enterobacteriaceae family in Israel.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrolysis; Israel; Microbial Sensitivity Tests; Plasmids | 2013 |
The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefmetazole; Culture Media; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Pyelonephritis; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Urine | 2013 |
Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Lebanon; Microbial Sensitivity Tests; Plasmids; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA; Tertiary Care Centers | 2013 |
Comparison of the SUPERCARBA, CHROMagar KPC, and Brilliance CRE screening media for detection of Enterobacteriaceae with reduced susceptibility to carbapenems.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2013 |
Detection of the carbapenemase GIM-1 in Enterobacter cloacae in Germany.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; Enterobacter cloacae; Enterobacteriaceae Infections; Germany; Humans; Male; Microbial Sensitivity Tests; Molecular Typing; Plasmids; Polymerase Chain Reaction; Pseudomonas aeruginosa; Sequence Analysis, DNA; Transformation, Genetic | 2013 |
First report of blaNDM-1 in Raoultella ornithinolytica.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Male; Minocycline; Molecular Sequence Data; Tigecycline | 2013 |
Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Treatment Outcome | 2014 |
Characterization of carbapenemases, extended spectrum β-lactamases and molecular epidemiology of carbapenem-non-susceptible Enterobacter cloacae in a Chinese hospital in Chongqing.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cluster Analysis; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2013 |
Temocillin and meropenem to discriminate resistance mechanisms leading to decreased carbapenem susceptibility with focus on OXA-48 in Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillins; Thienamycins | 2013 |
Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp.
Topics: beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Humans; Microbial Sensitivity Tests; Phenotype; Plasmids; RNA, Ribosomal, 16S | 2004 |
Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Citrobacter freundii; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Prevalence; Serratia marcescens; Thienamycins | 2005 |
First detection of a carbapenem-hydrolyzing metalloenzyme in two enterobacteriaceae isolates in Spain.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; Enterobacteriaceae Infections; Escherichia coli; Humans; Integrons; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Spain | 2005 |
Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome | 2005 |
Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Ceftazidime; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Rate; Taiwan; Treatment Outcome | 2006 |
Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Microbial Sensitivity Tests | 2006 |
Characterization of In3Mor, a new integron carrying VIM-1 metallo-beta-lactamase and sat1 gene, from Morganella morganii.
Topics: Aged; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Genes, Bacterial; Greece; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Morganella morganii; Reverse Transcriptase Polymerase Chain Reaction; Streptothricins | 2007 |
First detection of a VIM-1 metallo-beta-lactamase in a carbapenem-resistant Citrobacter freundii clinical isolate in an acute hospital in Germany.
Topics: Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cilastatin; Ciprofloxacin; Citrobacter freundii; Enterobacteriaceae Infections; Female; Germany; Humans; Imipenem; Polymerase Chain Reaction | 2007 |
[Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae].
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Plasmids | 2008 |
Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Citrobacter freundii; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Restriction Mapping | 2008 |
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate | 2000 |
Nosocomial bloodstream infections in a Turkish university hospital: study of Gram-negative bacilli and their sensitivity patterns.
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; In Vitro Techniques; Turkey | 2001 |
Long-Term outcome of neonatal Citrobacter koseri (diversus) meningitis treated with imipenem/meropenem and surgical drainage.
Topics: Carbapenems; Cefotaxime; Cephalosporins; Citrobacter; Combined Modality Therapy; Drainage; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Meningitis, Bacterial; Prognosis; Treatment Outcome | 2001 |
Cloning and sequencing of Enterobacter aerogenes OmpC-type osmoporin linked to carbapenem resistance.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; Carbapenems; Disease Outbreaks; Enterobacter aerogenes; Enterobacteriaceae Infections; Humans; Intensive Care Units; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Porins; Sequence Homology, Amino Acid | 2002 |
Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
Topics: Bacteria; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Positive Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1989 |
Neurotoxicity of beta-lactam antibiotics. Experimental kinetic and neurophysiological studies.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Carbapenems; Cilastatin; Drug Interactions; Electroencephalography; Enterobacteriaceae Infections; Female; Hippocampus; Imipenem; Male; Meningitis; Penicillin G; Rabbits; Rats; Rats, Inbred Strains; Seizures; Thiopental; Tissue Distribution; Uremia | 1988 |